General Information of Drug (ID: DMXZ84M)

Drug Name
Malathion Drug Info
Synonyms
Calmathion; Camathion; Carbafos; Carbetovur; Carbetox; Carbofos; Carbophos; Celthion; Chemathion; Cimexan; Cleensheen; Cythion; Dorthion; Emmatos; Ethiolacar; Etiol; Extermathion; Flair; Forthion; Fosfothion; Fosfotion; Fyfanon; Hilthion; Karbofos; Kypfos; Malacide; Malafor; Malagran; Malakill; Malamar; Malaphele; Malaphos; Malasol; Malaspray; Malataf; Malathiazol; Malathione; Malathiozoo; Malathon; Malathyl; Malation; Malatol; Malatox; Maldison; Malmed; Malphos; Maltox; Mercaptothion; Mercaptotion; Moscarda; Oleophosphothion; Organoderm; Ovide; Paladin; Phosphothion; Prioderm; Sadofos; Sadophos; Sumitox; TAK; Taskil; Vetiol; Zithiol; Carbethoxy malathion; Detm ol ma; Detmol MA; Emmatos extra; Lice Rid;Malathion LV Concentrate; Malathion [USP]; Malation [Polish]; Maltox MLT; Mercaptosuccinic acid diethyl ester; Mercaptotion [Spanish]; Ortho Malathion; Siptox I; Vegfru malatox; AC 26691; EL 4049; Experimental insecticide 4049; Fog 3; Fosfotion 550; Hilthion 25wdp; IFO 13140; Latka 4049; Latka 4049 [Czech]; MET86C_SUPELCO; Malamar 50; Malathion 60; Malathion E50; OMS 1; PS86_SUPELCO; SF 60; Sadofos 30; American cyanamid 4,049; Derbac-M; ENT 17,034; Four thousand forty-nine; Insecticide no. 4049; Kop-Thionkypfosmalacide; Kop-thion; Malathion (USP); Malathion (old ID); Ovide (TN); Staeubol-Puder; Suleo-M; TM-4049; Kill-A-Mite; MALATHION, 96%; Malathion-2,3-14C; 8059HC
Indication
Disease Entry ICD 11 Status REF
Pediculus capitis infestation 1G00.0 Approved [1]
Therapeutic Class
Parasympathomimetics
Cross-matching ID
PubChem CID
4004
ChEBI ID
CHEBI:6651
CAS Number
CAS 121-75-5
TTD Drug ID
DMXZ84M
INTEDE Drug ID
DR1000
ACDINA Drug ID
D01234

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
DME
DOT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Patented Agent(s)
Investigative Drug(s)
Preclinical Drug(s)
Discontinued Drug(s)
Drug(s) Targeting Acetylcholinesterase (AChE)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tacrine DM51FY6 Alzheimer disease 8A20 Approved [6]
Donepezil DMIYG7Z Advanced cancer 2A00-2F9Z Approved [7]
Galantamine DMEO794 Alzheimer disease 8A20 Approved [8]
Huperzine A DMMAWLU Alzheimer disease 8A20 Approved [9]
Neostigmine DM6T2J3 Myasthenia gravis 8C6Y Approved [10]
YM443 DMNZCI1 Functional dyspepsia DD90.3 Approved [11]
Ambenonium DMOP0BL Myasthenia gravis 8C6Y Approved [12]
Demecarium bromide DMAYEU1 Open-angle glaucoma 9C61 Approved [13]
Isoflurophate DMBSK7X Glaucoma/ocular hypertension 9C61 Approved [14]
Pyridostigmine DM8HO1L Myasthenia gravis 8C6Y Approved [15]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Metabolized By Cytochrome P450 1A2 (CYP1A2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [16]
Dinoprostone DMTYOPD Medical abortion JA00.1Z Approved [17]
Tamoxifen DMLB0EZ Breast cancer 2C60-2C65 Approved [18]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [19]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [20]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [21]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [22]
Oxaliplatin DMQNWRD Adenocarcinoma 2D40 Approved [23]
Verapamil DMA7PEW Angina pectoris BA40 Approved [24]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [25]
Zolmitriptan DM1IB4Q Migraine 8A80 Approved [36]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [36]
Etoricoxib DM6A4NW Rheumatoid arthritis FA20 Approved [36]
Capsaicin DMGMF6V Back pain ME84.Z Approved [37]
Hesperetin DMKER83 High blood cholesterol level 5C80.00 Approved [38]
Stiripentol DMMSDOY Dravet syndrome 8A61.11 Approved [39]
Nifedipine DMSVOZT Angina pectoris BA40 Approved [40]
Zileuton DMVRIC2 Allergic asthma CA23.0 Approved [41]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [42]
Clonidine DM6RZ9Q Attention deficit hyperactivity disorder 6A05.Z Approved [43]
⏷ Show the Full List of 20 Drug(s)
Drug(s) Metabolized By Cytochrome P450 2B6 (CYP2B6)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tamoxifen DMLB0EZ Breast cancer 2C60-2C65 Approved [26]
Verapamil DMA7PEW Angina pectoris BA40 Approved [27]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [28]
Estrone DM5T6US Acne vulgaris ED80 Approved [29]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [30]
Irinotecan DMP6SC2 Adenocarcinoma 2D40 Approved [31]
Propofol DMB4OLE Anaesthesia 9A78.6 Approved [32]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [33]
Phenytoin DMNOKBV Epilepsy 8A60-8A68 Approved [34]
Amitriptyline DMK7F9S Depression 6A70-6A7Z Approved [35]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [44]
Ritonavir DMU764S Human immunodeficiency virus infection 1C62 Approved [45]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [46]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [47]
Phenytoin DMNOKBV Epilepsy 8A60-8A68 Approved [48]
Clopidogrel DMOL54H Acute coronary syndrome BA41 Approved [49]
Artemisinin DMOY7W3 Malaria 1F40-1F45 Approved [50]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [51]
Permethrin DMZ0Q1G Pediculus capitis infestation 1G00.0 Approved [52]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [53]
⏷ Show the Full List of 20 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [54]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [55]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [56]
Methotrexate DM2TEOL Anterior urethra cancer Approved [57]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [59]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Testosterone DM7HUNW Hot flushes GA30 Approved [61]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [61]
Leflunomide DMR8ONJ Arthritis FA20 Approved [62]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [63]
Spironolactone DM2AQ5N Chronic heart failure BD1Z Approved [64]
Etretinate DM2CZFA Keratosis ED56 Approved [65]
Prednisone DM2HG4X Acute asthma CA23 Approved [66]
Methotrexate DM2TEOL Anterior urethra cancer Approved [67]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [68]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [69]
Fructose DM43AN2 Vomiting MD90 Approved [70]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [71]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [54]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [59]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [72]
Testosterone DM7HUNW Hot flushes GA30 Approved [61]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [61]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [74]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [75]
Dasatinib DMJV2EK Blast phase chronic myelogenous leukemia, BCR-ABL1 positive Approved [76]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Centromere protein F (CENPF)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [77]
Methotrexate DM2TEOL Anterior urethra cancer Approved [57]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [59]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Testosterone DM7HUNW Hot flushes GA30 Approved [61]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [61]
Leflunomide DMR8ONJ Arthritis FA20 Approved [62]
Lovastatin DM9OZWQ Arteriosclerosis BD40 Approved [79]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Meclofenamic acid DM05FXR Ankylosing spondylitis FA92.0 Approved [80]
Diazepam DM08E9O Alcohol withdrawal Approved [81]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [82]
Salicyclic acid DM2F8XZ Acne vulgaris ED80 Approved [83]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [80]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [84]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [80]
Liothyronine DM6IR3P Congenital hypothyroidism Approved [85]
Testosterone DM7HUNW Hot flushes GA30 Approved [86]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Progesterone DMUY35B Amenorrhea GA20.0 Approved [87]
Meclofenamic acid DM05FXR Ankylosing spondylitis FA92.0 Approved [80]
Diazepam DM08E9O Alcohol withdrawal Approved [81]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [88]
Salicyclic acid DM2F8XZ Acne vulgaris ED80 Approved [80]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [80]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [89]
Glimepiride DM5FSJA Diabetic complication 5A2Y Approved [90]
Ethacrynic acid DM60QMR Edema MG29 Approved [88]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [80]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cholinesterase (BCHE)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cocaine DMSOX7I Anaesthesia 9A78.6 Approved [91]
Tacrine DM51FY6 Alzheimer disease 8A20 Approved [92]
Galantamine DMEO794 Alzheimer disease 8A20 Approved [93]
Rivastigmine DMG629M Alzheimer disease 8A20 Approved [94]
Donepezil DMIYG7Z Advanced cancer 2A00-2F9Z Approved [43]
Succinylcholine DM2ET1M Plasma cell myeloma 2A83.1 Approved [95]
Ethopropazine DM0N3L7 Parkinson disease 8A00.0 Approved [92]
Dimenhydrinate DM264B3 Meniere disease AB31.0 Approved [96]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [97]
Chlorpheniramine DM5URA2 Allergic rhinitis CA08.0 Approved [96]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [54]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [55]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [98]
Methotrexate DM2TEOL Anterior urethra cancer Approved [57]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [59]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [99]
Testosterone DM7HUNW Hot flushes GA30 Approved [61]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [61]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Acetylcholinesterase (ACHE)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Acetylcholine DMDF79Z Cataract 9B10 Approved [100]
Imipramine DM2NUH3 Depression 6A70-6A7Z Approved [101]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [102]
Methotrexate DM2TEOL Anterior urethra cancer Approved [103]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [104]
L-Glutamic Acid DM4PUDW Schizophrenia 6A20 Approved [102]
Tacrine DM51FY6 Alzheimer disease 8A20 Approved [105]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [106]
Neostigmine DM6T2J3 Myasthenia gravis 8C6Y Approved [107]
Testosterone DM7HUNW Hot flushes GA30 Approved [86]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cytochrome P450 2C9 (CYP2C9)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [108]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [109]
Dapsone DM4LT8A Acne vulgaris ED80 Approved [110]
Voriconazole DMAOL2S Aspergillosis 1F20 Approved [111]
Capsaicin DMGMF6V Back pain ME84.Z Approved [37]
Zafirlukast DMHNQOG Asthma CA23 Approved [112]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [110]
Eicosapentaenoic acid/docosa-hexaenoic acid DMMUCG4 Hypertriglyceridemia 5C80.1 Approved [113]
Fluconazole DMOWZ6B Cryptococcal meningitis Approved [111]
Quinine DMSWYF5 Malaria 1F40-1F45 Approved [110]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cytochrome P450 3A4 (CYP3A4)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Eplerenone DMF0NQR Heart failure BD10-BD13 Approved [114]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [108]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [115]
Voriconazole DMAOL2S Aspergillosis 1F20 Approved [111]
Proguanil DMBL79I Malaria 1F40-1F45 Approved [110]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [110]
Loratadine DMF3AN7 Allergy 4A80-4A85 Approved [116]
Nelfinavir mesylate DMFX6G8 N. A. N. A. Approved [117]
Capsaicin DMGMF6V Back pain ME84.Z Approved [118]
Axitinib DMGVH6N Renal cell carcinoma 2C90 Approved [119]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cytochrome P450 2A6 (CYP2A6)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tegafur DM31ZQM Solid tumour/cancer 2A00-2F9Z Approved [120]
Methoxsalen DME8FZ9 Cutaneous T-cell lymphoma 2B01 Approved [121]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [122]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [123]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [124]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [125]
Ifosfamide DMCT3I8 Adult central nervous system germ cell tumor Approved [126]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [127]
Letrozole DMH07Y3 Estrogen-receptor positive breast cancer Approved [128]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [129]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [130]
Quercetin DM3NC4M Obesity 5B81 Approved [131]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [132]
Artemether DM48QOT Malaria 1F40-1F45 Approved [133]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [134]
Nefazodone DM4ZS8M Major depressive disorder 6A70.3 Approved [135]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [136]
Estrone DM5T6US Acne vulgaris ED80 Approved [137]
Leflunomide DMR8ONJ Arthritis FA20 Approved [138]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cytochrome P450 2E1 (CYP2E1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fomepizole DM6VOWQ Athylene glycol or methanol poisoning NE61 Approved [139]
Ademetionine DMYQDBO Hepatic fibrosis DB93.0 Approved [140]
Theophylline DMRJFN9 Bronchitis CA20 Approved [43]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [141]
Ethanol DMDRQZU Chronic pain MG30 Approved [142]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [124]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [143]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Didanosine DMI2QPE Human immunodeficiency virus infection 1C62 Approved [43]
Thioridazine DM35M8J Schizophrenia 6A20 Approved [145]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Catalase (CAT)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [146]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [147]
Haloperidol DM96SE0 Delirium Approved [43]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [148]
Selenium DM25CGV N. A. N. A. Approved [149]
Methimazole DM25FL8 Hyperthyroidism 5A02 Approved [150]
Citalopram DM2G9AE Acute coronary syndrome BA41 Approved [151]
Methotrexate DM2TEOL Anterior urethra cancer Approved [152]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [153]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [54]
Mechlorethamine DM0CVXA Chronic myelogenous leukaemia 2A20.0 Approved [154]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [155]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [77]
Selenium DM25CGV N. A. N. A. Approved [156]
Etretinate DM2CZFA Keratosis ED56 Approved [157]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [158]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [159]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [160]
Methotrexate DM2TEOL Anterior urethra cancer Approved [57]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cyclin-A2 (CCNA2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [161]
Mechlorethamine DM0CVXA Chronic myelogenous leukaemia 2A20.0 Approved [154]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [162]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [82]
Ribavirin DMEYLH9 Hepatitis C virus infection 1E51.1 Approved [163]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [164]
Methotrexate DM2TEOL Anterior urethra cancer Approved [57]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [89]
Lapatinib DM3BH1Y Breast cancer 2C60-2C65 Approved [165]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [166]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [167]
Ribavirin DMEYLH9 Hepatitis C virus infection 1E51.1 Approved [163]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [158]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [164]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Fluoxetine DM3PD2C Bipolar depression Approved [168]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [169]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [170]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [171]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Caspase-3 (CASP3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sevoflurane DMC9O43 Anaesthesia 9A78.6 Approved [172]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [173]
Lovastatin DM9OZWQ Arteriosclerosis BD40 Approved [174]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [175]
Docetaxel DMDI269 Advanced cancer 2A00-2F9Z Approved [176]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [177]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [178]
Mannitol DMSCDY9 Bronchiectasis CA24 Approved [179]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [180]
Aprepitant DM053KT Depression 6A70-6A7Z Approved [181]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Caspase-9 (CASP9)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Lovastatin DM9OZWQ Arteriosclerosis BD40 Approved [182]
Mannitol DMSCDY9 Bronchiectasis CA24 Approved [183]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [166]
Mechlorethamine DM0CVXA Chronic myelogenous leukaemia 2A20.0 Approved [184]
Leuprorelin acetate DM15HAT Prostate cancer 2C82.0 Approved [185]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [186]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [187]
Meloxicam DM2AR7L Arthritis FA20 Approved [188]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [189]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [190]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Apoptosis regulator BAX (BAX)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sevoflurane DMC9O43 Anaesthesia 9A78.6 Approved [191]
Aprepitant DM053KT Depression 6A70-6A7Z Approved [181]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [166]
Verapamil DMA7PEW Angina pectoris BA40 Approved [192]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [193]
Leuprorelin acetate DM15HAT Prostate cancer 2C82.0 Approved [185]
Talazoparib DM1KS78 Breast cancer 2C60-2C65 Approved [194]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [98]
Meloxicam DM2AR7L Arthritis FA20 Approved [195]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [158]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Shootin-1 (SHTN1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [196]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [197]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [75]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [199]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
Permethrin DMZ0Q1G Pediculus capitis infestation 1G00.0 Approved [4]
Vinblastine DM5TVS3 Advanced cancer 2A00-2F9Z Approved [201]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [202]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [203]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Ethanol DMDRQZU Chronic pain MG30 Approved [204]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [205]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [206]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [206]
Arsenic DMTL2Y1 N. A. N. A. Approved [207]
Permethrin DMZ0Q1G Pediculus capitis infestation 1G00.0 Approved [4]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [208]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Testosterone DM7HUNW Hot flushes GA30 Approved [61]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [61]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Azathioprine DMMZSXQ Lupus nephritis 4A40.0Y Approved [210]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [211]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
Cytarabine DMZD5QR Acute lymphoblastic leukaemia 2A85 Approved [212]
Urethane DM7NSI0 N. A. N. A. Phase 4 [213]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Panobinostat DM58WKG Chronic graft versus host disease Approved [214]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [215]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [216]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [208]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [214]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [217]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [218]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [208]
Urethane DM7NSI0 N. A. N. A. Phase 4 [213]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [217]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [219]
Drug(s) Affected By Calpain-8 (CAPN8)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [220]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [216]
Permethrin DMZ0Q1G Pediculus capitis infestation 1G00.0 Approved [4]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [221]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
⏷ Show the Full List of 6 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [222]
Leflunomide DMR8ONJ Arthritis FA20 Approved [62]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [223]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Ethanol DMDRQZU Chronic pain MG30 Approved [224]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [225]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [226]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [227]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [228]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic DMTL2Y1 N. A. N. A. Approved [207]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Folic Acid DMEMBJC Colorectal carcinoma Approved [229]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [230]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Drug(s) Affected By Protein shisa-9 (SHISA9)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [231]
Arsenic DMTL2Y1 N. A. N. A. Approved [207]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [232]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Leflunomide DMR8ONJ Arthritis FA20 Approved [62]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [233]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [234]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [225]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [208]
APR-246 DMNFADH Ovarian cancer 2C73 Phase 2 [235]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
⏷ Show the Full List of 7 Drug(s)
Drug(s) Affected By Homeobox protein Meis1 (MEIS1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [193]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Vitamin A DMJ2AH4 Night blindness 9D45 Approved [193]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [230]
Alitretinoin DMME8LH Kaposi sarcoma 2B57 Approved [193]
Arsenic DMTL2Y1 N. A. N. A. Approved [207]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [216]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [225]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Nuclear factor 1 B-type (NFIB)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [222]
Panobinostat DM58WKG Chronic graft versus host disease Approved [214]
Leflunomide DMR8ONJ Arthritis FA20 Approved [62]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [237]
Arsenic DMTL2Y1 N. A. N. A. Approved [238]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [199]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [239]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [240]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [77]
Methotrexate DM2TEOL Anterior urethra cancer Approved [103]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [241]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [242]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [71]
Fedratinib DM4ZBK6 Myelofibrosis 2A20.2 Approved [243]
Panobinostat DM58WKG Chronic graft versus host disease Approved [214]
Pyrimethamine DM5X7VY Malaria 1F40-1F45 Approved [243]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [242]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [152]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [222]
Testosterone DM7HUNW Hot flushes GA30 Approved [61]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [244]
Tofacitinib DMBS370 Rheumatoid arthritis FA20 Approved [245]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [228]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [246]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [246]
Urethane DM7NSI0 N. A. N. A. Phase 4 [213]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [247]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [248]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [234]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [249]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [250]
DTI-015 DMXZRW0 Brain cancer 2A00 Approved [251]
Tamibarotene DM3G74J T-cell leukaemia 2A90 Phase 3 [247]
Curcumin DMQPH29 Solid tumour/cancer 2A00-2F9Z Phase 3 [252]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [233]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Arsenic DMTL2Y1 N. A. N. A. Approved [207]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [253]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [254]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [218]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Calcidiol DMN4CV5 Hypophosphatemia Approved [255]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Sulfasalazine DMICA9H Irritable bowel syndrome DD91.0 Approved [256]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [230]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [257]
Melphalan DMOLNHF Hematologic disease 3C0Z Approved [258]
Arsenic DMTL2Y1 N. A. N. A. Approved [259]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [260]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Retinoschisin (RS1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Paclitaxel DMLB81S Breast carcinoma Approved [261]
Ximelegatran DMU8ANS Myocardial infarction BA41-BA43 Approved [261]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [262]
Drug Name Drug ID Indication ICD 11 Highest Status REF
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [263]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [59]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [244]
Leflunomide DMR8ONJ Arthritis FA20 Approved [62]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [228]
Fenofibrate DMFKXDY Coronary atherosclerosis Approved [264]
Mifepristone DMGZQEF Cushing disease 5A70 Approved [265]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Aquaporin-9 (AQP9)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [264]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [266]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [228]
Fenofibrate DMFKXDY Coronary atherosclerosis Approved [264]
Cholecalciferol DMGU74E Adult acute monocytic leukemia Approved [267]
Azacitidine DMTA5OE Acute myelogenous leukaemia 2A41 Approved [268]
Arsenic DMTL2Y1 N. A. N. A. Approved [269]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [199]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [266]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [270]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [271]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [75]
Enzalutamide DMGL19D Prostate cancer 2C82.0 Approved [272]
Melphalan DMOLNHF Hematologic disease 3C0Z Approved [258]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [222]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [273]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [199]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [73]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [226]
Urethane DM7NSI0 N. A. N. A. Phase 4 [213]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Perilipin-1 (PLIN1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Testosterone DM7HUNW Hot flushes GA30 Approved [86]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Fenofibrate DMFKXDY Coronary atherosclerosis Approved [264]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [264]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [274]
Arsenic DMTL2Y1 N. A. N. A. Approved [275]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [276]
OLEIC ACID DM54O1Z Discovery agent N.A. Investigative [277]
acetaldehyde DMJFKG4 Discovery agent N.A. Investigative [278]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [222]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Permethrin DMZ0Q1G Pediculus capitis infestation 1G00.0 Approved [4]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [73]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [219]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [218]
⏷ Show the Full List of 7 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [279]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [280]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [281]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [282]
Octanal DMTN0OK N. A. N. A. Investigative [283]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [234]
Urethane DM7NSI0 N. A. N. A. Phase 4 [213]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [284]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [217]
chloropicrin DMSGBQA Discovery agent N.A. Investigative [285]
⏷ Show the Full List of 7 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [219]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [205]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [230]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [234]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [221]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [217]
acetaldehyde DMJFKG4 Discovery agent N.A. Investigative [278]
⏷ Show the Full List of 6 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [220]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [228]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [230]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [234]
Arsenic DMTL2Y1 N. A. N. A. Approved [207]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [199]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [202]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [286]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [226]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [75]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [248]
3R14S-OCHRATOXIN A DM2KEW6 Discovery agent N.A. Investigative [287]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [219]
⏷ Show the Full List of 7 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [288]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [217]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [67]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [222]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [289]
Testosterone DM7HUNW Hot flushes GA30 Approved [61]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [61]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Clozapine DMFC71L Schizophrenia 6A20 Approved [290]
Menthol DMG2KW7 Back pain ME84.Z Approved [291]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [205]
Arsenic DMTL2Y1 N. A. N. A. Approved [292]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Netrin-1 (NTN1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [205]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [234]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [216]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [208]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [217]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [218]
BADGE DMCK5DG Discovery agent N.A. Investigative [293]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [219]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [279]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [294]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [74]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [274]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [295]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [296]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [219]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Dactinomycin DM2YGNW Adult kidney Wilms tumor Approved [297]
Methotrexate DM2TEOL Anterior urethra cancer Approved [103]
Quercetin DM3NC4M Obesity 5B81 Approved [298]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [59]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [297]
Panobinostat DM58WKG Chronic graft versus host disease Approved [214]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [299]
Leflunomide DMR8ONJ Arthritis FA20 Approved [62]
Atorvastatin DMF28YC Acute coronary syndrome BA41 Approved [300]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Complement factor B (CFB)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [59]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [301]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [302]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [264]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [205]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [230]
Danazol DML8KTN Menorrhagia GA20.50 Approved [303]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By GTPase HRas (HRAS)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [304]
Selenium DM25CGV N. A. N. A. Approved [305]
Deoxycholic acid DM3GYAL Subcutaneous fat disorder EF02 Approved [306]
Quercetin DM3NC4M Obesity 5B81 Approved [307]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [263]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [308]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [309]
Lovastatin DM9OZWQ Arteriosclerosis BD40 Approved [310]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [223]
Sevoflurane DMC9O43 Anaesthesia 9A78.6 Approved [311]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Tumor necrosis factor (TNF)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Indomethacin DMSC4A7 Bursitis Approved [312]
Amphotericin B DMTAJQE Acne vulgaris ED80 Approved [313]
Fructose DM43AN2 Vomiting MD90 Approved [43]
Ketoprofen DMRKXPT Bursitis Approved [43]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [314]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [315]
Baclofen DM0QV1J Multiple sclerosis 8A40 Approved [316]
Gefitinib DM15F0X Colon adenocarcinoma Approved [317]
Ganciclovir DM1MBYQ Cytomegalovirus infection 1D82 Approved [318]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [319]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Interferon alpha-2 (IFNA2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [320]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [216]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [320]
PF-3758309 DM36PKZ Solid tumour/cancer 2A00-2F9Z Phase 1 [321]
BIX-01294 DM5CBNY Breast cancer 2C60-2C65 Preclinical [322]
UNC0638 DM4A1KJ Discovery agent N.A. Investigative [322]
⏷ Show the Full List of 6 Drug(s)
Drug(s) Affected By Interleukin-1 alpha (IL1A)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [166]
Primidone DM0WX6I Epilepsy 8A60-8A68 Approved [323]
Fexofenadine DM17ONX Allergic rhinitis CA08.0 Approved [323]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [319]
Clavulanate DM2FGRT Bacteremia 1A73 Approved [323]
Methotrexate DM2TEOL Anterior urethra cancer Approved [152]
Quercetin DM3NC4M Obesity 5B81 Approved [324]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [323]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [325]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Interleukin-1 beta (IL1B)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [326]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [327]
Gefitinib DM15F0X Colon adenocarcinoma Approved [328]
Fexofenadine DM17ONX Allergic rhinitis CA08.0 Approved [323]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [146]
Lumiracoxib DM1S4AG Chronic renal failure GB61.Z Approved [323]
Imiquimod DM1TMA3 Alopecia areata ED70.2 Approved [329]
Selenium DM25CGV N. A. N. A. Approved [330]
Ribavirin DMEYLH9 Hepatitis C virus infection 1E51.1 Approved [331]
Spironolactone DM2AQ5N Chronic heart failure BD1Z Approved [332]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [333]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [71]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [71]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [334]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [335]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [75]
Folic Acid DMEMBJC Colorectal carcinoma Approved [336]
Alitretinoin DMME8LH Kaposi sarcoma 2B57 Approved [71]
Bexarotene DMOBIKY Cutaneous T-cell lymphoma 2B01 Approved [337]
Methamphetamine DMPM4SK Anxiety Approved [338]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Fibrinogen gamma chain (FGG)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [82]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [339]
LY2835219 DM93VBZ Breast cancer 2C60-2C65 Approved [340]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Ursodeoxycholic acid DMCUT21 Cholelithiasis DC11 Approved [341]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [342]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Gemcitabine DMSE3I7 Anterior urethra cancer Approved [343]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Myelin basic protein (MBP)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [152]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [344]
Testosterone DM7HUNW Hot flushes GA30 Approved [86]
Leflunomide DMR8ONJ Arthritis FA20 Approved [62]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [218]
Ursodeoxycholic acid DMCUT21 Cholelithiasis DC11 Approved [341]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [75]
Clozapine DMFC71L Schizophrenia 6A20 Approved [290]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [274]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [155]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [345]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [346]
Quercetin DM3NC4M Obesity 5B81 Approved [347]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [242]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [72]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [286]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [348]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [349]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [350]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Metallothionein-2 (MT2A)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [351]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [166]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [82]
Deoxycholic acid DM3GYAL Subcutaneous fat disorder EF02 Approved [352]
Quercetin DM3NC4M Obesity 5B81 Approved [353]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [325]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [348]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [354]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [355]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [356]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Estrogen receptor (ESR1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [357]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [358]
Gefitinib DM15F0X Colon adenocarcinoma Approved [359]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [360]
Lapatinib DM3BH1Y Breast cancer 2C60-2C65 Approved [361]
Liraglutide DM3FXPS Non-insulin dependent diabetes 5A11 Approved [362]
Quercetin DM3NC4M Obesity 5B81 Approved [363]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [364]
Procaine DM4LSNE Anaesthesia 9A78.6 Approved [360]
Estrone DM5T6US Acne vulgaris ED80 Approved [365]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [54]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [366]
Etretinate DM2CZFA Keratosis ED56 Approved [367]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [368]
Methotrexate DM2TEOL Anterior urethra cancer Approved [67]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [369]
Quercetin DM3NC4M Obesity 5B81 Approved [370]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [69]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [371]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [372]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [373]
Quercetin DM3NC4M Obesity 5B81 Approved [374]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [325]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [375]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [376]
Ergotidine DM78IME Osteoarthritis FA00-FA05 Approved [377]
Testosterone DM7HUNW Hot flushes GA30 Approved [86]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [378]
Acetylcholine DMDF79Z Cataract 9B10 Approved [379]
Docetaxel DMDI269 Advanced cancer 2A00-2F9Z Approved [380]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [381]
Phenytoin DMNOKBV Epilepsy 8A60-8A68 Approved [382]
Allopurinol DMLPAOB Gout FA25 Approved [383]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [384]
Clavulanate DM2FGRT Bacteremia 1A73 Approved [385]
Ticlopidine DMO946V Acute coronary syndrome BA41 Approved [386]
Amoxicillin DMUYNEI Acute otitis media AB00 Approved [385]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Erythromycin DM4K7GQ Acne vulgaris ED80 Approved [387]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [387]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [388]
Methotrexate DM2TEOL Anterior urethra cancer Approved [152]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [389]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [390]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [175]
Paclitaxel DMLB81S Breast carcinoma Approved [391]
Floxuridine DM04LR2 Colorectal cancer 2B91.Z Approved [392]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [393]
Mechlorethamine DM0CVXA Chronic myelogenous leukaemia 2A20.0 Approved [394]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [395]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Metallothionein-1E (MT1E)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [396]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [348]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [397]
Leflunomide DMR8ONJ Arthritis FA20 Approved [62]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Motexafin gadolinium DMEJKRF Brain cancer 2A00 Approved [398]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [399]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [230]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [400]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [401]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [305]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [223]
Propofol DMB4OLE Anaesthesia 9A78.6 Approved [402]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [75]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [403]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [234]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [211]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [166]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [327]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [71]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [71]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [404]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [405]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [355]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [244]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Interleukin-6 (IL6)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [406]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [407]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [166]
Pantothenic acid DM091H2 Vitamin deficiency 5B55-5B71 Approved [408]
Indinavir DM0T3YH Human immunodeficiency virus infection 1C62 Approved [409]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [327]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [319]
Imiquimod DM1TMA3 Alopecia areata ED70.2 Approved [329]
Methimazole DM25FL8 Hyperthyroidism 5A02 Approved [410]
Methotrexate DM2TEOL Anterior urethra cancer Approved [406]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Endothelin-1 (EDN1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Bosentan DMIOGBU Pulmonary arterial hypertension BB01.0 Approved [411]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [220]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [412]
Methotrexate DM2TEOL Anterior urethra cancer Approved [67]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [413]
Quercetin DM3NC4M Obesity 5B81 Approved [414]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [247]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [415]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [416]
Lisinopril DMUOK4C Chronic heart failure BD1Z Approved [417]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [279]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [205]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [230]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [418]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [234]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [124]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [226]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [220]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Bortezomib DMNO38U Leukemia Approved [419]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [420]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [221]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
⏷ Show the Full List of 6 Drug(s)
Drug(s) Affected By Metallothionein-1B (MT1B)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [354]
Disulfiram DMCL2OK Alcohol dependence 6C40.2 Approved [421]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [422]
Promegestone DMK4S8I Gynecological disease GA6Z Approved [423]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [274]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [424]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [77]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [425]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [426]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [427]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Decorin (DCN)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [319]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [428]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [59]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [222]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [233]
Testosterone DM7HUNW Hot flushes GA30 Approved [86]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [244]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [429]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Folic Acid DMEMBJC Colorectal carcinoma Approved [430]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Profilin-1 (PFN1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [288]
Selenium DM25CGV N. A. N. A. Approved [305]
Etretinate DM2CZFA Keratosis ED56 Approved [431]
Quercetin DM3NC4M Obesity 5B81 Approved [432]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [433]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [434]
Acocantherin DM7JT24 Atrial fibrillation BC81.3 Approved [435]
Haloperidol DM96SE0 Delirium Approved [436]
Dihydroartemisinin DMBXVMZ Malaria 1F40-1F45 Approved [437]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [75]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [152]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [438]
Leflunomide DMR8ONJ Arthritis FA20 Approved [62]
Terbutaline DMD4381 Asthma CA23 Approved [439]
Hydrocortisone DMGEMB7 Acne vulgaris ED80 Approved [439]
Cholecalciferol DMGU74E Adult acute monocytic leukemia Approved [440]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [441]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [440]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [440]
Permethrin DMZ0Q1G Pediculus capitis infestation 1G00.0 Approved [4]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Panobinostat DM58WKG Chronic graft versus host disease Approved [214]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [196]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [442]
Aldosterone DM9S2JW Hypertension BA00-BA04 Approved [443]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [444]
Testosterone enanthate DMB6871 N. A. N. A. Approved [445]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [75]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [274]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Stromelysin-1 (MMP3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [43]
Fluvastatin DM4MDJY Arteriosclerosis BD40 Approved [43]
Pravastatin DM6A0X7 Adult acute monocytic leukemia Approved [43]
Atorvastatin DMF28YC Acute coronary syndrome BA41 Approved [43]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [326]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [63]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [368]
Methotrexate DM2TEOL Anterior urethra cancer Approved [446]
Quercetin DM3NC4M Obesity 5B81 Approved [447]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [69]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Inhibin beta A chain (INHBA)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [222]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [196]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [279]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [244]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [448]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Mifepristone DMGZQEF Cushing disease 5A70 Approved [449]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [274]
Amphotericin B DMTAJQE Acne vulgaris ED80 Approved [450]
Arsenic DMTL2Y1 N. A. N. A. Approved [275]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [451]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [263]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [59]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [452]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [354]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [453]
Ergotidine DM78IME Osteoarthritis FA00-FA05 Approved [454]
Testosterone DM7HUNW Hot flushes GA30 Approved [61]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [455]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cabozantinib DMIYDT4 Medullary thyroid gland carcinoma Approved [456]
Crizotinib DM4F29C Non-small-cell lung cancer 2C25.Y Approved [457]
Fexofenadine DM17ONX Allergic rhinitis CA08.0 Approved [323]
Lumiracoxib DM1S4AG Chronic renal failure GB61.Z Approved [323]
Clavulanate DM2FGRT Bacteremia 1A73 Approved [323]
Methotrexate DM2TEOL Anterior urethra cancer Approved [406]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [323]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [458]
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [406]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [211]
Ifosfamide DMCT3I8 Adult central nervous system germ cell tumor Approved [43]
Rilmenidine DM13PQW Hypertension BA00-BA04 Approved [459]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [222]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [286]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [233]
Oxymetazoline DM8ZXT6 Arrhythmia BC9Z Approved [460]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [220]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Indapamide DMGN1PW Edema MG29 Approved [461]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Busulfan DMXYJ9C Chronic myelogenous leukaemia 2A20.0 Approved [462]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [234]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [463]
Chlorambucil DMRKE63 Chronic lymphocytic leukaemia 2A82.0 Approved [463]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [464]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [465]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [98]
Selenium DM25CGV N. A. N. A. Approved [305]
Etretinate DM2CZFA Keratosis ED56 Approved [431]
Imipramine DM2NUH3 Depression 6A70-6A7Z Approved [466]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Stromelysin-2 (MMP10)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [73]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [166]
Methotrexate DM2TEOL Anterior urethra cancer Approved [406]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [89]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [71]
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [406]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [71]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [294]
Haloperidol DM96SE0 Delirium Approved [436]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Galectin-1 (LGALS1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [240]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [433]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [467]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [196]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [468]
Acocantherin DM7JT24 Atrial fibrillation BC81.3 Approved [435]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [469]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [220]
Dihydroartemisinin DMBXVMZ Malaria 1F40-1F45 Approved [437]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [166]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [327]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [63]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [470]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [471]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [376]
Ethanol DMDRQZU Chronic pain MG30 Approved [472]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [400]
Azathioprine DMMZSXQ Lupus nephritis 4A40.0Y Approved [406]
Gemcitabine DMSE3I7 Anterior urethra cancer Approved [473]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [305]
Methotrexate DM2TEOL Anterior urethra cancer Approved [103]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [286]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [474]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [233]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [220]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [475]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [199]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [476]
Drug(s) Affected By Interleukin-8 (CXCL8)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrocortisone DMGEMB7 Acne vulgaris ED80 Approved [477]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [478]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [479]
Pantothenic acid DM091H2 Vitamin deficiency 5B55-5B71 Approved [408]
Mechlorethamine DM0CVXA Chronic myelogenous leukaemia 2A20.0 Approved [480]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [327]
Fexofenadine DM17ONX Allergic rhinitis CA08.0 Approved [323]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [146]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [481]
Lumiracoxib DM1S4AG Chronic renal failure GB61.Z Approved [323]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By C-C motif chemokine 3 (CCL3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Indinavir DM0T3YH Human immunodeficiency virus infection 1C62 Approved [409]
Methotrexate DM2TEOL Anterior urethra cancer Approved [152]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [325]
Penicillamine DM40EF6 Cystinuria 5C60.2 Approved [482]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [433]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [483]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [484]
Betamethasone DMAHJEF Acute adrenal insufficiency Approved [485]
Emetine DMCT2YF Hepatitis virus infection 1E50-1E51 Approved [485]
Nelfinavir mesylate DMFX6G8 N. A. N. A. Approved [409]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sevoflurane DMC9O43 Anaesthesia 9A78.6 Approved [191]
Docetaxel DMDI269 Advanced cancer 2A00-2F9Z Approved [486]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [487]
Gemcitabine DMSE3I7 Anterior urethra cancer Approved [488]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [43]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [166]
Verapamil DMA7PEW Angina pectoris BA40 Approved [192]
Mechlorethamine DM0CVXA Chronic myelogenous leukaemia 2A20.0 Approved [184]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [315]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [489]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [220]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [218]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [284]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [218]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [216]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [208]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
MG-132 DMKA2YS N. A. N. A. Preclinical [490]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Gefitinib DM15F0X Colon adenocarcinoma Approved [491]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [220]
Arsenic DMTL2Y1 N. A. N. A. Approved [292]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [492]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
AMINOHIPPURIC ACID DMUN54G Discovery agent N.A. Investigative [493]
⏷ Show the Full List of 6 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [98]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [247]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [286]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [494]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [372]
Lenalidomide DM6Q7U4 Adult T-cell leukemia/lymphoma Approved [495]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [495]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [442]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [223]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [166]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [162]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [270]
Selenium DM25CGV N. A. N. A. Approved [156]
Methimazole DM25FL8 Hyperthyroidism 5A02 Approved [496]
Ribavirin DMEYLH9 Hepatitis C virus infection 1E51.1 Approved [163]
Meloxicam DM2AR7L Arthritis FA20 Approved [195]
Methotrexate DM2TEOL Anterior urethra cancer Approved [67]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [89]
Epinephrine DM3KJBC Acute asthma CA23 Approved [497]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Nucleoprotein TPR (TPR)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [288]
Selenium DM25CGV N. A. N. A. Approved [305]
Quercetin DM3NC4M Obesity 5B81 Approved [498]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [247]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [499]
Testosterone enanthate DMB6871 N. A. N. A. Approved [445]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [75]
Benzatropine DMF7EXL Parkinsonian disorder Approved [436]
Clozapine DMFC71L Schizophrenia 6A20 Approved [436]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Tissue factor (F3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [500]
Primidone DM0WX6I Epilepsy 8A60-8A68 Approved [501]
Methotrexate DM2TEOL Anterior urethra cancer Approved [502]
Dactinomycin DM2YGNW Adult kidney Wilms tumor Approved [503]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [504]
Quercetin DM3NC4M Obesity 5B81 Approved [505]
Fructose DM43AN2 Vomiting MD90 Approved [70]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [506]
Crizotinib DM4F29C Non-small-cell lung cancer 2C25.Y Approved [501]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [467]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ofloxacin DM0VQN3 Acute gonococcal cervicitis Approved [387]
Clindamycin DM15HL8 Acne vulgaris ED80 Approved [387]
Selenium DM25CGV N. A. N. A. Approved [305]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [387]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [387]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [247]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [286]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [483]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [387]
Testosterone DM7HUNW Hot flushes GA30 Approved [86]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Plastin-3 (PLS3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [77]
Testosterone DM7HUNW Hot flushes GA30 Approved [86]
Haloperidol DM96SE0 Delirium Approved [436]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [75]
Clozapine DMFC71L Schizophrenia 6A20 Approved [436]
Azacitidine DMTA5OE Acute myelogenous leukaemia 2A41 Approved [507]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [199]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [226]
Arsenic DMTL2Y1 N. A. N. A. Approved [508]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
L-Tryptophan DMIBH7M Depression 6A70-6A7Z Approved [509]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [510]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [511]
Quercetin DM3NC4M Obesity 5B81 Approved [512]
Testosterone enanthate DMB6871 N. A. N. A. Approved [445]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [226]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [205]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [230]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [206]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [234]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [166]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [82]
Methotrexate DM2TEOL Anterior urethra cancer Approved [67]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [59]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [301]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [513]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [294]
Leflunomide DMR8ONJ Arthritis FA20 Approved [62]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [220]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [222]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [405]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [244]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [228]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [75]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [274]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [514]
Ethinyl Estradiol DMODJ40 Acne vulgaris ED80 Approved [514]
Estriol DMOEM2I Hormone deficiency 5A61.1 Approved [514]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Testosterone DM7HUNW Hot flushes GA30 Approved [61]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [61]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Arsenic DMTL2Y1 N. A. N. A. Approved [207]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [211]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
acetaldehyde DMJFKG4 Discovery agent N.A. Investigative [278]
⏷ Show the Full List of 7 Drug(s)
Drug(s) Affected By Desmoplakin (DSP)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [222]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [334]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [294]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [442]
Leflunomide DMR8ONJ Arthritis FA20 Approved [62]
Dihydroartemisinin DMBXVMZ Malaria 1F40-1F45 Approved [437]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Cocaine DMSOX7I Anaesthesia 9A78.6 Approved [515]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Ankyrin-1 (ANK1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Testosterone DM7HUNW Hot flushes GA30 Approved [61]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [61]
Testosterone enanthate DMB6871 N. A. N. A. Approved [445]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [226]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [516]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [234]
Arsenic DMTL2Y1 N. A. N. A. Approved [207]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [517]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [226]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [330]
Methotrexate DM2TEOL Anterior urethra cancer Approved [152]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [396]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [205]
Pioglitazone DMKJ485 Amyotrophic lateral sclerosis 8B60.0 Approved [518]
Arsenic DMTL2Y1 N. A. N. A. Approved [519]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [520]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [521]
EUGENOL DM7US1H Discovery agent N.A. Patented [522]
⏷ Show the Full List of 9 Drug(s)
Drug(s) Affected By Platelet glycoprotein 4 (CD36)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [523]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [524]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [525]
Tolcapone DM8MNVO Parkinson disease 8A00.0 Approved [526]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [527]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [223]
Disulfiram DMCL2OK Alcohol dependence 6C40.2 Approved [528]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [127]
Asasantin DMCZIHT Cerebrovascular ischaemia 8B1Z Approved [529]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [530]
Methotrexate DM2TEOL Anterior urethra cancer Approved [103]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [218]
Josamycin DMKJ8LB Bacterial infection 1A00-1C4Z Approved [531]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [216]
Ardeparin DMYRX8B Deep vein thrombosis BD71 Approved [532]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [219]
Maleic Acid DM4L0R7 Discovery agent N.A. Investigative [533]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Histidine decarboxylase (HDC)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [534]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [169]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [535]
Nilotinib DM7HXWT Chronic myelogenous leukaemia 2A20.0 Approved [536]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [536]
Isoflurophate DMBSK7X Glaucoma/ocular hypertension 9C61 Approved [537]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [214]
phorbol 12-myristate 13-acetate DMJWD62 Acute myeloid leukaemia 2A60 Phase 2 [538]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Elafin (PI3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [264]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [279]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [205]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [539]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [216]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [426]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
Methotrexate DM2TEOL Anterior urethra cancer Approved [201]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Levodopa DMN3E57 Parkinson disease 8A00.0 Approved [540]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [286]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Isoflurophate DMBSK7X Glaucoma/ocular hypertension 9C61 Approved [537]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [226]
Azathioprine DMMZSXQ Lupus nephritis 4A40.0Y Approved [210]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [541]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Interleukin-11 (IL11)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [63]
Methotrexate DM2TEOL Anterior urethra cancer Approved [57]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [59]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [542]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [294]
Leflunomide DMR8ONJ Arthritis FA20 Approved [62]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Ethanol DMDRQZU Chronic pain MG30 Approved [543]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cytochrome P450 3A5 (CYP3A5)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Eplerenone DMF0NQR Heart failure BD10-BD13 Approved [114]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [108]
Nelfinavir mesylate DMFX6G8 N. A. N. A. Approved [117]
Ritonavir DMU764S Human immunodeficiency virus infection 1C62 Approved [117]
Ifosfamide DMCT3I8 Adult central nervous system germ cell tumor Approved [544]
Omeprazole DM471KJ Cystic fibrosis CA25 Approved [545]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [546]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Hydrocortisone DMGEMB7 Acne vulgaris ED80 Approved [547]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By C-C motif chemokine 1 (CCL1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [548]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [228]
Clozapine DMFC71L Schizophrenia 6A20 Approved [290]
Dasatinib DMJV2EK Blast phase chronic myelogenous leukemia, BCR-ABL1 positive Approved [549]
Arsenic DMTL2Y1 N. A. N. A. Approved [550]
ACYLINE DM9GRTK Prostate cancer 2C82.0 Phase 2 [551]
ANW-32821 DMMJOZD N. A. N. A. Phase 2 [552]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [553]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [554]
Nickel chloride DMI12Y8 Discovery agent N.A. Investigative [555]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [556]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [82]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [339]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [196]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [557]
Testosterone DM7HUNW Hot flushes GA30 Approved [61]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [61]
Leflunomide DMR8ONJ Arthritis FA20 Approved [62]
Febuxostat DMDEXQ0 Hyperuricaemia 5C55.Y Approved [558]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [223]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [264]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [234]
Arsenic DMTL2Y1 N. A. N. A. Approved [207]
Permethrin DMZ0Q1G Pediculus capitis infestation 1G00.0 Approved [4]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [559]
⏷ Show the Full List of 8 Drug(s)
Drug(s) Affected By Protein S100-A1 (S100A1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [270]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [71]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [71]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [223]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [560]
Alitretinoin DMME8LH Kaposi sarcoma 2B57 Approved [71]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [234]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [249]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [561]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [562]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [294]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [562]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [220]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [563]
⏷ Show the Full List of 6 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Haloperidol DM96SE0 Delirium Approved [564]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [240]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [565]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [222]
Bupivacaine DM4PRFC Anaesthesia 9A78.6 Approved [566]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [567]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [294]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [244]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [220]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Paclitaxel DMLB81S Breast carcinoma Approved [568]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [568]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [568]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [569]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [570]
MICROCYSTIN-LR DMTMLRN Discovery agent N.A. Investigative [571]
⏷ Show the Full List of 7 Drug(s)
Drug(s) Affected By Chymase (CMA1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [284]
paraquat DMR8O3X Discovery agent N.A. Investigative [572]
Drug(s) Affected By Cytochrome P450 3A7 (CYP3A7)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [71]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [545]
Phenytoin DMNOKBV Epilepsy 8A60-8A68 Approved [573]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [574]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [575]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [53]
Prasterone DM67VKL Chronic obstructive pulmonary disease CA22 Approved [576]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [577]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [263]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [561]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [222]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [578]
Panobinostat DM58WKG Chronic graft versus host disease Approved [214]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [233]
Testosterone enanthate DMB6871 N. A. N. A. Approved [445]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [197]
Ethanol DMDRQZU Chronic pain MG30 Approved [579]
Mifepristone DMGZQEF Cushing disease 5A70 Approved [449]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [580]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [54]
Mechlorethamine DM0CVXA Chronic myelogenous leukaemia 2A20.0 Approved [154]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [167]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [581]
Selenium DM25CGV N. A. N. A. Approved [156]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [158]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [582]
Methotrexate DM2TEOL Anterior urethra cancer Approved [583]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [584]
Quercetin DM3NC4M Obesity 5B81 Approved [585]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Integrin beta-8 (ITGB8)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [67]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [442]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [228]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [230]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [426]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [586]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [444]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [202]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [166]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [451]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [587]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [588]
Methotrexate DM2TEOL Anterior urethra cancer Approved [589]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [301]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [494]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [557]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [294]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [590]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [354]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [591]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [75]
Bortezomib DMNO38U Leukemia Approved [592]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [593]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [199]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein PML (PML)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [305]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [594]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [242]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [301]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [242]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [75]
Menthol DMG2KW7 Back pain ME84.Z Approved [291]
Mitoxantrone DMM39BF Acute myelogenous leukaemia 2A41 Approved [595]
Epirubicin DMPDW6T Solid tumour/cancer 2A00-2F9Z Approved [595]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [596]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [597]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [75]
Benzatropine DMF7EXL Parkinsonian disorder Approved [436]
Clozapine DMFC71L Schizophrenia 6A20 Approved [436]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Cocaine DMSOX7I Anaesthesia 9A78.6 Approved [598]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [260]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Pasireotide DMHM7JS Cushing disease 5A70 Approved [599]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [222]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [233]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [422]
Permethrin DMZ0Q1G Pediculus capitis infestation 1G00.0 Approved [4]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [214]
Edotreotide DMQ08AJ Acromegaly 5A60.0 Phase 2 [600]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
PMID26394986-Compound-22 DM43Z1G N. A. N. A. Patented [601]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [228]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [193]
Selenium DM25CGV N. A. N. A. Approved [305]
Methotrexate DM2TEOL Anterior urethra cancer Approved [406]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [339]
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [406]
Testosterone DM7HUNW Hot flushes GA30 Approved [61]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [61]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Testosterone enanthate DMB6871 N. A. N. A. Approved [445]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [226]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Interleukin-13 (IL13)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [602]
Prednisone DM2HG4X Acute asthma CA23 Approved [603]
Methotrexate DM2TEOL Anterior urethra cancer Approved [604]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [471]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [605]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [606]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Budesonide DMJIBAW Allergic rhinitis CA08.0 Approved [607]
Alitretinoin DMME8LH Kaposi sarcoma 2B57 Approved [471]
Ethambutol DMR87LC Pulmonary tuberculosis 1B10.Z Approved [605]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [222]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Ibrutinib DMHZCPO Mantle cell lymphoma 2A85.5 Approved [608]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [609]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [230]
Melatonin DMKWFBT Depression 6A70-6A7Z Approved [610]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [234]
Arsenic DMTL2Y1 N. A. N. A. Approved [207]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [199]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [611]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Prohibitin 1 (PHB1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [436]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [98]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [562]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [612]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [613]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [562]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [127]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [75]
Ethanol DMDRQZU Chronic pain MG30 Approved [614]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Pro-adrenomedullin (ADM)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [615]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [616]
Methotrexate DM2TEOL Anterior urethra cancer Approved [152]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [222]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [592]
Leflunomide DMR8ONJ Arthritis FA20 Approved [62]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [220]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [617]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Eicosapentaenoic acid/docosa-hexaenoic acid DMMUCG4 Hypertriglyceridemia 5C80.1 Approved [618]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [619]
Gamolenic acid DMQN30Z Allergy 4A80-4A85 Approved [620]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [621]
Flupentixol DM0DJ9O Schizophrenia 6A20 Approved [622]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [623]
Ibandronate DM0QZBN Hypercalcaemia 5B91.0 Approved [624]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [240]
Fexofenadine DM17ONX Allergic rhinitis CA08.0 Approved [323]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [625]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [626]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [627]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [231]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [628]
PMID25656651-Compound-5 DMAI95U Chronic myeloid leukaemia 2A20 Patented [629]
Scriptaid DM9JZ21 Solid tumour/cancer 2A00-2F9Z Preclinical [630]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [631]
Nitrobenzanthrone DMN6L70 N. A. N. A. Investigative [632]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [406]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [89]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [406]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [483]
Testosterone DM7HUNW Hot flushes GA30 Approved [61]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [61]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Azathioprine DMMZSXQ Lupus nephritis 4A40.0Y Approved [406]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Platelet glycoprotein V (GP5)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
3R14S-OCHRATOXIN A DM2KEW6 Discovery agent N.A. Investigative [633]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [75]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [634]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Irinotecan DMP6SC2 Adenocarcinoma 2D40 Approved [635]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [237]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [199]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [202]
Permethrin DMZ0Q1G Pediculus capitis infestation 1G00.0 Approved [634]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [636]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [637]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [54]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [63]
Panobinostat DM58WKG Chronic graft versus host disease Approved [214]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [354]
Testosterone DM7HUNW Hot flushes GA30 Approved [86]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Clozapine DMFC71L Schizophrenia 6A20 Approved [290]
Mifepristone DMGZQEF Cushing disease 5A70 Approved [449]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [205]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [638]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ribavirin DMEYLH9 Hepatitis C virus infection 1E51.1 Approved [639]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [640]
Panobinostat DM58WKG Chronic graft versus host disease Approved [214]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [641]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [642]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [643]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [644]
Arsenic DMTL2Y1 N. A. N. A. Approved [207]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
Permethrin DMZ0Q1G Pediculus capitis infestation 1G00.0 Approved [4]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [305]
Methotrexate DM2TEOL Anterior urethra cancer Approved [103]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [263]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [308]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Sevoflurane DMC9O43 Anaesthesia 9A78.6 Approved [645]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [75]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Panobinostat DM58WKG Chronic graft versus host disease Approved [214]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [294]
Testosterone DM7HUNW Hot flushes GA30 Approved [86]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [75]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [205]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [230]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Caspase-4 (CASP4)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [326]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [451]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [155]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [77]
Quercetin DM3NC4M Obesity 5B81 Approved [646]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [647]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [648]
Testosterone DM7HUNW Hot flushes GA30 Approved [86]
Acocantherin DM7JT24 Atrial fibrillation BC81.3 Approved [649]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [244]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [166]
Quercetin DM3NC4M Obesity 5B81 Approved [324]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [59]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [301]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [289]
Testosterone DM7HUNW Hot flushes GA30 Approved [61]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [61]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Disulfiram DMCL2OK Alcohol dependence 6C40.2 Approved [421]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [75]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methimazole DM25FL8 Hyperthyroidism 5A02 Approved [650]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [474]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [226]
Ergocalciferol DMHO0AR Hypoparathyroidism 5A50 Approved [651]
Alitretinoin DMME8LH Kaposi sarcoma 2B57 Approved [652]
Masoprocol DMMVNZ0 Prostate cancer 2C82.0 Approved [651]
Azathioprine DMMZSXQ Lupus nephritis 4A40.0Y Approved [210]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [653]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ergotidine DM78IME Osteoarthritis FA00-FA05 Approved [654]
Selenium DM25CGV N. A. N. A. Approved [305]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Panobinostat DM58WKG Chronic graft versus host disease Approved [214]
Testosterone DM7HUNW Hot flushes GA30 Approved [86]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [77]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [225]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [575]
Methamphetamine DMPM4SK Anxiety Approved [655]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [228]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [77]
Methotrexate DM2TEOL Anterior urethra cancer Approved [67]
Quercetin DM3NC4M Obesity 5B81 Approved [324]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [263]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [656]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [657]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [75]
Folic Acid DMEMBJC Colorectal carcinoma Approved [658]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [77]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [223]
Bortezomib DMNO38U Leukemia Approved [419]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [231]
Arsenic DMTL2Y1 N. A. N. A. Approved [659]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
Epigallocatechin gallate DMCGWBJ Hepatic fibrosis DB93.0 Phase 3 [660]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [77]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [247]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [294]
Leflunomide DMR8ONJ Arthritis FA20 Approved [62]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [226]
Bexarotene DMOBIKY Cutaneous T-cell lymphoma 2B01 Approved [661]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [231]
Piroxicam DMTK234 Osteoarthritis FA00-FA05 Approved [662]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [242]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [475]
Enzalutamide DMGL19D Prostate cancer 2C82.0 Approved [272]
Arsenic DMTL2Y1 N. A. N. A. Approved [275]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [663]
Dihydrotestosterone DM3S8XC Prostate hyperplasia GA90 Phase 4 [272]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
⏷ Show the Full List of 7 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [664]
Epinephrine DM3KJBC Acute asthma CA23 Approved [665]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [222]
Panobinostat DM58WKG Chronic graft versus host disease Approved [214]
Estrone DM5T6US Acne vulgaris ED80 Approved [664]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [294]
Testosterone DM7HUNW Hot flushes GA30 Approved [86]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Mestranol DMG3F94 Contraception QA21 Approved [664]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By GTP-binding protein RAD (RRAD)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [279]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [244]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Testosterone enanthate DMB6871 N. A. N. A. Approved [445]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [228]
Ethanol DMDRQZU Chronic pain MG30 Approved [666]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [230]
Melphalan DMOLNHF Hematologic disease 3C0Z Approved [258]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Claudin-12 (CLDN12)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [59]
Testosterone DM7HUNW Hot flushes GA30 Approved [61]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [61]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [220]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [230]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [211]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [250]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Amphotericin B DMTAJQE Acne vulgaris ED80 Approved [450]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [211]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [208]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [559]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [217]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [219]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Glucosamine DM4ZLFD Osteoarthritis FA00-FA05 Approved [667]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [244]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [475]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [124]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [668]
Phenytoin DMNOKBV Epilepsy 8A60-8A68 Approved [669]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [202]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [218]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [222]
Panobinostat DM58WKG Chronic graft versus host disease Approved [214]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [233]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [218]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [75]
Ethanol DMDRQZU Chronic pain MG30 Approved [224]
Cocaine DMSOX7I Anaesthesia 9A78.6 Approved [670]
Permethrin DMZ0Q1G Pediculus capitis infestation 1G00.0 Approved [4]
Cytarabine DMZD5QR Acute lymphoblastic leukaemia 2A85 Approved [212]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Somatostatin (SST)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [82]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [222]
Panobinostat DM58WKG Chronic graft versus host disease Approved [214]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [429]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Octreotide DMHIDCJ Acromegaly 5A60.0 Approved [671]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [274]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [672]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [82]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein BTG1 (BTG1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Colchicine DM2POTE Acute gout flare FA25.0 Approved [673]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [562]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [674]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [434]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [468]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [562]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [223]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [228]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [56]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Leflunomide DMR8ONJ Arthritis FA20 Approved [62]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [75]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [56]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [199]
Urethane DM7NSI0 N. A. N. A. Phase 4 [213]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Pituitary homeobox 1 (PITX1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [305]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [160]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [230]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [234]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [295]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [675]
Cytarabine DMZD5QR Acute lymphoblastic leukaemia 2A85 Approved [212]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [208]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Reelin (RELN)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [219]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [222]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [676]
Panobinostat DM58WKG Chronic graft versus host disease Approved [214]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [223]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [75]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [677]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [216]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By C-C motif chemokine 20 (CCL20)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [166]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [327]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [63]
Methotrexate DM2TEOL Anterior urethra cancer Approved [406]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [59]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [548]
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [406]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [244]
Leflunomide DMR8ONJ Arthritis FA20 Approved [62]
Glutathione DMAHMT9 Human immunodeficiency virus infection 1C62 Approved [678]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By C-C motif chemokine 7 (CCL7)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [63]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [548]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [548]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Isoproterenol DMK7MEY Atrioventricular block Approved [679]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
Abexinostat DM91LGU Follicular lymphoma 2A80 Phase 3 [680]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [284]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [681]
Nickel chloride DMI12Y8 Discovery agent N.A. Investigative [555]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Serine protease HTRA4 (HTRA4)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [682]
L-serine DM6WPIS Pulmonary tuberculosis 1B10.Z Investigative [683]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [63]
Selenium DM25CGV N. A. N. A. Approved [330]
Clavulanate DM2FGRT Bacteremia 1A73 Approved [323]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [59]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [483]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [323]
Nevirapine DM6HX9B Human immunodeficiency virus infection 1C62 Approved [323]
Trihexyphenidyl DMB19L8 Dystonia 8A02 Approved [323]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [323]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [247]
Testosterone DM7HUNW Hot flushes GA30 Approved [61]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [61]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [223]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [684]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [685]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [686]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [206]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [231]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [225]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [219]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [59]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [247]
Testosterone DM7HUNW Hot flushes GA30 Approved [61]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [244]
Leflunomide DMR8ONJ Arthritis FA20 Approved [62]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [356]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [356]
Cotinine DMCEZ1B Insecticide N.A. Approved [687]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Angiopoietin-1 receptor (TEK)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Lenalidomide DM6Q7U4 Adult T-cell leukemia/lymphoma Approved [688]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [688]
Propranolol DM79NTF Angina pectoris BA40 Approved [689]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Capsaicin DMGMF6V Back pain ME84.Z Approved [690]
Mifepristone DMGZQEF Cushing disease 5A70 Approved [449]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [216]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
Cytarabine DMZD5QR Acute lymphoblastic leukaemia 2A85 Approved [212]
Rigosertib DMOSTXF Myelodysplastic syndrome 2A37 Phase 3 [691]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [692]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [693]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [294]
Testosterone enanthate DMB6871 N. A. N. A. Approved [445]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Ethanol DMDRQZU Chronic pain MG30 Approved [694]
Clozapine DMFC71L Schizophrenia 6A20 Approved [695]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [696]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [231]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [664]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [697]
Quercetin DM3NC4M Obesity 5B81 Approved [298]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [698]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [372]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [699]
Testosterone DM7HUNW Hot flushes GA30 Approved [61]
Acocantherin DM7JT24 Atrial fibrillation BC81.3 Approved [700]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [61]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [58]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [326]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [489]
Selenium DM25CGV N. A. N. A. Approved [305]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [594]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [701]
Deoxycholic acid DM3GYAL Subcutaneous fat disorder EF02 Approved [702]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [703]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [247]
Glucosamine DM4ZLFD Osteoarthritis FA00-FA05 Approved [704]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Calcipotriol DM03CP7 Psoriasis EA90 Approved [705]
Selenium DM25CGV N. A. N. A. Approved [305]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [89]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [71]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [71]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [705]
Leflunomide DMR8ONJ Arthritis FA20 Approved [62]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [223]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Alitretinoin DMME8LH Kaposi sarcoma 2B57 Approved [71]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Isoflurophate DMBSK7X Glaucoma/ocular hypertension 9C61 Approved [537]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Arsenic DMTL2Y1 N. A. N. A. Approved [207]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [202]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Glyphosate DM0AFY7 Malaria 1F40-1F45 Investigative [537]
Chlorphrifos oxon DMGBT68 Discovery agent N.A. Investigative [537]
CHLORPYRIFOS DMKPUI6 Discovery agent N.A. Investigative [537]
PARAOXON DMN4ZKC Discovery agent N.A. Investigative [537]
Hexadecanoic acid DMWUXDZ Discovery agent N.A. Investigative [706]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [219]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [643]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [643]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [209]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [211]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [208]
Resveratrol DM3RWXL Giant cell arteritis 4A44.2 Phase 3 [707]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [247]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [708]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [709]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [708]
Lindane DMB8CNL Infestations of lice and scabies 1G00.Z Approved [708]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [74]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [228]
Mifepristone DMGZQEF Cushing disease 5A70 Approved [449]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [205]
Dasatinib DMJV2EK Blast phase chronic myelogenous leukemia, BCR-ABL1 positive Approved [549]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [222]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [442]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [220]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [205]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [684]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [710]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [644]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [644]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [219]
Methotrexate DM2TEOL Anterior urethra cancer Approved [103]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [196]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [230]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [215]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [237]
Arsenic DMTL2Y1 N. A. N. A. Approved [207]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [711]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [295]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Interleukin-24 (IL24)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [166]
Primidone DM0WX6I Epilepsy 8A60-8A68 Approved [323]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [327]
Lumiracoxib DM1S4AG Chronic renal failure GB61.Z Approved [323]
Clavulanate DM2FGRT Bacteremia 1A73 Approved [323]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [712]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [59]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [71]
Penbutolol DM4ES8F Hypertension BA00-BA04 Approved [323]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [71]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [494]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [234]
Arsenic DMTL2Y1 N. A. N. A. Approved [713]
Vitamin C DMXJ7O8 Adenocarcinoma 2D40 Approved [714]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [208]
OTX-015 DMI8RG1 Acute myeloid leukaemia 2A60 Phase 1/2 [715]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [284]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [223]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
THAPSIGARGIN DMDMQIE N. A. N. A. Preclinical [716]
Z-Pro-Prolinal DM43O2U Discovery agent N.A. Investigative [717]
Milchsaure DM462BT Pruritus EC90 Investigative [718]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [719]
⏷ Show the Full List of 7 Drug(s)
Drug(s) Affected By Urea transporter 1 (SLC14A1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Testosterone DM7HUNW Hot flushes GA30 Approved [86]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [205]
Melphalan DMOLNHF Hematologic disease 3C0Z Approved [258]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [73]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [253]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [575]
Permethrin DMZ0Q1G Pediculus capitis infestation 1G00.0 Approved [4]
Hydroxyurea DMOQVU9 Chronic myelogenous leukaemia 2A20.0 Approved [720]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [721]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [270]
Testosterone DM7HUNW Hot flushes GA30 Approved [86]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [75]
Clozapine DMFC71L Schizophrenia 6A20 Approved [436]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [230]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [722]
Azacitidine DMTA5OE Acute myelogenous leukaemia 2A41 Approved [722]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [219]
Methotrexate DM2TEOL Anterior urethra cancer Approved [103]
Crizotinib DM4F29C Non-small-cell lung cancer 2C25.Y Approved [723]
Nefazodone DM4ZS8M Major depressive disorder 6A70.3 Approved [724]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Retigabine DMGNYIH Behcet disease 4A62 Approved [725]
Dasatinib DMJV2EK Blast phase chronic myelogenous leukemia, BCR-ABL1 positive Approved [76]
Arsenic DMTL2Y1 N. A. N. A. Approved [207]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
Verapamil DMA7PEW Angina pectoris BA40 Approved [726]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [615]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [77]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [348]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [294]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [226]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [75]
Motexafin gadolinium DMEJKRF Brain cancer 2A00 Approved [348]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [339]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [205]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [225]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [208]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [637]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [63]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Epanova DMHEAGL Hypertriglyceridemia 5C80.1 Approved [727]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [205]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [728]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [234]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [729]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [214]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [77]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [244]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [448]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [205]
Arsenic DMTL2Y1 N. A. N. A. Approved [207]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [427]
Epigallocatechin gallate DMCGWBJ Hepatic fibrosis DB93.0 Phase 3 [730]
Seocalcitol DMKL9QO Rickets 5B57 Phase 3 [731]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [221]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [429]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Mifepristone DMGZQEF Cushing disease 5A70 Approved [449]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [205]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [230]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [685]
Amphotericin B DMTAJQE Acne vulgaris ED80 Approved [450]
Arsenic DMTL2Y1 N. A. N. A. Approved [550]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [732]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [222]
Testosterone DM7HUNW Hot flushes GA30 Approved [61]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [61]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [234]
Arsenic DMTL2Y1 N. A. N. A. Approved [207]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [225]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
Urethane DM7NSI0 N. A. N. A. Phase 4 [213]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [305]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [442]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [234]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [216]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [202]
Mitoxantrone DMM39BF Acute myelogenous leukaemia 2A41 Approved [201]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [305]
Sphingosine-1-phosphate DMJCQKA Acne vulgaris ED80 Phase 1 [733]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [734]
Testosterone DM7HUNW Hot flushes GA30 Approved [86]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [735]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [214]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [400]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [736]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Irinotecan DMP6SC2 Adenocarcinoma 2D40 Approved [635]
Arsenic DMTL2Y1 N. A. N. A. Approved [207]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Olfactory receptor 4D1 (OR4D1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [211]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [737]
Drug(s) Affected By Disks large homolog 2 (DLG2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [436]
Haloperidol DM96SE0 Delirium Approved [436]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [220]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [422]
Benzatropine DMF7EXL Parkinsonian disorder Approved [436]
Clozapine DMFC71L Schizophrenia 6A20 Approved [436]
Gemcitabine DMSE3I7 Anterior urethra cancer Approved [343]
Dihydrotestosterone DM3S8XC Prostate hyperplasia GA90 Phase 4 [272]
Urethane DM7NSI0 N. A. N. A. Phase 4 [213]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Rhodopsin kinase GRK1 (GRK1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [220]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [738]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [223]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [197]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [234]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [124]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
Tetrodotoxin DMWMPRG Bacterial infection 1A00-1C4Z Approved [739]
Permethrin DMZ0Q1G Pediculus capitis infestation 1G00.0 Approved [4]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [740]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [124]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [741]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [426]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [208]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [742]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [217]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [743]
linalool DMGZQ5P Discovery agent N.A. Investigative [744]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cocaine DMSOX7I Anaesthesia 9A78.6 Approved [745]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [746]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [202]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [319]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [747]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [286]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [233]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [709]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [220]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Heroin diacetylmorphine DMDBWHY Neurological disorder 6B60 Approved [748]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [205]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [593]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [166]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [616]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Panobinostat DM58WKG Chronic graft versus host disease Approved [214]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [749]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [279]
Testosterone DM7HUNW Hot flushes GA30 Approved [61]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [356]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [244]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [219]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Arsenic DMTL2Y1 N. A. N. A. Approved [207]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [295]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [284]
Milchsaure DM462BT Pruritus EC90 Investigative [718]
Sulforaphane DMQY3L0 Skin disease EA00-EM0Z Investigative [750]
⏷ Show the Full List of 7 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [230]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [249]
Urethane DM7NSI0 N. A. N. A. Phase 4 [213]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [217]
⏷ Show the Full List of 6 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Gefitinib DM15F0X Colon adenocarcinoma Approved [751]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [752]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [223]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Folic Acid DMEMBJC Colorectal carcinoma Approved [753]
Sulfasalazine DMICA9H Irritable bowel syndrome DD91.0 Approved [754]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [230]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [206]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [206]
Arsenic DMTL2Y1 N. A. N. A. Approved [207]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [220]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic DMTL2Y1 N. A. N. A. Approved [207]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [755]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
CITCO DM0N634 Discovery agent N.A. Investigative [756]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [219]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [74]
Arsenic DMTL2Y1 N. A. N. A. Approved [207]
Urethane DM7NSI0 N. A. N. A. Phase 4 [213]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [202]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [757]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [219]
acetaldehyde DMJFKG4 Discovery agent N.A. Investigative [278]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Permethrin DMZ0Q1G Pediculus capitis infestation 1G00.0 Approved [4]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Panobinostat DM58WKG Chronic graft versus host disease Approved [214]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [244]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [475]
Irinotecan DMP6SC2 Adenocarcinoma 2D40 Approved [758]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [214]
PDX-101 DM6OC53 Plasma cell myeloma 2A83.1 Phase 2 [214]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [219]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [218]
⏷ Show the Full List of 9 Drug(s)
Drug(s) Affected By Protein FAM229B (FAM229B)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [223]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [197]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [403]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [202]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [217]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [219]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [759]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [222]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [442]
Leflunomide DMR8ONJ Arthritis FA20 Approved [62]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [223]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Ampicillin DMHWE7P Acute epiglottitis Approved [58]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [205]
Azacitidine DMTA5OE Acute myelogenous leukaemia 2A41 Approved [507]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Angiomotin (AMOT)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [233]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [220]
Testosterone enanthate DMB6871 N. A. N. A. Approved [445]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Ethanol DMDRQZU Chronic pain MG30 Approved [224]
Ampicillin DMHWE7P Acute epiglottitis Approved [58]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [684]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [230]
Arsenic DMTL2Y1 N. A. N. A. Approved [207]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [225]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [187]
Methotrexate DM2TEOL Anterior urethra cancer Approved [67]
Quercetin DM3NC4M Obesity 5B81 Approved [760]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [761]
Amifostine DM5FL14 Mucositis CA00 Approved [762]
Testosterone DM7HUNW Hot flushes GA30 Approved [86]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [763]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [356]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [356]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [356]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [406]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [406]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [279]
Testosterone DM7HUNW Hot flushes GA30 Approved [86]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [448]
Testosterone enanthate DMB6871 N. A. N. A. Approved [445]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [214]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [228]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [230]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [244]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [230]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
Urethane DM7NSI0 N. A. N. A. Phase 4 [213]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [203]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [563]
⏷ Show the Full List of 6 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [225]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [764]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [220]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Arsenic DMTL2Y1 N. A. N. A. Approved [207]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [225]
Permethrin DMZ0Q1G Pediculus capitis infestation 1G00.0 Approved [4]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [208]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [764]
acetaldehyde DMJFKG4 Discovery agent N.A. Investigative [278]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [244]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [211]
Drug(s) Affected By Speedy protein A (SPDYA)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [234]
Dihydrotestosterone DM3S8XC Prostate hyperplasia GA90 Phase 4 [272]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [219]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [765]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [215]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [211]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
PMID27336223-Compound-5 DM6E50A N. A. N. A. Patented [765]
Milchsaure DM462BT Pruritus EC90 Investigative [718]
⏷ Show the Full List of 6 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [77]
Leflunomide DMR8ONJ Arthritis FA20 Approved [62]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [75]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [199]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
Permethrin DMZ0Q1G Pediculus capitis infestation 1G00.0 Approved [4]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [217]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [219]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [225]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [221]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [75]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [216]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [202]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [226]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [214]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [217]
⏷ Show the Full List of 9 Drug(s)
Drug(s) Affected By Carboxypeptidase Z (CPZ)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [294]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [442]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [226]
Mifepristone DMGZQEF Cushing disease 5A70 Approved [449]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [211]
Cytarabine DMZD5QR Acute lymphoblastic leukaemia 2A85 Approved [212]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [208]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [737]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [217]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [219]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Kazrin (KAZN)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [223]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Amphotericin B DMTAJQE Acne vulgaris ED80 Approved [450]
Arsenic DMTL2Y1 N. A. N. A. Approved [207]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [249]
Vinblastine DM5TVS3 Advanced cancer 2A00-2F9Z Approved [201]
Mitomycin DMH0ZJE Breast cancer 2C60-2C65 Approved [201]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [201]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [279]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [685]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [575]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [226]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [214]
Genistein DM0JETC Menopause symptom GA30.0 Phase 2/3 [766]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [221]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Milchsaure DM462BT Pruritus EC90 Investigative [718]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [219]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [244]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [231]
Arsenic DMTL2Y1 N. A. N. A. Approved [207]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [767]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [73]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [274]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [218]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [288]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [530]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [223]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [211]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [768]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [226]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [228]
Deguelin DMXT7WG Esophageal squamous cell carcinoma 2E60.1 Investigative [769]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [737]
Drug(s) Affected By Opsin-5 (OPN5)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [219]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Arsenic DMTL2Y1 N. A. N. A. Approved [207]
Permethrin DMZ0Q1G Pediculus capitis infestation 1G00.0 Approved [4]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [219]
⏷ Show the Full List of 6 Drug(s)
Drug(s) Affected By ALK and LTK ligand 2 (ALKAL2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [222]
Panobinostat DM58WKG Chronic graft versus host disease Approved [214]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [220]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Permethrin DMZ0Q1G Pediculus capitis infestation 1G00.0 Approved [4]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [214]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [73]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [282]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [218]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic DMTL2Y1 N. A. N. A. Approved [713]
Permethrin DMZ0Q1G Pediculus capitis infestation 1G00.0 Approved [4]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [221]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Drug(s) Affected By R-spondin-2 (RSPO2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Panobinostat DM58WKG Chronic graft versus host disease Approved [214]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [233]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Melphalan DMOLNHF Hematologic disease 3C0Z Approved [258]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [211]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [214]
Cytarabine DMZD5QR Acute lymphoblastic leukaemia 2A85 Approved [212]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [214]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [218]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [228]
Arsenic DMTL2Y1 N. A. N. A. Approved [207]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [228]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Atorvastatin DMF28YC Acute coronary syndrome BA41 Approved [770]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Arsenic DMTL2Y1 N. A. N. A. Approved [207]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [211]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [202]
Pravastatin DM6A0X7 Adult acute monocytic leukemia Approved [771]
Rosuvastatin DMMIQ7G Arteriosclerosis BD40 Approved [771]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [771]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [202]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [262]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Panobinostat DM58WKG Chronic graft versus host disease Approved [772]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [230]
Arsenic DMTL2Y1 N. A. N. A. Approved [773]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [772]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [262]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [217]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [498]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [282]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [284]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [219]
GALLICACID DM6Y3A0 Discovery agent N.A. Investigative [774]
Drug(s) Affected By Olfactory receptor 2W3 (OR2W3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fenfluramine DM0762O Dravet syndrome 8A61.11 Phase 3 [775]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [217]
1,6-hexamethylene diisocyanate DMLB3RT Discovery agent N.A. Investigative [776]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Panobinostat DM58WKG Chronic graft versus host disease Approved [214]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [214]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [214]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic DMTL2Y1 N. A. N. A. Approved [207]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [615]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [219]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [222]
Panobinostat DM58WKG Chronic graft versus host disease Approved [214]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [220]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Azathioprine DMMZSXQ Lupus nephritis 4A40.0Y Approved [210]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [206]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [234]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [264]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [301]
Liothyronine DM6IR3P Congenital hypothyroidism Approved [777]
Testosterone DM7HUNW Hot flushes GA30 Approved [86]
Leflunomide DMR8ONJ Arthritis FA20 Approved [62]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [75]
Ethanol DMDRQZU Chronic pain MG30 Approved [579]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [196]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [279]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [244]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [205]
Dasatinib DMJV2EK Blast phase chronic myelogenous leukemia, BCR-ABL1 positive Approved [76]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [124]
Cytarabine DMZD5QR Acute lymphoblastic leukaemia 2A85 Approved [212]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Arsenic DMTL2Y1 N. A. N. A. Approved [207]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [218]
Drug(s) Affected By Protein FAM124A (FAM124A)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [222]
Panobinostat DM58WKG Chronic graft versus host disease Approved [214]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [208]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [219]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [218]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Permethrin DMZ0Q1G Pediculus capitis infestation 1G00.0 Approved [4]
Mivebresib DMCPF90 Acute myeloid leukaemia 2A60 Phase 1 [715]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Panobinostat DM58WKG Chronic graft versus host disease Approved [214]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [684]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [721]
DTI-015 DMXZRW0 Brain cancer 2A00 Approved [721]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [214]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [262]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [219]
Milchsaure DM462BT Pruritus EC90 Investigative [718]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [218]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [240]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Folic Acid DMEMBJC Colorectal carcinoma Approved [229]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [234]
Arsenic DMTL2Y1 N. A. N. A. Approved [207]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [240]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [217]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [218]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Contactin-4 (CNTN4)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [216]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [778]
3R14S-OCHRATOXIN A DM2KEW6 Discovery agent N.A. Investigative [778]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [219]
⏷ Show the Full List of 6 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [219]
Panobinostat DM58WKG Chronic graft versus host disease Approved [214]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [205]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [684]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [208]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [202]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [217]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Testosterone DM7HUNW Hot flushes GA30 Approved [61]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [61]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [216]
Dihydrotestosterone DM3S8XC Prostate hyperplasia GA90 Phase 4 [272]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [73]
Drug(s) Affected By Aquaporin-12A (AQP12A)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Drug(s) Affected By Copine-9 (CPNE9)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Clorgyline DMCEUJD Parkinson disease 8A00.0 Approved [779]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [220]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [205]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [230]
Ethinyl Estradiol DMODJ40 Acne vulgaris ED80 Approved [780]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [206]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [234]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [124]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Metallothionein-1M (MT1M)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [396]
Deoxycholic acid DM3GYAL Subcutaneous fat disorder EF02 Approved [352]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [483]
Phenoxybenzamine DM8KSQH Malignant essential hypertension BA00 Approved [352]
Leflunomide DMR8ONJ Arthritis FA20 Approved [62]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Disulfiram DMCL2OK Alcohol dependence 6C40.2 Approved [352]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [274]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Testosterone DM7HUNW Hot flushes GA30 Approved [61]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [61]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [684]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [234]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [202]
Permethrin DMZ0Q1G Pediculus capitis infestation 1G00.0 Approved [4]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [202]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Testosterone DM7HUNW Hot flushes GA30 Approved [86]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [356]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [205]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [230]
Adefovir Dipivoxil DMMAWY1 Hepatitis B virus infection 1E51.0 Approved [356]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [356]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
Permethrin DMZ0Q1G Pediculus capitis infestation 1G00.0 Approved [4]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [781]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [216]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [202]
Permethrin DMZ0Q1G Pediculus capitis infestation 1G00.0 Approved [4]
Urethane DM7NSI0 N. A. N. A. Phase 4 [213]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [217]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Testosterone DM7HUNW Hot flushes GA30 Approved [86]
Arsenic DMTL2Y1 N. A. N. A. Approved [207]
Permethrin DMZ0Q1G Pediculus capitis infestation 1G00.0 Approved [4]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Drug(s) Affected By Claudin-22 (CLDN22)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [234]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [217]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [570]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [219]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [263]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [294]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [244]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [782]
Fenofibrate DMFKXDY Coronary atherosclerosis Approved [264]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [264]
Melphalan DMOLNHF Hematologic disease 3C0Z Approved [258]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [222]
Panobinostat DM58WKG Chronic graft versus host disease Approved [214]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [475]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [216]
GSK2110183 DMZHB37 leukaemia 2A60-2B33 Phase 2 [783]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [218]
Sulforaphane DMQY3L0 Skin disease EA00-EM0Z Investigative [750]
⏷ Show the Full List of 8 Drug(s)
Drug(s) Affected By Beta-defensin 108B (DEFB108B)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Drug(s) Affected By Olfactory receptor 9G4 (OR9G4)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [784]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [219]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [785]
Arsenic DMTL2Y1 N. A. N. A. Approved [207]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [225]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [521]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [234]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [262]
Drug(s) Affected By Enkurin (ENKUR)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [57]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [124]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [559]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [219]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [279]
Testosterone DM7HUNW Hot flushes GA30 Approved [61]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [61]
Ethinyl Estradiol DMODJ40 Acne vulgaris ED80 Approved [786]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [208]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [217]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [682]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [56]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [223]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [56]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [211]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [73]
Milchsaure DM462BT Pruritus EC90 Investigative [718]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [228]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Sialidase-4 (NEU4)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [223]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [208]
Urethane DM7NSI0 N. A. N. A. Phase 4 [213]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [227]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [406]
Quercetin DM3NC4M Obesity 5B81 Approved [787]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [406]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [244]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [220]
Testosterone enanthate DMB6871 N. A. N. A. Approved [445]
Tofacitinib DMBS370 Rheumatoid arthritis FA20 Approved [788]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [230]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Barttin (BSND)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [216]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [270]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [222]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [372]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [244]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [230]
Piroxicam DMTK234 Osteoarthritis FA00-FA05 Approved [662]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [124]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [225]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Roundabout homolog 4 (ROBO4)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Arsenic DMTL2Y1 N. A. N. A. Approved [207]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [199]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [208]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [737]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [789]
AHPN DM8G6O4 Discovery agent N.A. Investigative [790]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [222]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [233]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [684]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [281]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [202]
Permethrin DMZ0Q1G Pediculus capitis infestation 1G00.0 Approved [4]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [208]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [233]
Leflunomide DMR8ONJ Arthritis FA20 Approved [62]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Paclitaxel DMLB81S Breast carcinoma Approved [791]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [216]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [225]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [520]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [202]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Mercaptopurine DMTM2IK Acute lymphoblastic leukaemia 2A85 Approved [43]
Methotrexate DM2TEOL Anterior urethra cancer Approved [406]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [406]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [434]
Leflunomide DMR8ONJ Arthritis FA20 Approved [62]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [74]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [274]
Azathioprine DMMZSXQ Lupus nephritis 4A40.0Y Approved [406]
Melphalan DMOLNHF Hematologic disease 3C0Z Approved [258]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [442]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [223]
Testosterone enanthate DMB6871 N. A. N. A. Approved [445]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [197]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [205]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [234]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Hyaluronan synthase 1 (HAS1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [208]
Resveratrol DM3RWXL Giant cell arteritis 4A44.2 Phase 3 [792]
Epigallocatechin gallate DMCGWBJ Hepatic fibrosis DB93.0 Phase 3 [792]
GUAIACOL DMN4E7T N. A. N. A. Phase 3 [792]
Genistein DM0JETC Menopause symptom GA30.0 Phase 2/3 [792]
DNCB DMDTVYC Immune System disease 4A01-4B41 Phase 2 [793]
Puerarin DMJIMXH Alcohol dependence 6C40.2 Phase 2 [792]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Chlorogenic acid DM2Y3P4 Discovery agent N.A. Investigative [792]
methyl p-hydroxybenzoate DMO58UW Discovery agent N.A. Investigative [794]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Ninjurin-1 (NINJ1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [305]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [562]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [434]
Testosterone DM7HUNW Hot flushes GA30 Approved [86]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [562]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [356]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [356]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [228]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [356]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein RFT1 homolog (RFT1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [220]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [75]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [685]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Urethane DM7NSI0 N. A. N. A. Phase 4 [213]
⏷ Show the Full List of 6 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [795]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [223]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [75]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [205]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [796]
Mitoxantrone DMM39BF Acute myelogenous leukaemia 2A41 Approved [201]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Testosterone DM7HUNW Hot flushes GA30 Approved [86]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [220]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [216]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [225]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [208]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [797]
⏷ Show the Full List of 7 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Panobinostat DM58WKG Chronic graft versus host disease Approved [214]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Arsenic DMTL2Y1 N. A. N. A. Approved [207]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [216]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [73]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [214]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [575]
PDX-101 DM6OC53 Plasma cell myeloma 2A83.1 Phase 2 [214]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [530]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [218]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
Urethane DM7NSI0 N. A. N. A. Phase 4 [213]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [798]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [719]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [339]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [220]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [228]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [230]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [559]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [228]
acetaldehyde DMJFKG4 Discovery agent N.A. Investigative [278]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Testosterone DM7HUNW Hot flushes GA30 Approved [61]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [61]
Leflunomide DMR8ONJ Arthritis FA20 Approved [62]
Bortezomib DMNO38U Leukemia Approved [419]
Amphotericin B DMTAJQE Acne vulgaris ED80 Approved [450]
Arsenic DMTL2Y1 N. A. N. A. Approved [207]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [799]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [559]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [222]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [442]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [684]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [234]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [225]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
Testosterone undecanoate DMZO10Y Hypogonadism 5A61.0 Approved [800]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [226]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [221]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Tumor protein D55 (TPD52L3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [225]
Fenfluramine DM0762O Dravet syndrome 8A61.11 Phase 3 [775]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Arsenic DMTL2Y1 N. A. N. A. Approved [207]
Urethane DM7NSI0 N. A. N. A. Phase 4 [213]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [282]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [295]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
Permethrin DMZ0Q1G Pediculus capitis infestation 1G00.0 Approved [4]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [214]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [637]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [219]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [218]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [223]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [218]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [230]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Arsenic DMTL2Y1 N. A. N. A. Approved [207]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [199]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [226]
Urethane DM7NSI0 N. A. N. A. Phase 4 [213]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [205]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [230]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [124]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [203]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [215]
Melphalan DMOLNHF Hematologic disease 3C0Z Approved [258]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [206]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [234]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [755]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [202]
Permethrin DMZ0Q1G Pediculus capitis infestation 1G00.0 Approved [4]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [282]
Sulforaphane DMQY3L0 Skin disease EA00-EM0Z Investigative [750]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein FAM227B (FAM227B)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [211]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [225]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [234]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [284]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [219]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [205]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [230]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Arsenic DMTL2Y1 N. A. N. A. Approved [801]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
Nabiximols DMHKJ5I Cancer related pain MG30 Phase 3 [802]
GSK2110183 DMZHB37 leukaemia 2A60-2B33 Phase 2 [783]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [684]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [216]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [637]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [219]
⏷ Show the Full List of 6 Drug(s)
Drug(s) Affected By Protocadherin-15 (PCDH15)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic DMTL2Y1 N. A. N. A. Approved [207]
Permethrin DMZ0Q1G Pediculus capitis infestation 1G00.0 Approved [4]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [208]
Chlorothiazide DMLHESP Chronic heart failure BD1Z Approved [803]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
COUMARIN DM0N8ZM Discovery agent N.A. Investigative [498]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [219]
⏷ Show the Full List of 7 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [442]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [804]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [249]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [202]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [208]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [214]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [217]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [465]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [805]
Dactinomycin DM2YGNW Adult kidney Wilms tumor Approved [806]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [71]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [71]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [807]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [279]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [294]
Testosterone DM7HUNW Hot flushes GA30 Approved [61]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [103]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [222]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [676]
Panobinostat DM58WKG Chronic graft versus host disease Approved [214]
Leflunomide DMR8ONJ Arthritis FA20 Approved [62]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [220]
Isoflurophate DMBSK7X Glaucoma/ocular hypertension 9C61 Approved [537]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [643]
Clozapine DMFC71L Schizophrenia 6A20 Approved [695]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Perilipin-2 (PLIN2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [808]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [264]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [72]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [286]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [196]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [356]
Leflunomide DMR8ONJ Arthritis FA20 Approved [62]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [809]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [127]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [75]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By C-C motif chemokine 19 (CCL19)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [152]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [160]
Arsenic DMTL2Y1 N. A. N. A. Approved [550]
Capecitabine DMTS85L Adenocarcinoma 2D40 Approved [810]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [216]
EUGENOL DM7US1H Discovery agent N.A. Patented [539]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [228]
PHENCYCLIDINE DMQBEYX Discovery agent N.A. Investigative [811]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Leflunomide DMR8ONJ Arthritis FA20 Approved [62]
ANW-32821 DMMJOZD N. A. N. A. Phase 2 [552]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [223]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [74]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [230]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Urethane DM7NSI0 N. A. N. A. Phase 4 [213]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [798]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [498]
COUMARIN DM0N8ZM Discovery agent N.A. Investigative [498]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [77]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [372]
Testosterone DM7HUNW Hot flushes GA30 Approved [86]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [356]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [356]
Propofol DMB4OLE Anaesthesia 9A78.6 Approved [311]
Testosterone enanthate DMB6871 N. A. N. A. Approved [445]
Sevoflurane DMC9O43 Anaesthesia 9A78.6 Approved [311]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [222]
Panobinostat DM58WKG Chronic graft versus host disease Approved [214]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [354]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [230]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [225]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [214]
Permethrin DMZ0Q1G Pediculus capitis infestation 1G00.0 Approved [4]
Vitamin A DMJ2AH4 Night blindness 9D45 Approved [812]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [214]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [305]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [199]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [219]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [270]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [230]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Clorgyline DMCEUJD Parkinson disease 8A00.0 Approved [779]
Arsenic DMTL2Y1 N. A. N. A. Approved [275]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [219]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Aspirin DM672AH Acute coronary syndrome BA41 Approved [43]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [59]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [535]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [356]
Leflunomide DMR8ONJ Arthritis FA20 Approved [62]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [356]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [356]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [220]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [127]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Panobinostat DM58WKG Chronic graft versus host disease Approved [214]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [237]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [216]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [813]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [202]
Permethrin DMZ0Q1G Pediculus capitis infestation 1G00.0 Approved [4]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [226]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [202]
PDX-101 DM6OC53 Plasma cell myeloma 2A83.1 Phase 2 [214]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [339]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [483]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [279]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [220]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Bosentan DMIOGBU Pulmonary arterial hypertension BB01.0 Approved [814]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [205]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [216]
Resveratrol DM3RWXL Giant cell arteritis 4A44.2 Phase 3 [815]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Arsenic DMTL2Y1 N. A. N. A. Approved [207]
Cocaine DMSOX7I Anaesthesia 9A78.6 Approved [816]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [219]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [218]
⏷ Show the Full List of 7 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [339]
Testosterone DM7HUNW Hot flushes GA30 Approved [61]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [61]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [220]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Arsenic DMTL2Y1 N. A. N. A. Approved [207]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [199]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [202]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [637]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [556]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [59]
Panobinostat DM58WKG Chronic graft versus host disease Approved [214]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [196]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [220]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [205]
Isoproterenol DMK7MEY Atrioventricular block Approved [679]
Ethinyl Estradiol DMODJ40 Acne vulgaris ED80 Approved [786]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [234]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [219]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [205]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [230]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [206]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [234]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [199]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [73]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [308]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [244]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [220]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [197]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [234]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [211]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [225]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [226]
Urethane DM7NSI0 N. A. N. A. Phase 4 [213]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [214]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Letrozole DMH07Y3 Estrogen-receptor positive breast cancer Approved [817]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Drug(s) Affected By Palmdelphin (PALMD)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [279]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [230]
Ethinyl Estradiol DMODJ40 Acne vulgaris ED80 Approved [786]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [234]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [199]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [225]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [406]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [241]
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [406]
Misoprostol DMHVJFK Medical abortion JA00.1Z Approved [818]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [419]
Azathioprine DMMZSXQ Lupus nephritis 4A40.0Y Approved [406]
Bortezomib DMNO38U Leukemia Approved [819]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [406]
Prednisolone DMQ8FR2 Acute adrenal insufficiency Approved [406]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Toll-like receptor 8 (TLR8)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Chloroquine DMSI5CB Malaria 1F40-1F45 Approved [820]
Arsenic DMTL2Y1 N. A. N. A. Approved [821]
Nabiximols DMHKJ5I Cancer related pain MG30 Phase 3 [802]
PF-4878691 DM24I0N Melanoma 2C30 Phase 2 [822]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Leflunomide DMR8ONJ Arthritis FA20 Approved [62]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [218]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [214]
Permethrin DMZ0Q1G Pediculus capitis infestation 1G00.0 Approved [4]
Clozapine DMFC71L Schizophrenia 6A20 Approved [823]
Dextroamphetamine DMMIHVP Attention deficit hyperactivity disorder 6A05.Z Approved [824]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [270]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [74]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
Drug(s) Affected By Gamma-1-syntrophin (SNTG1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Testosterone DM7HUNW Hot flushes GA30 Approved [86]
Arsenic DMTL2Y1 N. A. N. A. Approved [207]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [755]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [214]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [226]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [214]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [274]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [214]
acetaldehyde DMJFKG4 Discovery agent N.A. Investigative [278]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [124]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Drug(s) Affected By Interleukin-36 gamma (IL36G)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [279]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [228]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [205]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [685]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [825]
Milchsaure DM462BT Pruritus EC90 Investigative [718]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [228]
⏷ Show the Full List of 7 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [510]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Panobinostat DM58WKG Chronic graft versus host disease Approved [826]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [160]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [827]
Testosterone DM7HUNW Hot flushes GA30 Approved [61]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [244]
Leflunomide DMR8ONJ Arthritis FA20 Approved [62]
Sevoflurane DMC9O43 Anaesthesia 9A78.6 Approved [828]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [829]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [830]
Quercetin DM3NC4M Obesity 5B81 Approved [831]
Glucosamine DM4ZLFD Osteoarthritis FA00-FA05 Approved [832]
Folic Acid DMEMBJC Colorectal carcinoma Approved [229]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [784]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [675]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [833]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [284]
phenamil DMJLUFM Discovery agent N.A. Investigative [831]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [305]
Panobinostat DM58WKG Chronic graft versus host disease Approved [214]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [475]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [668]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [202]
Carbachol DMX9K8F Glaucoma/ocular hypertension 9C61 Approved [834]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [217]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [218]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Testosterone enanthate DMB6871 N. A. N. A. Approved [445]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [218]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [209]
Indomethacin DMSC4A7 Bursitis Approved [232]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [124]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [675]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [637]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [219]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Mucin-12 (MUC12)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [219]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [222]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [223]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [274]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [234]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [202]
Urethane DM7NSI0 N. A. N. A. Phase 4 [213]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [637]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [799]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [448]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [74]
Dasatinib DMJV2EK Blast phase chronic myelogenous leukemia, BCR-ABL1 positive Approved [76]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [230]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [199]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
Cytarabine DMZD5QR Acute lymphoblastic leukaemia 2A85 Approved [212]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [208]
Urethane DM7NSI0 N. A. N. A. Phase 4 [213]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [637]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein BCAP (ODF2L)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Testosterone DM7HUNW Hot flushes GA30 Approved [86]
Leflunomide DMR8ONJ Arthritis FA20 Approved [62]
Clorgyline DMCEUJD Parkinson disease 8A00.0 Approved [779]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [217]
Torcetrapib DMDHYM7 Hyperlipidaemia 5C80 Discontinued in Phase 2 [835]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [219]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Leflunomide DMR8ONJ Arthritis FA20 Approved [62]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [223]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [202]
Urethane DM7NSI0 N. A. N. A. Phase 4 [213]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [73]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [219]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [234]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [199]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [225]
Urethane DM7NSI0 N. A. N. A. Phase 4 [213]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [799]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [73]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [217]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [228]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [222]
Panobinostat DM58WKG Chronic graft versus host disease Approved [214]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [244]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [75]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [205]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [230]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [206]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [206]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [202]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Rabphilin-3A (RPH3A)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Ethanol DMDRQZU Chronic pain MG30 Approved [836]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [282]
Drug(s) Affected By Dystrobrevin alpha (DTNA)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Testosterone DM7HUNW Hot flushes GA30 Approved [86]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [223]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
Ethanol DMDRQZU Chronic pain MG30 Approved [614]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [230]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [198]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [237]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [837]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [200]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [214]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [226]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [284]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [217]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [498]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [209]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [77]
Methotrexate DM2TEOL Anterior urethra cancer Approved [406]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [406]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [286]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [348]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [838]
Leflunomide DMR8ONJ Arthritis FA20 Approved [62]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [223]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [236]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [305]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [222]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [244]
Leflunomide DMR8ONJ Arthritis FA20 Approved [62]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [73]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [144]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [75]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [237]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [199]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Acetylcholinesterase (AChE) TT1RS9F ACES_HUMAN Inhibitor [2]

Drug-Metabolizing Enzyme (DME)
DME Name DME ID UniProt ID MOA REF
Cytochrome P450 1A2 (CYP1A2) DEJGDUW CP1A2_HUMAN Substrate [3]
Cytochrome P450 2B6 (CYP2B6) DEPKLMQ CP2B6_HUMAN Substrate [3]

Drug Off-Target (DOT)
DOT Name DOT ID UniProt ID Interaction REF
1,5-anhydro-D-fructose reductase (AKR1E2) OT7GBQEB AKCL2_HUMAN Gene/Protein Processing [4]
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 (PLCB4) OTPA0QHW PLCB4_HUMAN Gene/Protein Processing [4]
25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial (CYP27B1) OTTK98BH CP27B_HUMAN Gene/Protein Processing [4]
A disintegrin and metalloproteinase with thrombospondin motifs 12 (ADAMTS12) OTG7HEA2 ATS12_HUMAN Gene/Protein Processing [4]
A disintegrin and metalloproteinase with thrombospondin motifs 20 (ADAMTS20) OTU0EKLN ATS20_HUMAN Gene/Protein Processing [4]
A disintegrin and metalloproteinase with thrombospondin motifs 6 (ADAMTS6) OTSZE6L4 ATS6_HUMAN Gene/Protein Processing [4]
Acetylcholinesterase (ACHE) OT2H8HG6 ACES_HUMAN Gene/Protein Processing [5]
Acid-sensing ion channel 5 (ASIC5) OT1KWTC1 ASIC5_HUMAN Gene/Protein Processing [4]
Acyl-CoA-binding domain-containing protein 5 (ACBD5) OT7L16DY ACBD5_HUMAN Gene/Protein Processing [4]
Acyl-coenzyme A thioesterase 6 (ACOT6) OTDE5QKC ACOT6_HUMAN Gene/Protein Processing [4]

References

1 FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 078743.
2 Acetylcholinesterase activity in Corbicula fluminea Mull., as a biomarker of organophosphate pesticide pollution in Pinacanauan River, Philippines. Environ Monit Assess. 2010 Jun;165(1-4):331-40.
3 Malathion bioactivation in the human liver: the contribution of different cytochrome p450 isoforms. Drug Metab Dispos. 2005 Mar;33(3):295-302.
4 Exposure to Insecticides Modifies Gene Expression and DNA Methylation in Hematopoietic Tissues In Vitro. Int J Mol Sci. 2023 Mar 26;24(7):6259. doi: 10.3390/ijms24076259.
5 Potency of several oximes to reactivate human acetylcholinesterase and butyrylcholinesterase inhibited by paraoxon in vitro. Chem Biol Interact. 2008 Sep 25;175(1-3):421-4.
6 Evidence that the clinical effects of cholinesterase inhibitors are related to potency and targeting of action. Int J Clin Pract Suppl. 2002 Jun;(127):6-19.
7 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2465).
8 [From symptomatic to disease modifying therapy Recent developments in the pharmacotherapy of Alzheimer's disease]. Fortschr Neurol Psychiatr. 2009 Jun;77(6):326-33.
9 Huperzine A attenuates cognitive deficits and brain injury in neonatal rats after hypoxia-ischemia. Brain Res. 2002 Sep 13;949(1-2):162-70.
10 Screening of acetylcholinesterase inhibitors by CE after enzymatic reaction at capillary inlet. J Sep Sci. 2009 May;32(10):1748-56.
11 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
12 Alpha6-containing nicotinic acetylcholine receptors dominate the nicotine control of dopamine neurotransmission in nucleus accumbens. Neuropsychopharmacology. 2008 Aug;33(9):2158-66.
13 The effects of topical ocular application of 0.25% demecarium bromide on serum acetylcholinesterase levels in normal dogs. Vet Ophthalmol. 2003 Mar;6(1):23-5.
14 Rational design of alkylene-linked bis-pyridiniumaldoximes as improved acetylcholinesterase reactivators. Chem Biol. 2003 Jun;10(6):491-502.
15 Neuromuscular blockade, reversal agent use, and operating room time: retrospective analysis of US inpatient surgeries. Curr Med Res Opin. 2009 Apr;25(4):943-50.
16 Roles of cytochromes P450 1A2, 2A6, and 2C8 in 5-fluorouracil formation from tegafur, an anticancer prodrug, in human liver microsomes. Drug Metab Dispos. 2000 Dec;28(12):1457-63.
17 Effects of polyunsaturated fatty acids on prostaglandin synthesis and cyclooxygenase-mediated DNA adduct formation by heterocyclic aromatic amines in human adenocarcinoma colon cells. Mol Carcinog. 2004 Jul;40(3):180-8.
18 Endoxifen and other metabolites of tamoxifen inhibit human hydroxysteroid sulfotransferase 2A1 (hSULT2A1). Drug Metab Dispos. 2014 Nov;42(11):1843-50.
19 Cytochrome P450 1A2 (CYP1A2) activity and risk factors for breast cancer: a cross-sectional study. Breast Cancer Res. 2004;6(4):R352-65.
20 PharmGKB summary: pathways of acetaminophen metabolism at the therapeutic versus toxic doses. Pharmacogenet Genomics. 2015 Aug;25(8):416-26.
21 The effect of apigenin on pharmacokinetics of imatinib and its metabolite N-desmethyl imatinib in rats. Biomed Res Int. 2013;2013:789184.
22 Effects of morin on the pharmacokinetics of etoposide in rats. Biopharm Drug Dispos. 2007 Apr;28(3):151-6.
23 The influence of metabolic gene polymorphisms on urinary 1-hydroxypyrene concentrations in Chinese coke oven workers. Sci Total Environ. 2007 Aug 1;381(1-3):38-46.
24 Identification of P450 enzymes involved in metabolism of verapamil in humans. Naunyn Schmiedebergs Arch Pharmacol. 1993 Sep;348(3):332-7.
25 Metabolism and metabolic inhibition of xanthotoxol in human liver microsomes. Evid Based Complement Alternat Med. 2016;2016:5416509.
26 Effect of tamoxifen on the enzymatic activity of human cytochrome CYP2B6. J Pharmacol Exp Ther. 2002 Jun;301(3):945-52.
27 Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab Rev. 2002 Feb-May;34(1-2):83-448.
28 Hepatic metabolism of diclofenac: role of human CYP in the minor oxidative pathways. Biochem Pharmacol. 1999 Sep 1;58(5):787-96.
29 Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms. Endocrinology. 2003 Aug;144(8):3382-98.
30 Insights into CYP2B6-mediated drug-drug interactions. Acta Pharm Sin B. 2016 Sep;6(5):413-425.
31 Drugs that may have potential CYP2B6 interactions.
32 Involvement of human cytochrome P450 2B6 in the omega- and 4-hydroxylation of the anesthetic agent propofol. Xenobiotica. 2007 Jul;37(7):717-24.
33 Nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-butanone metabolism by cytochrome P450 2B6. Drug Metab Dispos. 2005 Dec;33(12):1760-4.
34 PharmGKB summary: phenytoin pathway. Pharmacogenet Genomics. 2012 Jun;22(6):466-70.
35 Application of the relative activity factor approach in scaling from heterologously expressed cytochromes p450 to human liver microsomes: studies on amitriptyline as a model substrate. J Pharmacol Exp Ther. 2001 Apr;297(1):326-37.
36 In vitro inhibition of CYP1A2 by model inhibitors, anti-inflammatory analgesics and female sex steroids: predictability of in vivo interactions. Basic Clin Pharmacol Toxicol. 2008 Aug;103(2):157-65.
37 Effects of capsaicin and dihydrocapsaicin on human and rat liver microsomal CYP450 enzyme activities in vitro and in vivo. J Asian Nat Prod Res. 2012;14(4):382-95.
38 Drug interaction study of flavonoids toward CYP3A4 and their quantitative structure activity relationship (QSAR) analysis for predicting potential effects. Toxicol Lett. 2018 Sep 15;294:27-36.
39 Stiripentol. Expert Opin Investig Drugs. 2005 Jul;14(7):905-11.
40 Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug-drug interactions. Eur J Clin Pharmacol. 2000 Feb-Mar;55(11-12):843-52.
41 Mechanism-based inhibition of human liver microsomal cytochrome P450 1A2 by zileuton, a 5-lipoxygenase inhibitor. Drug Metab Dispos. 2003 Nov;31(11):1352-60.
42 Predictive three-dimensional quantitative structure-activity relationship of cytochrome P450 1A2 inhibitors. J Med Chem. 2005 Jun 2;48(11):3808-15.
43 ADReCS-Target: target profiles for aiding drug safety research and application. Nucleic Acids Res. 2018 Jan 4;46(D1):D911-D917. doi: 10.1093/nar/gkx899.
44 Cytochrome P450 inhibition potential of new psychoactive substances of the tryptamine class. Toxicol Lett. 2016 Jan 22;241:82-94.
45 Transcriptional profiling suggests that Nevirapine and Ritonavir cause drug induced liver injury through distinct mechanisms in primary human hepatocytes. Chem Biol Interact. 2016 Aug 5;255:31-44.
46 Evaluation of gene induction of drug-metabolizing enzymes and transporters in primary culture of human hepatocytes using high-sensitivity real-time reverse transcription PCR. Yakugaku Zasshi. 2002 May;122(5):339-61.
47 Thalidomide increases human hepatic cytochrome P450 3A enzymes by direct activation of the pregnane X receptor. Chem Res Toxicol. 2014 Feb 17;27(2):304-308.
48 Human constitutive androstane receptor mediates induction of CYP2B6 gene expression by phenytoin. J Biol Chem. 2004 Jul 9;279(28):29295-301. doi: 10.1074/jbc.M400580200. Epub 2004 Apr 28.
49 Identification of novel agonists by high-throughput screening and molecular modelling of human constitutive androstane receptor isoform 3. Arch Toxicol. 2019 Aug;93(8):2247-2264. doi: 10.1007/s00204-019-02495-6. Epub 2019 Jul 16.
50 Antimalarial artemisinin drugs induce cytochrome P450 and MDR1 expression by activation of xenosensors pregnane X receptor and constitutive androstane receptor. Mol Pharmacol. 2005 Jun;67(6):1954-65.
51 Species-specific mechanisms for cholesterol 7alpha-hydroxylase (CYP7A1) regulation by drugs and bile acids. Arch Biochem Biophys. 2005 Feb 1;434(1):75-85.
52 Pyrethroids: cytotoxicity and induction of CYP isoforms in human hepatocytes. Drug Metabol Drug Interact. 2008;23(3-4):211-36.
53 Transcriptional profiling of genes induced in the livers of patients treated with carbamazepine. Clin Pharmacol Ther. 2006 Nov;80(5):440-456.
54 Cannabidiol-induced transcriptomic changes and cellular senescence in human Sertoli cells. Toxicol Sci. 2023 Feb 17;191(2):227-238. doi: 10.1093/toxsci/kfac131.
55 mTOR inhibition reverses acquired endocrine therapy resistance of breast cancer cells at the cell proliferation and gene-expression levels. Cancer Sci. 2008 Oct;99(10):1992-2003. doi: 10.1111/j.1349-7006.2008.00955.x.
56 Time series analysis of oxidative stress response patterns in HepG2: a toxicogenomics approach. Toxicology. 2013 Apr 5;306:24-34.
57 Methotrexate modulates folate phenotype and inflammatory profile in EA.hy 926 cells. Eur J Pharmacol. 2014 Jun 5;732:60-7.
58 Comparison of phenotypic and transcriptomic effects of false-positive genotoxins, true genotoxins and non-genotoxins using HepG2 cells. Mutagenesis. 2011 Sep;26(5):593-604.
59 Effects of ciglitazone and troglitazone on the proliferation of human stomach cancer cells. World J Gastroenterol. 2009 Jan 21;15(3):310-20.
60 Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling. PLoS One. 2013 May 28;8(5):e63862.
61 Effects of 1alpha,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells. Mol Cancer. 2011 May 18;10:58.
62 Endoplasmic reticulum stress and MAPK signaling pathway activation underlie leflunomide-induced toxicity in HepG2 Cells. Toxicology. 2017 Dec 1;392:11-21.
63 Unique signatures of stress-induced senescent human astrocytes. Exp Neurol. 2020 Dec;334:113466. doi: 10.1016/j.expneurol.2020.113466. Epub 2020 Sep 17.
64 Effect of spironolactone on impaired fibrinolysis of hypertensive patients. Kidney Blood Press Res. 2002;25(4):260-4. doi: 10.1159/000066348.
65 Involvement of retinoic acid receptor alpha in the stimulation of tissue-type plasminogen-activator gene expression in human endothelial cells. Eur J Biochem. 1995 Sep 1;232(2):425-32.
66 Relation between long-term steroid treatment after heart transplantation, hypofibrinolysis and myocardial microthrombi generation. J Heart Lung Transplant. 1999 Jul;18(7):693-700. doi: 10.1016/s1053-2498(99)00021-2.
67 Functional gene expression profile underlying methotrexate-induced senescence in human colon cancer cells. Tumour Biol. 2011 Oct;32(5):965-76.
68 Simvastatin increases fibrinolytic activity in human peritoneal mesothelial cells independent of cholesterol lowering. Kidney Int. 2002 Nov;62(5):1611-9. doi: 10.1046/j.1523-1755.2002.00601.x.
69 Rofecoxib regulates the expression of genes related to the matrix metalloproteinase pathway in humans: implication for the adverse effects of cyclooxygenase-2 inhibitors. Clin Pharmacol Ther. 2006 Apr;79(4):303-15. doi: 10.1016/j.clpt.2005.12.306.
70 Non-nutritional sweeteners effects on endothelial vascular function. Toxicol In Vitro. 2020 Feb;62:104694. doi: 10.1016/j.tiv.2019.104694. Epub 2019 Oct 23.
71 Retinoic acid and its 4-oxo metabolites are functionally active in human skin cells in vitro. J Invest Dermatol. 2005 Jul;125(1):143-53.
72 Retinoic acid-induced downmodulation of telomerase activity in human cancer cells. Exp Mol Pathol. 2005 Oct;79(2):108-17.
73 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.
74 Stem cell transcriptome responses and corresponding biomarkers that indicate the transition from adaptive responses to cytotoxicity. Chem Res Toxicol. 2017 Apr 17;30(4):905-922.
75 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22.
76 Dasatinib reverses cancer-associated fibroblasts (CAFs) from primary lung carcinomas to a phenotype comparable to that of normal fibroblasts. Mol Cancer. 2010 Jun 27;9:168.
77 Global gene expression analysis reveals differences in cellular responses to hydroxyl- and superoxide anion radical-induced oxidative stress in caco-2 cells. Toxicol Sci. 2010 Apr;114(2):193-203. doi: 10.1093/toxsci/kfp309. Epub 2009 Dec 31.
78 Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 2020 Nov 5;9(11):2423. doi: 10.3390/cells9112423.
79 Synergistic interaction of lovastatin and paclitaxel in human cancer cells. Mol Cancer Ther. 2001 Dec;1(2):141-9.
80 Type 5 17beta-hydroxysteroid dehydrogenase/prostaglandin F synthase (AKR1C3): role in breast cancer and inhibition by non-steroidal anti-inflammatory drug analogs. Chem Biol Interact. 2009 Mar 16;178(1-3):221-7.
81 Substrate specificity of human 3(20)alpha-hydroxysteroid dehydrogenase for neurosteroids and its inhibition by benzodiazepines. Biol Pharm Bull. 2002 Apr;25(4):441-5.
82 Gene expression after treatment with hydrogen peroxide, menadione, or t-butyl hydroperoxide in breast cancer cells. Cancer Res. 2002 Nov 1;62(21):6246-54.
83 A new in vitro method for identifying chemical sensitizers combining peptide binding with ARE/EpRE-mediated gene expression in human skin cells. Cutan Ocul Toxicol. 2010 Sep;29(3):171-92.
84 Aberrantly expressed genes in HaCaT keratinocytes chronically exposed to arsenic trioxide. Biomark Insights. 2011 Feb 8;6:7-16.
85 Thyroid hormone responsive genes in cultured human fibroblasts. J Clin Endocrinol Metab. 2005 Feb;90(2):936-43.
86 The exosome-like vesicles derived from androgen exposed-prostate stromal cells promote epithelial cells proliferation and epithelial-mesenchymal transition. Toxicol Appl Pharmacol. 2021 Jan 15;411:115384. doi: 10.1016/j.taap.2020.115384. Epub 2020 Dec 25.
87 Progestin effects on expression of AKR1C1-AKR1C3, SRD5A1 and PGR in the Z-12 endometriotic epithelial cell line. Chem Biol Interact. 2013 Feb 25;202(1-3):218-25.
88 Isoform-specific induction of a human aldo-keto reductase by polycyclic aromatic hydrocarbons (PAHs), electrophiles, and oxidative stress: implications for the alternative pathway of PAH activation catalyzed by human dihydrodiol dehydrogenase. Cancer Res. 1999 Feb 1;59(3):607-14.
89 Simvastatin inactivates beta1-integrin and extracellular signal-related kinase signaling and inhibits cell proliferation in head and neck squamous cell carcinoma cells. Cancer Sci. 2007 Jun;98(6):890-9.
90 Initro inhibition of AKR1Cs by sulphonylureas and the structural basis. Chem Biol Interact. 2015 Oct 5;240:310-5.
91 Increased organophosphate scavenging in a butyrylcholinesterase mutant. Chem Biol Interact. 2008 Sep 25;175(1-3):376-9. doi: 10.1016/j.cbi.2008.04.012. Epub 2008 Apr 22.
92 Comparative effects of cationic triarylmethane, phenoxazine and phenothiazine dyes on horse serum butyrylcholinesterase. Arch Biochem Biophys. 2008 Oct 15;478(2):201-5.
93 Lichens of parmelioid clade as promising multitarget neuroprotective agents. Chem Res Toxicol. 2019 Jun 17;32(6):1165-1177.
94 Potencies and selectivities of inhibitors of acetylcholinesterase and its molecular forms in normal and Alzheimer's disease brain. Acta Biol Hung. 2003;54(2):183-9. doi: 10.1556/ABiol.54.2003.2.7.
95 Response of the newborn to succinlycholine injection in homozygotic atypical mothers. Anesthesiology. 1975 Jul;43(1):115-6. doi: 10.1097/00000542-197507000-00028.
96 Cholinesterase inhibition by phenothiazine and nonphenothiazine antihistaminics: analysis of its postulated role in synergizing organophosphate toxicity. Toxicol Appl Pharmacol. 1975 Feb;31(2):179-90.
97 Qualitative defects of pseudocholinesterase activity. Anaesthesia. 1967 Jan;22(1):55-68.
98 Microarray analysis of H2O2-, HNE-, or tBH-treated ARPE-19 cells. Free Radic Biol Med. 2002 Nov 15;33(10):1419-32.
99 [Effects of Arsenic Trioxide on Cdc20 and Mad2 in Acute Myeloid Leukemia HL-60 Cell Line]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018 Jun;26(3):710-715. doi: 10.7534/j.issn.1009-2137.2018.03.013.
100 Monitoring the reaction of carbachol with acetylcholinesterase by thioflavin T fluorescence and acetylthiocholine hydrolysis. Chem Biol Interact. 2008 Sep 25;175(1-3):235-41. doi: 10.1016/j.cbi.2008.06.002. Epub 2008 Jun 17.
101 Effect of reversible ligands on oxime-induced reactivation of sarin- and cyclosarin-inhibited human acetylcholinesterase. Toxicol Lett. 2015 Feb 3;232(3):557-65.
102 Dihydroactinidiolide regulates Nrf2/HO-1 expression and inhibits caspase-3/Bax pathway to protect SH-SY5Y human neuroblastoma cells from oxidative stress induced neuronal apoptosis. Neurotoxicology. 2021 May;84:53-63. doi: 10.1016/j.neuro.2021.02.006. Epub 2021 Feb 20.
103 Global molecular effects of tocilizumab therapy in rheumatoid arthritis synovium. Arthritis Rheumatol. 2014 Jan;66(1):15-23.
104 Tribromophenol induces the differentiation of SH-SY5Y human neuroblastoma cells in vitro. Toxicol In Vitro. 2003 Oct-Dec;17(5-6):635-41. doi: 10.1016/s0887-2333(03)00110-3.
105 Correlation of brain levels of 9-amino-1,2,3,4-tetrahydroacridine (THA) with neurochemical and behavioral changes. Eur J Pharmacol. 1989 Nov 28;173(1):53-64. doi: 10.1016/0014-2999(89)90008-3.
106 Interaction of dichlorvos and anticholinesterases on the in vitro inhibition of human blood cholinesterases. Toxicol Appl Pharmacol. 1974 Feb;27(2):456-63.
107 Hairy-root organ cultures for the production of human acetylcholinesterase. BMC Biotechnol. 2008 Dec 23;8:95.
108 Characterization of the structural determinants required for potent mechanism-based inhibition of human cytochrome P450 1A1 by cannabidiol. Chem Biol Interact. 2014 May 25;215:62-8.
109 Comparative effects of thiazolidinediones on in vitro P450 enzyme induction and inhibition. Drug Metab Dispos. 2003 Apr;31(4):439-46.
110 Application of higher throughput screening (HTS) inhibition assays to evaluate the interaction of antiparasitic drugs with cytochrome P450s. Drug Metab Dispos. 2001 Jan;29(1):30-5.
111 The novel azole R126638 is a selective inhibitor of ergosterol synthesis in Candida albicans, Trichophyton spp., and Microsporum canis. Antimicrob Agents Chemother. 2004 Sep;48(9):3272-8.
112 Potential of pranlukast and zafirlukast in the inhibition of human liver cytochrome P450 enzymes. Xenobiotica. 2004 May;34(5):429-38.
113 The inhibitory effect of polyunsaturated fatty acids on human CYP enzymes. Life Sci. 2006 Nov 25;79(26):2432-40.
114 The relative role of CYP3A4 and CYP3A5 in eplerenone metabolism. Toxicol Lett. 2019 Oct 15;315:9-13.
115 Retinoids activate the RXR/SXR-mediated pathway and induce the endogenous CYP3A4 activity in Huh7 human hepatoma cells. Toxicol Sci. 2006 Jul;92(1):51-60.
116 Cetirizine and loratadine-based antihistamines with 5-lipoxygenase inhibitory activity. Bioorg Med Chem Lett. 2004 Nov 15;14(22):5591-4.
117 Mechanism-based inactivation of CYP3A by HIV protease inhibitors. J Pharmacol Exp Ther. 2005 Feb;312(2):583-91.
118 Studies of the toxicological potential of capsinoids, XIII: inhibitory effects of capsaicin and capsinoids on cytochrome P450 3A4 in human liver microsomes. Int J Toxicol. 2010 Mar;29(2 Suppl):22S-6S.
119 Investigation of the effects of axitinib on the pharmacokinetics of loperamide and its main metabolite N-demethylated loperamide in rats by UPLC-MS/MS. Chem Biol Interact. 2019 Sep 1;310:108744. doi: 10.1016/j.cbi.2019.108744. Epub 2019 Jul 9.
120 Cyp2a6 is a principal enzyme involved in hydroxylation of 1,7-dimethylxanthine, a main caffeine metabolite, in humans. Drug Metab Dispos. 2005 Sep;33(9):1361-6. doi: 10.1124/dmd.105.004796. Epub 2005 Jun 24.
121 Mimicking gene defects to treat drug dependence. Ann N Y Acad Sci. 2000;909:233-46. doi: 10.1111/j.1749-6632.2000.tb06685.x.
122 Expression of CYP2A6 in tumor cells augments cellular sensitivity to tegafur. Jpn J Cancer Res. 2001 May;92(5):524-8. doi: 10.1111/j.1349-7006.2001.tb01125.x.
123 CYP1A1/1B1 and CYP2A6/2A13 activity is conserved in cultures of differentiated primary human tracheobronchial epithelial cells. Toxicol In Vitro. 2011 Jun;25(4):922-9.
124 Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans. Arch Toxicol. 2018 Feb;92(2):845-858.
125 Isoform-specific regulation of cytochromes P450 expression by estradiol and progesterone. Drug Metab Dispos. 2013 Feb;41(2):263-9.
126 Measurement of 4-hydroxylation of ifosfamide in human liver microsomes using the estimation of free and protein-bound acrolein and codetermination of keto- and carboxyifosfamide. J Cancer Res Clin Oncol. 2002 Jul;128(7):385-92.
127 Integrated 'omics analysis reveals new drug-induced mitochondrial perturbations in human hepatocytes. Toxicol Lett. 2018 Jun 1;289:1-13.
128 Deactivation of anti-cancer drug letrozole to a carbinol metabolite by polymorphic cytochrome P450 2A6 in human liver microsomes. Xenobiotica. 2009 Nov;39(11):795-802. doi: 10.3109/00498250903171395.
129 A novel single nucleotide polymorphism altering stability and activity of CYP2a6. Biochem Biophys Res Commun. 2001 Mar 2;281(3):810-4. doi: 10.1006/bbrc.2001.4422.
130 Identification of HMG-CoA reductase inhibitors as activators for human, mouse and rat constitutive androstane receptor. Drug Metab Dispos. 2005 Jul;33(7):924-9.
131 Bioactive terpenoids and flavonoids from Ginkgo biloba extract induce the expression of hepatic drug-metabolizing enzymes through pregnane X receptor, constitutive androstane receptor, and aryl hydrocarbon receptor-mediated pathways. Pharm Res. 2009 Apr;26(4):872-82.
132 Species-specific toxicity of diclofenac and troglitazone in primary human and rat hepatocytes. Chem Biol Interact. 2009 Apr 15;179(1):17-24.
133 Fetal bovine serum and human constitutive androstane receptor: evidence for activation of the SV23 splice variant by artemisinin, artemether, and arteether in a serum-free cell culture system. Toxicol Appl Pharmacol. 2014 Jun 1;277(2):221-30. doi: 10.1016/j.taap.2014.03.023. Epub 2014 Apr 12.
134 Constitutive androstane/active receptor is a target of retinoic acid receptor in humans. Biochem Pharmacol. 2010 Jul 1;80(1):129-35. doi: 10.1016/j.bcp.2010.02.023. Epub 2010 Mar 6.
135 Robustness testing and optimization of an adverse outcome pathway on cholestatic liver injury. Arch Toxicol. 2020 Apr;94(4):1151-1172. doi: 10.1007/s00204-020-02691-9. Epub 2020 Mar 10.
136 Expression and inducibility of cytochrome P450s (CYP1A1, 2B6, 2E1, 3A4) in human cord blood CD34(+) stem cell-derived differentiating neuronal cells. Toxicol Sci. 2012 Oct;129(2):392-410.
137 Agonistic effects of diverse xenobiotics on the constitutive androstane receptor as detected in a recombinant yeast-cell assay. Toxicol In Vitro. 2018 Feb;46:335-349. doi: 10.1016/j.tiv.2017.09.014. Epub 2017 Sep 18.
138 Teriflunomide is an indirect human constitutive androstane receptor (CAR) activator interacting with epidermal growth factor (EGF) signaling. Front Pharmacol. 2018 Oct 11;9:993.
139 Chemical inhibitors of cytochrome P450 isoforms in human liver microsomes: a re-evaluation of P450 isoform selectivity. Eur J Drug Metab Pharmacokinet. 2011 Mar;36(1):1-16.
140 Inhibition of CYP2E1 catalytic activity in vitro by S-adenosyl-L-methionine. Biochem Pharmacol. 2005 Apr 1;69(7):1081-93.
141 Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins. Cell Biol Toxicol. 2012 Apr;28(2):69-87.
142 An in vitro model of human acute ethanol exposure that incorporates CXCR3- and CXCR4-dependent recruitment of immune cells. Toxicol Sci. 2013 Mar;132(1):131-41.
143 Proteomic analysis of hepatic effects of phenobarbital in mice with humanized liver. Arch Toxicol. 2022 Oct;96(10):2739-2754. doi: 10.1007/s00204-022-03338-7. Epub 2022 Jul 26.
144 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
145 Inhibition of cytochrome P450 enzymes participating in p-nitrophenol hydroxylation by drugs known as CYP2E1 inhibitors. Chem Biol Interact. 2004 Apr 15;147(3):331-40.
146 Gypenosides protect retinal pigment epithelium cells from oxidative stress. Food Chem Toxicol. 2018 Feb;112:76-85.
147 Role of antioxidant systems in human androgen-independent prostate cancer cells. Prostate. 2000 May 1;43(2):144-9. doi: 10.1002/(sici)1097-0045(20000501)43:2<144::aid-pros9>3.0.co;2-h.
148 Cytotoxic Effects of Cannabinoids on Human HT-29 Colorectal Adenocarcinoma Cells: Different Mechanisms of THC, CBD, and CB83. Int J Mol Sci. 2020 Aug 1;21(15):5533. doi: 10.3390/ijms21155533.
149 Selenium deficiency alters epithelial cell morphology and responses to influenza. Free Radic Biol Med. 2007 Jun 15;42(12):1826-37.
150 Hepatocellular peroxisomes in human alcoholic and drug-induced hepatitis: a quantitative study. Hepatology. 1991 Nov;14(5):811-7.
151 Antioxidant enzyme and malondialdehyde values in social phobia before and after citalopram treatment. Eur Arch Psychiatry Clin Neurosci. 2004 Aug;254(4):231-5.
152 The contribution of methotrexate exposure and host factors on transcriptional variance in human liver. Toxicol Sci. 2007 Jun;97(2):582-94.
153 The effect of statins on lipids peroxidation and activities of antioxidants enzymes in patients with dyslipidemia. Przegl Lek. 2006;63(9):738-42.
154 G2 delay induced by nitrogen mustard in human cells affects cyclin A/cdk2 and cyclin B1/cdc2-kinase complexes differently. J Biol Chem. 1993 Apr 15;268(11):8298-308.
155 Gene expression profiles with activation of the estrogen receptor alpha-selective estrogen receptor modulator complex in breast cancer cells expressing wild-type estrogen receptor. Cancer Res. 2002 Aug 1;62(15):4419-26.
156 Selenite and selenomethionine promote HL-60 cell cycle progression. J Nutr. 2002 Apr;132(4):674-9. doi: 10.1093/jn/132.4.674.
157 Bexarotene activates the p53/p73 pathway in human cutaneous T-cell lymphoma. Br J Dermatol. 2009 Mar;160(3):519-26. doi: 10.1111/j.1365-2133.2008.08931.x. Epub 2008 Nov 25.
158 Ciprofloxacin mediated cell growth inhibition, S/G2-M cell cycle arrest, and apoptosis in a human transitional cell carcinoma of the bladder cell line. Clin Cancer Res. 2000 Mar;6(3):891-900.
159 Synthesis and antitumor evaluation of nitrovinyl biphenyls: anticancer agents based on allocolchicines. ChemMedChem. 2011 May 2;6(5):859-68. doi: 10.1002/cmdc.201100019. Epub 2011 Apr 6.
160 Expression profile analysis of colon cancer cells in response to sulindac or aspirin. Biochem Biophys Res Commun. 2002 Mar 29;292(2):498-512.
161 Cannabidiol and Oxygen-Ozone Combination Induce Cytotoxicity in Human Pancreatic Ductal Adenocarcinoma Cell Lines. Cancers (Basel). 2020 Sep 27;12(10):2774. doi: 10.3390/cancers12102774.
162 Estrogen regulation in human breast cancer cells of new downstream gene targets involved in estrogen metabolism, cell proliferation and cell transformation. J Mol Endocrinol. 2004 Apr;32(2):397-414.
163 Ribavirin inhibits colorectal cancer growth by downregulating PRMT5 expression and H3R8me2s and H4R3me2s accumulation. Toxicol Appl Pharmacol. 2021 Mar 15;415:115450. doi: 10.1016/j.taap.2021.115450. Epub 2021 Feb 9.
164 Sulindac induces specific degradation of the HPV oncoprotein E7 and causes growth arrest and apoptosis in cervical carcinoma cells. Cancer Lett. 2007 Jan 8;245(1-2):103-11. doi: 10.1016/j.canlet.2005.12.034. Epub 2006 Feb 20.
165 CDK4/6 inhibition provides a potent adjunct to Her2-targeted therapies in preclinical breast cancer models. Genes Cancer. 2014 Jul;5(7-8):261-72. doi: 10.18632/genesandcancer.24.
166 Cannabidiol enhances cytotoxicity of anti-cancer drugs in human head and neck squamous cell carcinoma. Sci Rep. 2020 Nov 26;10(1):20622. doi: 10.1038/s41598-020-77674-y.
167 Estrogen receptor regulates E2F1 expression to mediate tamoxifen resistance. Mol Cancer Res. 2010 Mar;8(3):343-52. doi: 10.1158/1541-7786.MCR-09-0395. Epub 2010 Mar 9.
168 Fluoxetine mediates G0/G1 arrest by inducing functional inhibition of cyclin dependent kinase subunit (CKS)1. Biochem Pharmacol. 2008 May 15;75(10):1924-34. doi: 10.1016/j.bcp.2008.02.013. Epub 2008 Feb 17.
169 Troglitazone suppresses cell growth of KU812 cells independently of PPARgamma. Eur J Pharmacol. 2002 Feb 1;436(1-2):7-13. doi: 10.1016/s0014-2999(01)01577-1.
170 Retinoic acid regulates cell cycle progression and cell differentiation in human monocytic THP-1 cells. Exp Cell Res. 2004 Jul 1;297(1):68-81. doi: 10.1016/j.yexcr.2004.02.017.
171 [P27(Kip1), cyclin E and endogenous TGF-beta1 changes in apoptosis of NB4 cells induced by As(2)O(3) and/or TGF-beta1 and their significance]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Feb;17(1):74-9.
172 Different apoptosis ratios and gene expressions in two human cell lines after sevoflurane anaesthesia. Acta Anaesthesiol Scand. 2009 Oct;53(9):1192-9. doi: 10.1111/j.1399-6576.2009.02036.x. Epub 2009 Jun 30.
173 [Mechanisms underlying the effect of arsenic trioxide on proliferation inhibition and apoptosis induction in myeloma cell line u266]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007 Oct;15(5):982-5.
174 Lovastatin lactone elicits human lung cancer cell apoptosis via a COX-2/PPAR-dependent pathway. Oncotarget. 2016 Mar 1;7(9):10345-62. doi: 10.18632/oncotarget.7213.
175 Induction of apoptosis by cidofovir in human papillomavirus (HPV)-positive cells. Oncol Res. 2000;12(9-10):397-408. doi: 10.3727/096504001108747855.
176 Comparison of burst of reactive oxygen species and activation of caspase-3 in apoptosis of K562 and HL-60 cells induced by docetaxel. Cancer Lett. 2004 Oct 8;214(1):103-13. doi: 10.1016/j.canlet.2004.03.047.
177 Induction of mitochondrial manganese superoxide dismutase confers resistance to apoptosis in acute myeloblastic leukaemia cells exposed to etoposide. Br J Haematol. 2000 Mar;108(3):574-81. doi: 10.1046/j.1365-2141.2000.01852.x.
178 Cisplatin-enhanced sensitivity of glioblastoma multiforme U251 cells to adenovirus-delivered TRAIL in vitro. Tumour Biol. 2010 Dec;31(6):613-22. doi: 10.1007/s13277-010-0077-x. Epub 2010 Jul 11.
179 Insulin-like growth factor I is the key growth factor in serum that protects neuroblastoma cells from hyperosmotic-induced apoptosis. J Cell Physiol. 2000 Jan;182(1):24-32. doi: 10.1002/(SICI)1097-4652(200001)182:1<24::AID-JCP3>3.0.CO;2-6.
180 mRNA expression analysis of a variety of apoptosis-related genes, including the novel gene of the BCL2-family, BCL2L12, in HL-60 leukemia cells after treatment with carboplatin and doxorubicin. Biol Chem. 2004 Nov;385(11):1099-103. doi: 10.1515/BC.2004.143.
181 Neurokinin-1 receptor (NK1R) inhibition sensitizes APL cells to anti-tumor effect of arsenic trioxide via restriction of NF-B axis: Shedding new light on resistance to Aprepitant. Int J Biochem Cell Biol. 2018 Oct;103:105-114. doi: 10.1016/j.biocel.2018.08.010. Epub 2018 Aug 23.
182 Lovastatin induces apoptosis of anaplastic thyroid cancer cells via inhibition of protein geranylgeranylation and de novo protein synthesis. Endocrinology. 2003 Sep;144(9):3852-9. doi: 10.1210/en.2003-0098.
183 Insulin-like growth factor I prevents mannitol-induced degradation of focal adhesion kinase and Akt. J Biol Chem. 2002 Jul 26;277(30):27393-400. doi: 10.1074/jbc.M201963200. Epub 2002 May 14.
184 Inhibition of caspase-dependent mitochondrial permeability transition protects airway epithelial cells against mustard-induced apoptosis. Apoptosis. 2006 Sep;11(9):1545-59. doi: 10.1007/s10495-006-8764-1.
185 Effects of gonadotrophin-releasing hormone agonists on apoptosis of granulosa cells. Ann N Y Acad Sci. 2005 May;1042:531-7. doi: 10.1196/annals.1338.065.
186 The effects of quercetin in cultured human RPE cells under oxidative stress and in Ccl2/Cx3cr1 double deficient mice. Exp Eye Res. 2010 Jul;91(1):15-25.
187 Apoptotic signaling pathways induced by nitric oxide in human lymphoblastoid cells expressing wild-type or mutant p53. Cancer Res. 2004 May 1;64(9):3022-9. doi: 10.1158/0008-5472.can-03-1880.
188 Inhibiting AKT signaling pathway with cilostazol and meloxicam synergism for suppressing K562 cells in vitro. J Biochem Mol Toxicol. 2022 Nov;36(11):e23185. doi: 10.1002/jbt.23185. Epub 2022 Aug 3.
189 Ciprofloxacin induces apoptosis and inhibits proliferation of human colorectal carcinoma cells. Br J Cancer. 2002 Feb 1;86(3):443-8. doi: 10.1038/sj.bjc.6600079.
190 Colchicine-induced apoptosis in human normal liver L-02 cells by mitochondrial mediated pathways. Toxicol In Vitro. 2012 Aug;26(5):649-55. doi: 10.1016/j.tiv.2012.01.024. Epub 2012 Feb 8.
191 4.8% sevoflurane induces activation of autophagy in human neuroblastoma SH-SY5Y cells by the AMPK/mTOR signaling pathway. Neurotoxicology. 2022 May;90:256-264. doi: 10.1016/j.neuro.2022.04.008. Epub 2022 Apr 23.
192 Verapamil potentiates anti-glioblastoma efficacy of temozolomide by modulating apoptotic signaling. Toxicol In Vitro. 2018 Oct;52:306-313. doi: 10.1016/j.tiv.2018.07.001. Epub 2018 Jul 9.
193 Beta-carotene and apocarotenals promote retinoid signaling in BEAS-2B human bronchioepithelial cells. Arch Biochem Biophys. 2006 Nov 1;455(1):48-60.
194 BMN 673 (talazoparib): A potent PARP inhibitor for triple negative breast cancer with different genetic profile. J Biochem Mol Toxicol. 2019 May;33(5):e22286. doi: 10.1002/jbt.22286. Epub 2019 Jan 23.
195 Combining kallistatin gene therapy and meloxicam to treat hepatocellular carcinoma in mice. Cancer Sci. 2009 Nov;100(11):2226-33. doi: 10.1111/j.1349-7006.2009.01306.x. Epub 2009 Aug 4.
196 Essential role of cell cycle regulatory genes p21 and p27 expression in inhibition of breast cancer cells by arsenic trioxide. Med Oncol. 2011 Dec;28(4):1225-54.
197 The neuroprotective action of the mood stabilizing drugs lithium chloride and sodium valproate is mediated through the up-regulation of the homeodomain protein Six1. Toxicol Appl Pharmacol. 2009 Feb 15;235(1):124-34.
198 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
199 Gene expression analysis of precision-cut human liver slices indicates stable expression of ADME-Tox related genes. Toxicol Appl Pharmacol. 2011 May 15;253(1):57-69.
200 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
201 Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations. Int J Cancer. 2006 Apr 1;118(7):1699-712. doi: 10.1002/ijc.21570.
202 Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Toxukn and STOP-Toxukk tests. Arch Toxicol. 2017 Feb;91(2):839-864.
203 Transcriptional signature of human macrophages exposed to the environmental contaminant benzo(a)pyrene. Toxicol Sci. 2010 Apr;114(2):247-59.
204 Chronic ethanol exposure increases goosecoid (GSC) expression in human embryonic carcinoma cell differentiation. J Appl Toxicol. 2014 Jan;34(1):66-75.
205 Interleukin-19 as a translational indicator of renal injury. Arch Toxicol. 2015 Jan;89(1):101-6.
206 Acute hypersensitivity of pluripotent testicular cancer-derived embryonal carcinoma to low-dose 5-aza deoxycytidine is associated with global DNA Damage-associated p53 activation, anti-pluripotency and DNA demethylation. PLoS One. 2012;7(12):e53003. doi: 10.1371/journal.pone.0053003. Epub 2012 Dec 27.
207 Prenatal arsenic exposure and the epigenome: identifying sites of 5-methylcytosine alterations that predict functional changes in gene expression in newborn cord blood and subsequent birth outcomes. Toxicol Sci. 2015 Jan;143(1):97-106. doi: 10.1093/toxsci/kfu210. Epub 2014 Oct 10.
208 Transcriptome and DNA methylome dynamics during triclosan-induced cardiomyocyte differentiation toxicity. Stem Cells Int. 2018 Oct 29;2018:8608327.
209 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
210 A transcriptomics-based in vitro assay for predicting chemical genotoxicity in vivo. Carcinogenesis. 2012 Jul;33(7):1421-9.
211 Predictive toxicology using systemic biology and liver microfluidic "on chip" approaches: application to acetaminophen injury. Toxicol Appl Pharmacol. 2012 Mar 15;259(3):270-80.
212 Cytosine arabinoside induces ectoderm and inhibits mesoderm expression in human embryonic stem cells during multilineage differentiation. Br J Pharmacol. 2011 Apr;162(8):1743-56.
213 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
214 A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors. Arch Toxicol. 2015 Sep;89(9):1599-618.
215 Identification by automated screening of a small molecule that selectively eliminates neural stem cells derived from hESCs but not dopamine neurons. PLoS One. 2009 Sep 23;4(9):e7155.
216 Blood transcript immune signatures distinguish a subset of people with elevated serum ALT from others given acetaminophen. Clin Pharmacol Ther. 2016 Apr;99(4):432-41.
217 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761. doi: 10.1016/j.taap.2019.114761. Epub 2019 Sep 15.
218 From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects. Arch Toxicol. 2014 Jul;88(7):1451-68.
219 DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer. Clin Epigenetics. 2019 Oct 10;11(1):138. doi: 10.1186/s13148-019-0725-y.
220 Integrative "-Omics" analysis in primary human hepatocytes unravels persistent mechanisms of cyclosporine A-induced cholestasis. Chem Res Toxicol. 2016 Dec 19;29(12):2164-2174.
221 CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer. J Clin Invest. 2016 Feb;126(2):639-52.
222 Development of a neural teratogenicity test based on human embryonic stem cells: response to retinoic acid exposure. Toxicol Sci. 2011 Dec;124(2):370-7.
223 Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015 Apr;29(3):489-501.
224 Gene expression signatures after ethanol exposure in differentiating embryoid bodies. Toxicol In Vitro. 2018 Feb;46:66-76.
225 17-Estradiol Activates HSF1 via MAPK Signaling in ER-Positive Breast Cancer Cells. Cancers (Basel). 2019 Oct 11;11(10):1533. doi: 10.3390/cancers11101533.
226 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20. doi: 10.1093/toxsci/kfv094. Epub 2015 May 15.
227 Comprehensive analysis of transcriptomic changes induced by low and high doses of bisphenol A in HepG2 spheroids in vitro and rat liver in vivo. Environ Res. 2019 Jun;173:124-134. doi: 10.1016/j.envres.2019.03.035. Epub 2019 Mar 18.
228 Characterization of formaldehyde's genotoxic mode of action by gene expression analysis in TK6 cells. Arch Toxicol. 2013 Nov;87(11):1999-2012.
229 Folic acid supplementation dysregulates gene expression in lymphoblastoid cells--implications in nutrition. Biochem Biophys Res Commun. 2011 Sep 9;412(4):688-92. doi: 10.1016/j.bbrc.2011.08.027. Epub 2011 Aug 16.
230 Temozolomide induces activation of Wnt/-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy. Cell Biol Toxicol. 2020 Jun;36(3):273-278. doi: 10.1007/s10565-019-09502-7. Epub 2019 Nov 22.
231 Low doses of cisplatin induce gene alterations, cell cycle arrest, and apoptosis in human promyelocytic leukemia cells. Biomark Insights. 2016 Aug 24;11:113-21.
232 Evaluation of developmental toxicity using undifferentiated human embryonic stem cells. J Appl Toxicol. 2015 Feb;35(2):205-18.
233 Identification of transcriptome signatures and biomarkers specific for potential developmental toxicants inhibiting human neural crest cell migration. Arch Toxicol. 2016 Jan;90(1):159-80.
234 Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress. Toxicol Lett. 2016 Sep 6;258:227-236.
235 Mutant p53 reactivation by PRIMA-1MET induces multiple signaling pathways converging on apoptosis. Oncogene. 2010 Mar 4;29(9):1329-38. doi: 10.1038/onc.2009.425. Epub 2009 Nov 30.
236 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
237 The thioxotriazole copper(II) complex A0 induces endoplasmic reticulum stress and paraptotic death in human cancer cells. J Biol Chem. 2009 Sep 4;284(36):24306-19.
238 Influence of Iron on Cytotoxicity and Gene Expression Profiles Induced by Arsenic in HepG2 Cells. Int J Environ Res Public Health. 2019 Nov 14;16(22):4484. doi: 10.3390/ijerph16224484.
239 Transcriptional profiling of MCF7 breast cancer cells in response to 5-Fluorouracil: relationship with cell cycle changes and apoptosis, and identification of novel targets of p53. Int J Cancer. 2006 Sep 1;119(5):1164-75.
240 Arsenite and cadmium promote the development of mammary tumors. Carcinogenesis. 2020 Jul 14;41(7):1005-1014. doi: 10.1093/carcin/bgz176.
241 Simvastatin inhibits IL-17 secretion by targeting multiple IL-17-regulatory cytokines and by inhibiting the expression of IL-17 transcription factor RORC in CD4+ lymphocytes. J Immunol. 2008 May 15;180(10):6988-96. doi: 10.4049/jimmunol.180.10.6988.
242 Rofecoxib modulates multiple gene expression pathways in a clinical model of acute inflammatory pain. Pain. 2007 Mar;128(1-2):136-47.
243 The antimicrobial drug pyrimethamine inhibits STAT3 transcriptional activity by targeting the enzyme dihydrofolate reductase. J Biol Chem. 2022 Feb;298(2):101531. doi: 10.1016/j.jbc.2021.101531. Epub 2021 Dec 23.
244 Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol Endocrinol. 2005 Nov;19(11):2685-95.
245 Regulation of inflammatory responses in tumor necrosis factor-activated and rheumatoid arthritis synovial macrophages by JAK inhibitors. Arthritis Rheum. 2012 Dec;64(12):3856-66. doi: 10.1002/art.37691.
246 Recruitment of uterine NK cells: induction of CXC chemokine ligands 10 and 11 in human endometrium by estradiol and progesterone. J Immunol. 2004 Dec 1;173(11):6760-6. doi: 10.4049/jimmunol.173.11.6760.
247 Differential modulation of PI3-kinase/Akt pathway during all-trans retinoic acid- and Am80-induced HL-60 cell differentiation revealed by DNA microarray analysis. Biochem Pharmacol. 2004 Dec 1;68(11):2177-86.
248 Growth inhibition of ovarian tumor-initiating cells by niclosamide. Mol Cancer Ther. 2012 Aug;11(8):1703-12.
249 Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner. Genome Res. 2012 Nov;22(11):2153-62.
250 Reproducible chemical-induced changes in gene expression profiles in human hepatoma HepaRG cells under various experimental conditions. Toxicol In Vitro. 2009 Apr;23(3):466-75. doi: 10.1016/j.tiv.2008.12.018. Epub 2008 Dec 30.
251 Gene expression profile induced by BCNU in human glioma cell lines with differential MGMT expression. J Neurooncol. 2005 Jul;73(3):189-98.
252 Potent growth suppressive activity of curcumin in human breast cancer cells: Modulation of Wnt/beta-catenin signaling. Chem Biol Interact. 2009 Oct 7;181(2):263-71. doi: 10.1016/j.cbi.2009.06.012. Epub 2009 Jun 30.
253 Progesterone regulation of implantation-related genes: new insights into the role of oestrogen. Cell Mol Life Sci. 2007 Apr;64(7-8):1009-32.
254 Transcriptomic?pathway?and?benchmark dose analysis of Bisphenol A, Bisphenol S, Bisphenol F, and 3,3',5,5'-Tetrabromobisphenol A in H9 human embryonic stem cells. Toxicol In Vitro. 2021 Apr;72:105097. doi: 10.1016/j.tiv.2021.105097. Epub 2021 Jan 18.
255 Effects of 25-hydroxyvitamin D(3) on proliferation and osteoblast differentiation of human marrow stromal cells require CYP27B1/1alpha-hydroxylase. J Bone Miner Res. 2011 May;26(5):1145-53.
256 Down-regulation by nuclear factor kappaB of human 25-hydroxyvitamin D3 1alpha-hydroxylase promoter. Mol Endocrinol. 2004 Oct;18(10):2440-50. doi: 10.1210/me.2002-0441. Epub 2004 Jul 8.
257 Differential regulation of vitamin D receptor (VDR) by the p53 Family: p73-dependent induction of VDR upon DNA damage. J Biol Chem. 2007 Oct 12;282(41):29847-54.
258 Bone marrow osteoblast damage by chemotherapeutic agents. PLoS One. 2012;7(2):e30758. doi: 10.1371/journal.pone.0030758. Epub 2012 Feb 17.
259 Association of Arsenic Exposure with Whole Blood DNA Methylation: An Epigenome-Wide Study of Bangladeshi Adults. Environ Health Perspect. 2019 May;127(5):57011. doi: 10.1289/EHP3849. Epub 2019 May 28.
260 Increased mitochondrial ROS formation by acetaminophen in human hepatic cells is associated with gene expression changes suggesting disruption of the mitochondrial electron transport chain. Toxicol Lett. 2015 Apr 16;234(2):139-50.
261 Regulation of retinoschisin secretion in Weri-Rb1 cells by the F-actin and microtubule cytoskeleton. PLoS One. 2011;6(6):e20707. doi: 10.1371/journal.pone.0020707. Epub 2011 Jun 27.
262 Effect of aflatoxin B(1), benzo[a]pyrene, and methapyrilene on transcriptomic and epigenetic alterations in human liver HepaRG cells. Food Chem Toxicol. 2018 Nov;121:214-223. doi: 10.1016/j.fct.2018.08.034. Epub 2018 Aug 26.
263 Pharmacotoxicology of clinically-relevant concentrations of obeticholic acid in an organotypic human hepatocyte system. Toxicol In Vitro. 2017 Mar;39:93-103.
264 Transcriptomic analysis of untreated and drug-treated differentiated HepaRG cells over a 2-week period. Toxicol In Vitro. 2015 Dec 25;30(1 Pt A):27-35.
265 Expression and modulation of progesterone induced blocking factor (PIBF) and innate immune factors in human leukemia cell lines by progesterone and mifepristone. Leuk Lymphoma. 2007 Aug;48(8):1610-7. doi: 10.1080/10428190701471999.
266 Relationship of expression of aquaglyceroporin 9 with arsenic uptake and sensitivity in leukemia cells. Blood. 2007 Jan 15;109(2):740-6. doi: 10.1182/blood-2006-04-019588. Epub 2006 Sep 12.
267 Drug uptake and pharmacological modulation of drug sensitivity in leukemia by AQP9. Biochem Biophys Res Commun. 2004 Sep 24;322(3):836-41. doi: 10.1016/j.bbrc.2004.08.002.
268 Azacytidine sensitizes acute myeloid leukemia cells to arsenic trioxide by up-regulating the arsenic transporter aquaglyceroporin 9. J Hematol Oncol. 2015 May 8;8:46. doi: 10.1186/s13045-015-0143-3.
269 Association between In Utero arsenic exposure, placental gene expression, and infant birth weight: a US birth cohort study. Environ Health. 2013 Jul 16;12:58. doi: 10.1186/1476-069X-12-58.
270 Minimal peroxide exposure of neuronal cells induces multifaceted adaptive responses. PLoS One. 2010 Dec 17;5(12):e14352. doi: 10.1371/journal.pone.0014352.
271 Role of NADPH oxidase in arsenic-induced reactive oxygen species formation and cytotoxicity in myeloid leukemia cells. Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4578-83.
272 LSD1 activates a lethal prostate cancer gene network independently of its demethylase function. Proc Natl Acad Sci U S A. 2018 May 1;115(18):E4179-E4188.
273 Chronic cyclophosphamide exposure alters the profile of rat sperm nuclear matrix proteins. Biol Reprod. 2007 Aug;77(2):303-11. doi: 10.1095/biolreprod.107.060244. Epub 2007 May 2.
274 Identification of mechanisms of action of bisphenol a-induced human preadipocyte differentiation by transcriptional profiling. Obesity (Silver Spring). 2014 Nov;22(11):2333-43.
275 Arsenic alters transcriptional responses to Pseudomonas aeruginosa infection and decreases antimicrobial defense of human airway epithelial cells. Toxicol Appl Pharmacol. 2017 Sep 15;331:154-163.
276 Comparative study of bisphenol A and its analogue bisphenol S on human hepatic cells: a focus on their potential involvement in nonalcoholic fatty liver disease. Food Chem Toxicol. 2014 Aug;70:9-18. doi: 10.1016/j.fct.2014.04.011. Epub 2014 May 1.
277 A cellular model to study drug-induced liver injury in nonalcoholic fatty liver disease: application to acetaminophen. Toxicol Appl Pharmacol. 2016 Feb 1;292:40-55.
278 Transcriptome profile analysis of saturated aliphatic aldehydes reveals carbon number-specific molecules involved in pulmonary toxicity. Chem Res Toxicol. 2014 Aug 18;27(8):1362-70.
279 Keratinocyte-derived IL-36gama plays a role in hydroquinone-induced chemical leukoderma through inhibition of melanogenesis in human epidermal melanocytes. Arch Toxicol. 2019 Aug;93(8):2307-2320.
280 Multi-level gene expression profiles affected by thymidylate synthase and 5-fluorouracil in colon cancer. BMC Genomics. 2006 Apr 3;7:68. doi: 10.1186/1471-2164-7-68.
281 Research resource: STR DNA profile and gene expression comparisons of human BG-1 cells and a BG-1/MCF-7 clonal variant. Mol Endocrinol. 2014 Dec;28(12):2072-81.
282 Comparison of transcriptome expression alterations by chronic exposure to low-dose bisphenol A in different subtypes of breast cancer cells. Toxicol Appl Pharmacol. 2019 Dec 15;385:114814. doi: 10.1016/j.taap.2019.114814. Epub 2019 Nov 9.
283 DNA Methylome Analysis of Saturated Aliphatic Aldehydes in Pulmonary Toxicity. Sci Rep. 2018 Jul 12;8(1):10497. doi: 10.1038/s41598-018-28813-z.
284 Benzo[a]pyrene-induced changes in microRNA-mRNA networks. Chem Res Toxicol. 2012 Apr 16;25(4):838-49.
285 Transcriptomic analysis of human primary bronchial epithelial cells after chloropicrin treatment. Chem Res Toxicol. 2015 Oct 19;28(10):1926-35.
286 Temporal changes in gene expression in the skin of patients treated with isotretinoin provide insight into its mechanism of action. Dermatoendocrinol. 2009 May;1(3):177-87.
287 In vitro gene expression data supporting a DNA non-reactive genotoxic mechanism for ochratoxin A. Toxicol Appl Pharmacol. 2007 Apr 15;220(2):216-24.
288 MS4A3-HSP27 target pathway reveals potential for haematopoietic disorder treatment in alimentary toxic aleukia. Cell Biol Toxicol. 2023 Feb;39(1):201-216. doi: 10.1007/s10565-021-09639-4. Epub 2021 Sep 28.
289 Arsenic trioxide induces different gene expression profiles of genes related to growth and apoptosis in glioma cells dependent on the p53 status. Mol Biol Rep. 2008 Sep;35(3):421-9.
290 Histamine H4 receptor agonists have more activities than H4 agonism in antigen-specific human T-cell responses. Immunology. 2007 Jun;121(2):266-75. doi: 10.1111/j.1365-2567.2007.02574.x. Epub 2007 Mar 7.
291 Repurposing L-menthol for systems medicine and cancer therapeutics? L-menthol induces apoptosis through caspase 10 and by suppressing HSP90. OMICS. 2016 Jan;20(1):53-64.
292 Prenatal arsenic exposure and shifts in the newborn proteome: interindividual differences in tumor necrosis factor (TNF)-responsive signaling. Toxicol Sci. 2014 Jun;139(2):328-37. doi: 10.1093/toxsci/kfu053. Epub 2014 Mar 27.
293 Recombinant Netrin-1 binding UNC5B receptor attenuates neuroinflammation and brain injury via PPAR/NFB signaling pathway after subarachnoid hemorrhage in rats. Brain Behav Immun. 2018 Mar;69:190-202. doi: 10.1016/j.bbi.2017.11.012. Epub 2017 Nov 21.
294 THC exposure of human iPSC neurons impacts genes associated with neuropsychiatric disorders. Transl Psychiatry. 2018 Apr 25;8(1):89. doi: 10.1038/s41398-018-0137-3.
295 Effects of progesterone treatment on expression of genes involved in uterine quiescence. Reprod Sci. 2011 Aug;18(8):781-97.
296 Synergistic effect of JQ1 and rapamycin for treatment of human osteosarcoma. Int J Cancer. 2015 May 1;136(9):2055-64.
297 Genomic profiling uncovers a molecular pattern for toxicological characterization of mutagens and promutagens in vitro. Toxicol Sci. 2011 Jul;122(1):185-97.
298 Quercetin inhibits invasion, migration and signalling molecules involved in cell survival and proliferation of prostate cancer cell line (PC-3). Cell Biochem Funct. 2011 Mar;29(2):87-95. doi: 10.1002/cbf.1725. Epub 2011 Feb 9.
299 Arsenic trioxide (As2O3) inhibits invasion of HT1080 human fibrosarcoma cells: role of nuclear factor-kappaB and reactive oxygen species. J Cell Biochem. 2005 Aug 1;95(5):955-69. doi: 10.1002/jcb.20452.
300 Atorvastatin affects several angiogenic mediators in human endothelial cells. Endothelium. 2005 Sep-Dec;12(5-6):233-41.
301 Effect of retinoic acid on gene expression in human conjunctival epithelium: secretory phospholipase A2 mediates retinoic acid induction of MUC16. Invest Ophthalmol Vis Sci. 2005 Nov;46(11):4050-61.
302 Classification of heavy-metal toxicity by human DNA microarray analysis. Environ Sci Technol. 2007 May 15;41(10):3769-74.
303 Guillain-Barr syndrome following danazol and corticosteroid therapy for hereditary angioedema. Am J Med. 1985 Jul;79(1):111-4. doi: 10.1016/0002-9343(85)90553-4.
304 Profiles of antioxidant/electrophile response element (ARE/EpRE) nuclear protein binding and c-Ha-ras transactivation in vascular smooth muscle cells treated with oxidative metabolites of benzo[a]pyrene. Biochem Pharmacol. 2000 Nov 1;60(9):1285-96.
305 Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer. J Natl Cancer Inst. 2009 Mar 4;101(5):306-20.
306 Ursodeoxycholic acid suppresses Cox-2 expression in colon cancer: roles of Ras, p38, and CCAAT/enhancer-binding protein. Nutr Cancer. 2008;60(3):389-400.
307 Quercetin inhibits p21-RAS expression in human colon cancer cell lines and in primary colorectal tumors. Int J Cancer. 2000 Feb 1;85(3):438-45.
308 A comprehensive analysis of Wnt/beta-catenin signaling pathway-related genes and crosstalk pathways in the treatment of As2O3 in renal cancer. Ren Fail. 2018 Nov;40(1):331-339.
309 Poly(ADP-ribosyl)ation enhances H-RAS protein stability and causes abnormal cell cycle progression in human TK6 lymphoblastoid cells treated with hydroquinone. Chem Biol Interact. 2015 Aug 5;238:1-8. doi: 10.1016/j.cbi.2015.05.019. Epub 2015 Jun 3.
310 Combining prenylation inhibitors causes synergistic cytotoxicity, apoptosis and disruption of RAS-to-MAP kinase signalling in multiple myeloma cells. Br J Haematol. 2005 Sep;130(6):912-25. doi: 10.1111/j.1365-2141.2005.05696.x.
311 The differential cancer growth associated with anaesthetics in a cancer xenograft model of mice: mechanisms and implications of postoperative cancer recurrence. Cell Biol Toxicol. 2023 Aug;39(4):1561-1575. doi: 10.1007/s10565-022-09747-9. Epub 2022 Aug 12.
312 Indomethacin and juglone inhibit inflammatory molecules to induce apoptosis in colon cancer cells. J Biochem Mol Toxicol. 2020 Feb;34(2):e22433. doi: 10.1002/jbt.22433. Epub 2020 Jan 9.
313 A cell impedance-based real-time in vitro assay to assess the toxicity of amphotericin B formulations. Toxicol Appl Pharmacol. 2017 Nov 1;334:18-23. doi: 10.1016/j.taap.2017.08.017. Epub 2017 Sep 1.
314 CBD Promotes Oral Ulcer Healing via Inhibiting CMPK2-Mediated Inflammasome. J Dent Res. 2022 Feb;101(2):206-215. doi: 10.1177/00220345211024528. Epub 2021 Jul 16.
315 Sertraline, an antidepressant, induces apoptosis in hepatic cells through the mitogen-activated protein kinase pathway. Toxicol Sci. 2014 Feb;137(2):404-15. doi: 10.1093/toxsci/kft254. Epub 2013 Nov 5.
316 Anti-inflammatory effects of the GABA(B) receptor agonist baclofen in allergic contact dermatitis. Exp Dermatol. 2010 Jul 1;19(7):661-6. doi: 10.1111/j.1600-0625.2010.01076.x. Epub 2010 Feb 25.
317 Frankincense myrrh attenuates hepatocellular carcinoma by regulating tumor blood vessel development through multiple epidermal growth factor receptor-mediated signaling pathways. World J Gastrointest Oncol. 2022 Feb 15;14(2):450-477. doi: 10.4251/wjgo.v14.i2.450.
318 Sulfasalazine unveils a contact-independent HSV-TK/ganciclovir gene therapy bystander effect in malignant gliomas. Int J Oncol. 2007 Jan;30(1):283-90.
319 Oxidative Stress Alters miRNA and Gene Expression Profiles in Villous First Trimester Trophoblasts. Biomed Res Int. 2015;2015:257090. doi: 10.1155/2015/257090. Epub 2015 Aug 3.
320 Progesterone and calcitriol attenuate inflammatory cytokines CXCL1 and CXCL2 in ovarian and endometrial cancer cells. J Cell Biochem. 2012 Oct;113(10):3143-52. doi: 10.1002/jcb.24191.
321 Inhibition of neuroblastoma proliferation by PF-3758309, a small-molecule inhibitor that targets p21-activated kinase 4. Oncol Rep. 2017 Nov;38(5):2705-2716. doi: 10.3892/or.2017.5989. Epub 2017 Sep 22.
322 Inhibition of euchromatic histone methyltransferase 1 and 2 sensitizes chronic myeloid leukemia cells to interferon treatment. PLoS One. 2014 Jul 31;9(7):e103915. doi: 10.1371/journal.pone.0103915. eCollection 2014.
323 An in vitro coculture system of human peripheral blood mononuclear cells with hepatocellular carcinoma-derived cells for predicting drug-induced liver injury. Arch Toxicol. 2021 Jan;95(1):149-168. doi: 10.1007/s00204-020-02882-4. Epub 2020 Aug 20.
324 Quercetin potentiates apoptosis by inhibiting nuclear factor-kappaB signaling in H460 lung cancer cells. Biol Pharm Bull. 2013;36(6):944-51. doi: 10.1248/bpb.b12-01004.
325 Increased sensitivity for troglitazone-induced cytotoxicity using a human in vitro co-culture model. Toxicol In Vitro. 2009 Oct;23(7):1387-95.
326 Cannabidiol Modulates the Immunophenotype and Inhibits the Activation of the Inflammasome in Human Gingival Mesenchymal Stem Cells. Front Physiol. 2016 Nov 24;7:559. doi: 10.3389/fphys.2016.00559. eCollection 2016.
327 ERE-independent ERalpha target genes differentially expressed in human breast tumors. Mol Cell Endocrinol. 2005 Dec 21;245(1-2):53-9. doi: 10.1016/j.mce.2005.10.003. Epub 2005 Nov 17.
328 Reactive metabolite of gefitinib activates inflammasomes: implications for gefitinib-induced idiosyncratic reaction. J Toxicol Sci. 2020;45(11):673-680. doi: 10.2131/jts.45.673.
329 (9)-Tetrahydrocannabinol Suppresses Monocyte-Mediated Astrocyte Production of Monocyte Chemoattractant Protein 1 and Interleukin-6 in a Toll-Like Receptor 7-Stimulated Human Coculture. J Pharmacol Exp Ther. 2019 Oct;371(1):191-201. doi: 10.1124/jpet.119.260661. Epub 2019 Aug 5.
330 Changes in gene expression profiles in response to selenium supplementation among individuals with arsenic-induced pre-malignant skin lesions. Toxicol Lett. 2007 Mar 8;169(2):162-76. doi: 10.1016/j.toxlet.2007.01.006. Epub 2007 Jan 19.
331 Profiling the immunotoxicity of chemicals based on in vitro evaluation by a combination of the Multi-ImmunoTox assay and the IL-8 Luc assay. Arch Toxicol. 2018 Jun;92(6):2043-2054. doi: 10.1007/s00204-018-2199-7. Epub 2018 Mar 29.
332 Spironolactone induces apoptosis in human mononuclear cells. Association between apoptosis and cytokine suppression. Apoptosis. 2006 Apr;11(4):573-9. doi: 10.1007/s10495-006-4919-3.
333 Activation of PPAR and inhibition of cell proliferation reduces key proteins associated with the basal subtype of bladder cancer in As3+-transformed UROtsa cells. PLoS One. 2020 Aug 21;15(8):e0237976. doi: 10.1371/journal.pone.0237976. eCollection 2020.
334 Proteomics-based identification of differentially abundant proteins from human keratinocytes exposed to arsenic trioxide. J Proteomics Bioinform. 2014 Jul;7(7):166-178.
335 Oral lichenoid eruption secondary to imatinib (Glivec). J Dermatolog Treat. 2004 Jul;15(4):253-5. doi: 10.1080/09546630410015556.
336 Impact of extracellular folate levels on global gene expression. Mol Pharmacol. 2001 Dec;60(6):1288-95. doi: 10.1124/mol.60.6.1288.
337 Retinoic acid receptor- and retinoid X receptor-selective retinoids activate signaling pathways that converge on AP-1 and inhibit squamous differentiation in human bronchial epithelial cells. Cell Growth Differ. 1996 Aug;7(8):997-1004.
338 Methamphetamine alters the normal progression by inducing cell cycle arrest in astrocytes. PLoS One. 2014 Oct 7;9(10):e109603.
339 Retinoic acid receptor alpha amplifications and retinoic acid sensitivity in breast cancers. Clin Breast Cancer. 2013 Oct;13(5):401-8.
340 Biological specificity of CDK4/6 inhibitors: dose response relationship, in vivo signaling, and composite response signature. Oncotarget. 2017 Jul 4;8(27):43678-43691. doi: 10.18632/oncotarget.18435.
341 Gene expression profiling of early primary biliary cirrhosis: possible insights into the mechanism of action of ursodeoxycholic acid. Liver Int. 2008 Aug;28(7):997-1010. doi: 10.1111/j.1478-3231.2008.01744.x. Epub 2008 Apr 15.
342 Proteomic analysis of human adipose tissue after rosiglitazone treatment shows coordinated changes to promote glucose uptake. Obesity (Silver Spring). 2010 Jan;18(1):27-34. doi: 10.1038/oby.2009.208. Epub 2009 Jun 25.
343 Gene expression profiling of breast cancer cells in response to gemcitabine: NF-kappaB pathway activation as a potential mechanism of resistance. Breast Cancer Res Treat. 2007 Apr;102(2):157-72.
344 A prominent elevation of glial fibrillary acidic protein in the cerebrospinal fluid during relapse in neuromyelitis optica. Tohoku J Exp Med. 2008 May;215(1):55-9. doi: 10.1620/tjem.215.55.
345 Relationships and distinctions in iron-regulatory networks responding to interrelated signals. Blood. 2003 May 1;101(9):3690-8. doi: 10.1182/blood-2002-07-2140. Epub 2002 Sep 26.
346 Differential effects of statins on relevant functions of human monocyte-derived dendritic cells. J Leukoc Biol. 2006 Mar;79(3):529-38. doi: 10.1189/jlb.0205064. Epub 2005 Dec 30.
347 Quantitative proteomic analysis of HepG2 cells treated with quercetin suggests IQGAP1 involved in quercetin-induced regulation of cell proliferation and migration. OMICS. 2009 Apr;13(2):93-103. doi: 10.1089/omi.2008.0075.
348 Motexafin gadolinium and zinc induce oxidative stress responses and apoptosis in B-cell lymphoma lines. Cancer Res. 2005 Dec 15;65(24):11676-88.
349 Arsenic trioxide induces apoptosis of human monocytes during macrophagic differentiation through nuclear factor-kappaB-related survival pathway down-regulation. J Pharmacol Exp Ther. 2006 Jan;316(1):304-14. doi: 10.1124/jpet.105.092874. Epub 2005 Sep 20.
350 Phenolic metabolites of benzene inhibited the erythroid differentiation of K562 cells. Toxicol Lett. 2011 Jun 24;203(3):190-9. doi: 10.1016/j.toxlet.2011.03.012. Epub 2011 Mar 23.
351 Expression pattern of cisplatin-induced metallothionein isoforms in squamous cell carcinoma. Anticancer Res. 2003 Jan-Feb;23(1A):299-303.
352 Identification of novel activators of the metal responsive transcription factor (MTF-1) using a gene expression biomarker in a microarray compendium. Metallomics. 2020 Sep 23;12(9):1400-1415. doi: 10.1039/d0mt00071j.
353 Expression of antioxidant proteins in human intestinal Caco-2 cells treated with dietary flavonoids. Cancer Lett. 1999 Nov 15;146(2):161-7.
354 Chronic occupational exposure to arsenic induces carcinogenic gene signaling networks and neoplastic transformation in human lung epithelial cells. Toxicol Appl Pharmacol. 2012 Jun 1;261(2):204-16.
355 JunD is involved in the antiproliferative effect of Delta9-tetrahydrocannabinol on human breast cancer cells. Oncogene. 2008 Aug 28;27(37):5033-44.
356 Transcriptomics hit the target: monitoring of ligand-activated and stress response pathways for chemical testing. Toxicol In Vitro. 2015 Dec 25;30(1 Pt A):7-18.
357 Estrogen-like activity of metals in MCF-7 breast cancer cells. Endocrinology. 2003 Jun;144(6):2425-36. doi: 10.1210/en.2002-221054.
358 Cross-talk between non-genomic and genomic signalling pathways--distinct effect profiles of environmental estrogens. Toxicol Appl Pharmacol. 2010 Jun 1;245(2):160-70. doi: 10.1016/j.taap.2010.02.015. Epub 2010 Mar 4.
359 Bidirectional cross talk between ERalpha and EGFR signalling pathways regulates tamoxifen-resistant growth. Breast Cancer Res Treat. 2006 Mar;96(2):131-46. doi: 10.1007/s10549-005-9070-2. Epub 2005 Oct 27.
360 Sensitivity of human dental pulp cells to eighteen chemical agents used for endodontic treatments in dentistry. Odontology. 2013 Jan;101(1):43-51.
361 The dual ErbB1/ErbB2 inhibitor, lapatinib (GW572016), cooperates with tamoxifen to inhibit both cell proliferation- and estrogen-dependent gene expression in antiestrogen-resistant breast cancer. Cancer Res. 2005 Jan 1;65(1):18-25.
362 Antitumoral activity of liraglutide, a new DNMT inhibitor in breast cancer cells in vitro and in vivo. Chem Biol Interact. 2021 Nov 1;349:109641. doi: 10.1016/j.cbi.2021.109641. Epub 2021 Sep 14.
363 Estrogen receptor alpha mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells. Mol Pharmacol. 2001 Sep;60(3):595-602.
364 Novel retinoic acid metabolism blocking agents have potent inhibitory activities on human breast cancer cells and tumour growth. Br J Cancer. 2007 Apr 23;96(8):1204-15. doi: 10.1038/sj.bjc.6603705. Epub 2007 Mar 27.
365 Prediction of the combined effects of multiple estrogenic chemicals on MCF-7 human breast cancer cells and a preliminary molecular exploration of the estrogenic proliferative effects and related gene expression. Ecotoxicol Environ Saf. 2018 Sep 30;160:1-9. doi: 10.1016/j.ecoenv.2018.05.025. Epub 2018 May 21.
366 Oxidative Stress-Protective and Anti-Melanogenic Effects of Loliolide and Ethanol Extract from Fresh Water Green Algae, Prasiola japonica. Int J Mol Sci. 2018 Sep 18;19(9):2825. doi: 10.3390/ijms19092825.
367 The effects of a novel synthetic retinoid, seletinoid G, on the expression of extracellular matrix proteins in aged human skin in vivo. Clin Chim Acta. 2005 Dec;362(1-2):161-9. doi: 10.1016/j.cccn.2005.06.016. Epub 2005 Aug 1.
368 Ciprofloxacin enhances the stimulation of matrix metalloproteinase 3 expression by interleukin-1beta in human tendon-derived cells. A potential mechanism of fluoroquinolone-induced tendinopathy. Arthritis Rheum. 2002 Nov;46(11):3034-40. doi: 10.1002/art.10617.
369 Simvastatin reduces MMP1 expression in human smooth muscle cells cultured on polymerized collagen by inhibiting Rac1 activation. Arterioscler Thromb Vasc Biol. 2007 May;27(5):1043-9. doi: 10.1161/ATVBAHA.107.139881. Epub 2007 Feb 15.
370 Quercetin inhibits matrix metalloproteinase-1 expression in human vascular endothelial cells through extracellular signal-regulated kinase. Arch Biochem Biophys. 2001 Jul 1;391(1):72-8. doi: 10.1006/abbi.2001.2402.
371 Interaction between the aryl hydrocarbon receptor and retinoic acid pathways increases matrix metalloproteinase-1 expression in keratinocytes. J Biol Chem. 2004 Jun 11;279(24):25284-93. doi: 10.1074/jbc.M402168200. Epub 2004 Apr 9.
372 Arsenic suppresses gene expression in promyelocytic leukemia cells partly through Sp1 oxidation. Blood. 2005 Jul 1;106(1):304-10.
373 Cytokine mRNA profiles in cultured human skin component cells exposed to various chemicals: a simulation model of epicutaneous stimuli induced by skin barrier perturbation in comparison with that due to exposure to haptens or irritant. J Dermatol Sci. 2001 Jun;26(2):85-93. doi: 10.1016/s0923-1811(00)00165-1.
374 Effects of luteolin, quercetin and baicalein on immunoglobulin E-mediated mediator release from human cultured mast cells. Clin Exp Allergy. 2000 Apr;30(4):501-8. doi: 10.1046/j.1365-2222.2000.00768.x.
375 Altered cytokine profiles of human retinal pigment epithelium: oxidant injury and replicative senescence. Mol Vis. 2013;19:718-28. Epub 2013 Mar 21.
376 Combination of thalidomide and cisplatin in an head and neck squamous cell carcinomas model results in an enhanced antiangiogenic activity in vitro and in vivo. Int J Cancer. 2007 Oct 15;121(8):1697-704. doi: 10.1002/ijc.22867.
377 Human corneal epithelial cell functional responses to inflammatory agents and their antagonists. Invest Ophthalmol Vis Sci. 1998 Dec;39(13):2562-71.
378 Increased inflammasome related gene expression profile in PBMC may facilitate T helper 17 cell induction in multiple sclerosis. Mol Immunol. 2015 Feb;63(2):521-9. doi: 10.1016/j.molimm.2014.10.008.
379 Acetylcholine and nicotine stimulate the release of granulocyte-macrophage colony stimulating factor from cultured human bronchial epithelial cells. Naunyn Schmiedebergs Arch Pharmacol. 1998 Apr;357(4):472-5. doi: 10.1007/pl00005195.
380 Kaempferol and quercetin stimulate granulocyte-macrophage colony-stimulating factor secretion in human prostate cancer cells. Mol Cell Endocrinol. 2008 Jun 11;287(1-2):57-64. doi: 10.1016/j.mce.2008.01.015. Epub 2008 Feb 3.
381 HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans. N Engl J Med. 2011 Mar 24;364(12):1134-43. doi: 10.1056/NEJMoa1013297.
382 Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese. Pharmacogenomics. 2010 Mar;11(3):349-56. doi: 10.2217/pgs.09.162.
383 Positive and negative associations of HLA class I alleles with allopurinol-induced SCARs in Koreans. Pharmacogenet Genomics. 2011 May;21(5):303-7. doi: 10.1097/FPC.0b013e32834282b8.
384 A study of HLA class I and class II 4-digit allele level in Stevens-Johnson syndrome and toxic epidermal necrolysis. Int J Immunogenet. 2011 Aug;38(4):303-9. doi: 10.1111/j.1744-313X.2011.01011.x. Epub 2011 May 4.
385 HLA alleles influence the clinical signature of amoxicillin-clavulanate hepatotoxicity. PLoS One. 2013 Jul 9;8(7):e68111. doi: 10.1371/journal.pone.0068111. Print 2013.
386 Ticlopidine-induced hepatotoxicity is associated with specific human leukocyte antigen genomic subtypes in Japanese patients: a preliminary case-control study. Pharmacogenomics J. 2008 Feb;8(1):29-33. doi: 10.1038/sj.tpj.6500442. Epub 2007 Mar 6.
387 Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis. Chem Res Toxicol. 2015 May 18;28(5):927-34. doi: 10.1021/tx5005248. Epub 2015 Apr 3.
388 p53-R175H mutant gains new function in regulation of doxorubicin-induced apoptosis. Int J Cancer. 2005 Apr 10;114(3):331-6. doi: 10.1002/ijc.20818.
389 Azidothymidine and cisplatin increase p14ARF expression in OVCAR-3 ovarian cancer cell line. Toxicol Appl Pharmacol. 2006 Oct 1;216(1):89-97. doi: 10.1016/j.taap.2006.04.015. Epub 2006 May 19.
390 Quantitative analysis of gene expression changes in response to genotoxic compounds. Toxicol In Vitro. 2017 Mar;39:15-28. doi: 10.1016/j.tiv.2016.11.004. Epub 2016 Nov 5.
391 Gallic acid potentiates the apoptotic effect of paclitaxel and carboplatin via overexpression of Bax and P53 on the MCF-7 human breast cancer cell line. J Biochem Mol Toxicol. 2021 Feb;35(2):e22638. doi: 10.1002/jbt.22638. Epub 2020 Oct 1.
392 Regulation of human dUTPase gene expression and p53-mediated transcriptional repression in response to oxaliplatin-induced DNA damage. Nucleic Acids Res. 2009 Jan;37(1):78-95. doi: 10.1093/nar/gkn910. Epub 2008 Nov 16.
393 Role of miRNA in the regulation of cannabidiol-mediated apoptosis in neuroblastoma cells. Oncotarget. 2019 Jan 1;10(1):45-59. doi: 10.18632/oncotarget.26534. eCollection 2019 Jan 1.
394 Nitrogen Mustard Alkylates and Cross-Links p53 in Human Keratinocytes. Chem Res Toxicol. 2022 Apr 18;35(4):636-650. doi: 10.1021/acs.chemrestox.1c00420. Epub 2022 Mar 21.
395 Fulvestrant induces resistance by modulating GPER and CDK6 expression: implication of methyltransferases, deacetylases and the hSWI/SNF chromatin remodelling complex. Br J Cancer. 2013 Nov 12;109(10):2751-62. doi: 10.1038/bjc.2013.583. Epub 2013 Oct 29.
396 Inhibiting Heat Shock Proteins Can Potentiate the Cytotoxic Effect of Cannabidiol in Human Glioma Cells. Anticancer Res. 2015 Nov;35(11):5827-37.
397 Arsenic trioxide (ATO) influences the gene expression of metallothioneins in human glioblastoma cells. Biol Trace Elem Res. 2012 Dec;149(3):331-9.
398 Motexafin gadolinium disrupts zinc metabolism in human cancer cell lines. Cancer Res. 2005 May 1;65(9):3837-45.
399 Computational discovery of niclosamide ethanolamine, a repurposed drug candidate that reduces growth of hepatocellular carcinoma cells initro and in mice by inhibiting cell division cycle 37 signaling. Gastroenterology. 2017 Jun;152(8):2022-2036.
400 Glucocorticoids inhibit cell death in ovarian cancer and up-regulate caspase inhibitor cIAP2. Clin Cancer Res. 2005 Sep 1;11(17):6325-32. doi: 10.1158/1078-0432.CCR-05-0182.
401 Capturing time-dependent activation of genes and stress-response pathways using transcriptomics in iPSC-derived renal proximal tubule cells. Cell Biol Toxicol. 2023 Aug;39(4):1773-1793. doi: 10.1007/s10565-022-09783-5. Epub 2022 Dec 31.
402 Propofol suppresses proliferation, migration, invasion, and tumor growth of liver cancer cells via suppressing cancer susceptibility candidate 9/phosphatase and tensin homolog/AKT serine/threonine kinase/mechanistic target of rapamycin kinase axis. Hum Exp Toxicol. 2022 Jan-Dec;41:9603271211065972. doi: 10.1177/09603271211065972.
403 Identification of biomarkers and outcomes of endocrine disruption in human ovarian cortex using In Vitro Models. Toxicology. 2023 Feb;485:153425. doi: 10.1016/j.tox.2023.153425. Epub 2023 Jan 5.
404 [Effects of As2O3 on tissue factor, plasminogen activator inhibitor-1 and -2 expression in NB4, HL-60 and THP-1 cells]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2003 Oct;34(4):645-9.
405 Effects of aspirin on metastasis-associated gene expression detected by cDNA microarray. Acta Pharmacol Sin. 2004 Oct;25(10):1327-33.
406 Antirheumatic drug response signatures in human chondrocytes: potential molecular targets to stimulate cartilage regeneration. Arthritis Res Ther. 2009;11(1):R15.
407 Mechanisms of dexamethasone-induced disturbed sleep and fatigue in paediatric patients receiving treatment for ALL. Eur J Cancer. 2010 Jul;46(10):1848-55. doi: 10.1016/j.ejca.2010.03.026. Epub 2010 Apr 17.
408 Calcium pantothenate modulates gene expression in proliferating human dermal fibroblasts. Exp Dermatol. 2009 Nov;18(11):969-78. doi: 10.1111/j.1600-0625.2009.00884.x. Epub 2009 Apr 8.
409 Some HIV antiretrovirals increase oxidative stress and alter chemokine, cytokine or adiponectin production in human adipocytes and macrophages. Antivir Ther. 2007;12(4):489-500.
410 Blood cell oxidative stress precedes hemolysis in whole blood-liver slice co-cultures of rat, dog, and human tissues. Toxicol Appl Pharmacol. 2010 May 1;244(3):354-65. doi: 10.1016/j.taap.2010.01.017. Epub 2010 Feb 6.
411 ?-adrenoceptors and muscarinic receptors mediate opposing effects on endothelin-1 expression in human lung fibroblasts. Eur J Pharmacol. 2012 Sep 15;691(1-3):218-24. doi: 10.1016/j.ejphar.2012.07.002. Epub 2012 Jul 13.
412 Induction of endothelin-1 expression by oxidative stress in vascular smooth muscle cells. Cardiovasc Pathol. 2001 Nov-Dec;10(6):311-5. doi: 10.1016/s1054-8807(01)00095-3.
413 [Effect of simvastatin on endothelin-1 expression in endothelial cell cultured hypoxically]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2008 Jan;39(1):72-5.
414 Effects of dietary polyphenols on gene expression in human vascular endothelial cells. Proc Nutr Soc. 2008 Feb;67(1):42-7.
415 Nucleoside reverse transcriptase inhibitors induce a mitophagy-associated endothelial cytotoxicity that is reversed by coenzyme Q10 cotreatment. Toxicol Sci. 2013 Aug;134(2):323-34. doi: 10.1093/toxsci/kft105. Epub 2013 May 2.
416 Cardiac toxicity of high-dose cyclophosphamide in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation. Int J Hematol. 2007 Jun;85(5):408-14. doi: 10.1532/IJH97.E0620.
417 Different effects of angiotensin converting enzyme inhibitors on endothelin-1 and nitric oxide balance in human vascular endothelial cells: evidence of an oxidant-sensitive pathway. Mediators Inflamm. 2008;2008:305087. doi: 10.1155/2008/305087. Epub 2008 Dec 1.
418 SGNE1/7B2 is epigenetically altered and transcriptionally downregulated in human medulloblastomas. Oncogene. 2007 Aug 16;26(38):5662-8. doi: 10.1038/sj.onc.1210338. Epub 2007 Mar 5.
419 The proapoptotic effect of zoledronic acid is independent of either the bone microenvironment or the intrinsic resistance to bortezomib of myeloma cells and is enhanced by the combination with arsenic trioxide. Exp Hematol. 2011 Jan;39(1):55-65.
420 Molecular mechanism of action of bisphenol and bisphenol A mediated by oestrogen receptor alpha in growth and apoptosis of breast cancer cells. Br J Pharmacol. 2013 May;169(1):167-78.
421 High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth. Clin Cancer Res. 2009 Oct 1;15(19):6070-8.
422 Effects of lithium and valproic acid on gene expression and phenotypic markers in an NT2 neurosphere model of neural development. PLoS One. 2013;8(3):e58822.
423 Short-chain fatty acids enhance nuclear receptor activity through mitogen-activated protein kinase activation and histone deacetylase inhibition. Proc Natl Acad Sci U S A. 2004 May 4;101(18):7199-204.
424 Extremely low copper concentrations affect gene expression profiles of human prostate epithelial cell lines. Chem Biol Interact. 2010 Oct 6;188(1):214-9.
425 Gene expression changes associated with cytotoxicity identified using cDNA arrays. Funct Integr Genomics. 2000 Sep;1(2):114-26.
426 Identification of novel low-dose bisphenol a targets in human foreskin fibroblast cells derived from hypospadias patients. PLoS One. 2012;7(5):e36711. doi: 10.1371/journal.pone.0036711. Epub 2012 May 4.
427 Gene expression in endometrial cancer cells (Ishikawa) after short time high dose exposure to progesterone. Steroids. 2008 Jan;73(1):116-28.
428 p21(WAF1/cip1) is an important determinant of intestinal cell response to sulindac in vitro and in vivo. Cancer Res. 2001 Aug 15;61(16):6297-302.
429 Evaluation of a human iPSC-derived BBB model for repeated dose toxicity testing with cyclosporine A as model compound. Toxicol In Vitro. 2021 Jun;73:105112. doi: 10.1016/j.tiv.2021.105112. Epub 2021 Feb 22.
430 Folic acid induces cell type-specific changes in the transcriptome of breast cancer cell lines: a proof-of-concept study. J Nutr Sci. 2016 Apr 26;5:e17. doi: 10.1017/jns.2016.8. eCollection 2016.
431 Consequences of the natural retinoid/retinoid X receptor ligands action in human breast cancer MDA-MB-231 cell line: Focus on functional proteomics. Toxicol Lett. 2017 Nov 5;281:26-34. doi: 10.1016/j.toxlet.2017.09.001. Epub 2017 Sep 5.
432 Identification of biomarkers for the initiation of apoptosis in human preneoplastic colonocytes by proteome analysis. Int J Cancer. 2004 Mar 20;109(2):220-9. doi: 10.1002/ijc.11692.
433 Pharmacogenomic analysis of acute promyelocytic leukemia cells highlights CYP26 cytochrome metabolism in differential all-trans retinoic acid sensitivity. Blood. 2007 May 15;109(10):4450-60.
434 Expression profile analysis of human peripheral blood mononuclear cells in response to aspirin. Arch Immunol Ther Exp (Warsz). 2005 Mar-Apr;53(2):151-8.
435 Proteomics investigation of protein expression changes in ouabain induced apoptosis in human umbilical vein endothelial cells. J Cell Biochem. 2008 Jun 1;104(3):1054-64. doi: 10.1002/jcb.21691.
436 Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13. Front Mol Neurosci. 2021 May 28;14:673144. doi: 10.3389/fnmol.2021.673144. eCollection 2021.
437 Untargeted Proteomics and Systems-Based Mechanistic Investigation of Artesunate in Human Bronchial Epithelial Cells. Chem Res Toxicol. 2015 Oct 19;28(10):1903-13. doi: 10.1021/acs.chemrestox.5b00105. Epub 2015 Sep 21.
438 Regulation of human pulmonary surfactant protein gene expression by 1alpha,25-dihydroxyvitamin D3. Am J Physiol Lung Cell Mol Physiol. 2005 Oct;289(4):L617-26. doi: 10.1152/ajplung.00129.2004. Epub 2005 Jun 10.
439 Regulation of messenger RNAs for the hydrophobic surfactant proteins in human lung. J Clin Invest. 1989 Apr;83(4):1191-7. doi: 10.1172/JCI114000.
440 Glucocorticoid regulation of human pulmonary surfactant protein-B (SP-B) mRNA stability is independent of activated glucocorticoid receptor. Am J Physiol Lung Cell Mol Physiol. 2011 Jun;300(6):L940-50. doi: 10.1152/ajplung.00420.2010. Epub 2011 Mar 11.
441 Reduction of glucocorticoid receptor ligand binding by the 11-beta hydroxysteroid dehydrogenase type 2 inhibitor, Thiram. Steroids. 2006 Oct;71(10):895-901.
442 Identification of vitamin D3 target genes in human breast cancer tissue. J Steroid Biochem Mol Biol. 2016 Nov;164:90-97.
443 Modelling cardiac fibrosis using three-dimensional cardiac microtissues derived from human embryonic stem cells. J Biol Eng. 2019 Feb 13;13:15. doi: 10.1186/s13036-019-0139-6. eCollection 2019.
444 Primary Human Hepatocyte Spheroids as Tools to Study the Hepatotoxic Potential of Non-Pharmaceutical Chemicals. Int J Mol Sci. 2021 Oct 12;22(20):11005. doi: 10.3390/ijms222011005.
445 Transcriptional profiling of testosterone-regulated genes in the skeletal muscle of human immunodeficiency virus-infected men experiencing weight loss. J Clin Endocrinol Metab. 2007 Jul;92(7):2793-802. doi: 10.1210/jc.2006-2722. Epub 2007 Apr 17.
446 Reduction of synovial sublining layer inflammation and proinflammatory cytokine expression in psoriatic arthritis treated with methotrexate. Arthritis Rheum. 2004 Oct;50(10):3286-95. doi: 10.1002/art.20518.
447 Quercetin inhibits IL-1-induced proliferation and production of MMPs, COX-2, and PGE2 by rheumatoid synovial fibroblast. Inflammation. 2012 Aug;35(4):1585-94. doi: 10.1007/s10753-012-9473-2.
448 Cyclosporine A--induced oxidative stress in human renal mesangial cells: a role for ERK 1/2 MAPK signaling. Toxicol Sci. 2012 Mar;126(1):101-13.
449 Mifepristone induced progesterone withdrawal reveals novel regulatory pathways in human endometrium. Mol Hum Reprod. 2007 Sep;13(9):641-54.
450 Differential expression of microRNAs and their predicted targets in renal cells exposed to amphotericin B and its complex with copper (II) ions. Toxicol Mech Methods. 2017 Sep;27(7):537-543. doi: 10.1080/15376516.2017.1333554. Epub 2017 Jun 8.
451 Sertraline induces endoplasmic reticulum stress in hepatic cells. Toxicology. 2014 Aug 1;322:78-88. doi: 10.1016/j.tox.2014.05.007. Epub 2014 May 24.
452 Real-time PCR analysis of the apoptosis related genes in ATRA treated APL t(15;17) patients. Exp Mol Med. 2003 Oct 31;35(5):454-9. doi: 10.1038/emm.2003.59.
453 Epigenetic activation of O-linked -N-acetylglucosamine transferase overrides the differentiation blockage in acute leukemia. EBioMedicine. 2020 Apr;54:102678. doi: 10.1016/j.ebiom.2020.102678. Epub 2020 Apr 6.
454 Histamine downregulates CD14 expression via H2 receptors on human monocytes. Clin Immunol. 2003 Sep;108(3):274-81. doi: 10.1016/s1521-6616(03)00140-2.
455 The anti-proliferative effect of calcitriol on HL-60 cells is neutralized by uraemic biological fluids. Nephrol Dial Transplant. 2001 Feb;16(2):246-52. doi: 10.1093/ndt/16.2.246.
456 ROS-dependent DNA damage contributes to crizotinib-induced hepatotoxicity via the apoptotic pathway. Toxicol Appl Pharmacol. 2019 Nov 15;383:114768. doi: 10.1016/j.taap.2019.114768. Epub 2019 Oct 19.
457 Antitumor action of the MET tyrosine kinase inhibitor crizotinib (PF-02341066) in gastric cancer positive for MET amplification. Mol Cancer Ther. 2012 Jul;11(7):1557-64. doi: 10.1158/1535-7163.MCT-11-0934. Epub 2012 Jun 22.
458 All-trans retinoic acid inhibits the cell proliferation but enhances the cell invasion through up-regulation of c-met in pancreatic cancer cells. Cancer Lett. 2005 Jun 28;224(2):303-10. doi: 10.1016/j.canlet.2004.10.016. Epub 2004 Dec 8.
459 Cardiovascular effects of rilmenidine, moxonidine and clonidine in conscious wild-type and D79N alpha2A-adrenoceptor transgenic mice. Br J Pharmacol. 1999 Mar;126(6):1522-30. doi: 10.1038/sj.bjp.0702429.
460 Alpha-adrenoceptor agonistic activity of oxymetazoline and xylometazoline. Fundam Clin Pharmacol. 2010 Dec;24(6):729-39.
461 Platelet alpha 2-adrenoceptor modifications induced by long-term treatment with indapamide in essential hypertension. Am J Med. 1988 Jan 29;84(1B):31-5.
462 Influence of glutathione S-transferase A1, P1, M1, T1 polymorphisms on oral busulfan pharmacokinetics in children with congenital hemoglobinopathies undergoing hematopoietic stem cell transplantation. Pediatr Blood Cancer. 2010 Dec 1;55(6):1172-9. doi: 10.1002/pbc.22739.
463 The influence of coordinate overexpression of glutathione phase II detoxification gene products on drug resistance. J Pharmacol Exp Ther. 2000 Aug;294(2):480-7.
464 Cell-type-specific responses to chemotherapeutics in breast cancer. Cancer Res. 2004 Jun 15;64(12):4218-26.
465 Cannabidiol induces antioxidant pathways in keratinocytes by targeting BACH1. Redox Biol. 2020 Jan;28:101321. doi: 10.1016/j.redox.2019.101321. Epub 2019 Sep 5.
466 Glutathione S-transferase pi as a target for tricyclic antidepressants in human brain. Acta Biochim Pol. 2004;51(1):207-12.
467 Comparative gene expression analysis of a chronic myelogenous leukemia cell line resistant to cyclophosphamide using oligonucleotide arrays and response to tyrosine kinase inhibitors. Leuk Res. 2007 Nov;31(11):1511-20.
468 Single-cell Transcriptome Mapping Identifies Common and Cell-type Specific Genes Affected by Acute Delta9-tetrahydrocannabinol in Humans. Sci Rep. 2020 Feb 26;10(1):3450. doi: 10.1038/s41598-020-59827-1.
469 Protein profile in neuroblastoma cells incubated with S- and R-enantiomers of ibuprofen by iTRAQ-coupled 2-D LC-MS/MS analysis: possible action of induced proteins on Alzheimer's disease. Proteomics. 2008 Apr;8(8):1595-607. doi: 10.1002/pmic.200700556.
470 Adipogenic Effects and Gene Expression Profiling of Firemaster? 550 Components in Human Primary Preadipocytes. Environ Health Perspect. 2017 Sep 14;125(9):097013. doi: 10.1289/EHP1318.
471 Direct and indirect effects of retinoic acid on human Th2 cytokine and chemokine expression by human T lymphocytes. BMC Immunol. 2006 Nov 21;7:27. doi: 10.1186/1471-2172-7-27.
472 Alcohol and Cannabinoids Differentially Affect HIV Infection and Function of Human Monocyte-Derived Dendritic Cells (MDDC). Front Microbiol. 2015 Dec 22;6:1452. doi: 10.3389/fmicb.2015.01452. eCollection 2015.
473 Metronomic gemcitabine suppresses tumour growth, improves perfusion, and reduces hypoxia in human pancreatic ductal adenocarcinoma. Br J Cancer. 2010 Jun 29;103(1):52-60.
474 Integrated analysis of rifampicin-induced microRNA and gene expression changes in human hepatocytes. Drug Metab Pharmacokinet. 2014;29(4):333-40.
475 Design principles of concentration-dependent transcriptome deviations in drug-exposed differentiating stem cells. Chem Res Toxicol. 2014 Mar 17;27(3):408-20.
476 Bisphenol A Exposure Changes the Transcriptomic and Proteomic Dynamics of Human Retinoblastoma Y79 Cells. Genes (Basel). 2021 Feb 11;12(2):264. doi: 10.3390/genes12020264.
477 Monomeric and oligomeric flavanols maintain the endogenous glucocorticoid response in human macrophages in pro-oxidant conditions in vitro. Chem Biol Interact. 2018 Aug 1;291:237-244.
478 Nicotine up-regulates IL-8 expression in human gingival epithelial cells following stimulation with IL-1 or P. gingivalis lipopolysaccharide via nicotinic acetylcholine receptor signalling. Arch Oral Biol. 2012 May;57(5):483-90. doi: 10.1016/j.archoralbio.2011.10.007. Epub 2011 Nov 25.
479 Ca(2+) Signaling and IL-8 Secretion in Human Testicular Peritubular Cells Involve the Cation Channel TRPV2. Int J Mol Sci. 2018 Sep 19;19(9):2829. doi: 10.3390/ijms19092829.
480 Nitrogen mustard prevents transport of Fra-1 into the nucleus to promote c-Fos- and FosB-dependent IL-8 induction in injured mouse epidermis. Toxicol Lett. 2020 Feb 1;319:256-263. doi: 10.1016/j.toxlet.2019.10.006. Epub 2019 Oct 19.
481 Nitric oxide synthase inhibitors attenuate ozone-induced airway inflammation in guinea pigs. Possible role of interleukin-8. Am J Respir Crit Care Med. 2000 Jan;161(1):249-56. doi: 10.1164/ajrccm.161.1.9804096.
482 D-Penicillamine targets metastatic melanoma cells with induction of the unfolded protein response (UPR) and Noxa (PMAIP1)-dependent mitochondrial apoptosis. Apoptosis. 2012 Oct;17(10):1079-94.
483 Global effects of inorganic arsenic on gene expression profile in human macrophages. Mol Immunol. 2009 Feb;46(4):649-56.
484 Identification of human cell responses to benzene and benzene metabolites. Genomics. 2007 Sep;90(3):324-33.
485 Cell-based and cytokine-directed chemical screen to identify potential anti-multiple myeloma agents. Leuk Res. 2010 Jul;34(7):917-24. doi: 10.1016/j.leukres.2009.12.002. Epub 2010 Feb 8.
486 Enhanced chemotherapeutic efficacy of docetaxel in human lung cancer cell line via GLUT1 inhibitor. J Biochem Mol Toxicol. 2023 Jun;37(6):e23348. doi: 10.1002/jbt.23348. Epub 2023 Mar 31.
487 Breast cancer cells response to the antineoplastic agents cisplatin, carboplatin, and doxorubicin at the mRNA expression levels of distinct apoptosis-related genes, including the new member, BCL2L12. Ann N Y Acad Sci. 2007 Jan;1095:35-44. doi: 10.1196/annals.1397.005.
488 Extracellular signal-regulated kinase activation and Bcl-2 downregulation mediate apoptosis after gemcitabine treatment partly via a p53-independent pathway. Eur J Pharmacol. 2004 Oct 19;502(3):169-83. doi: 10.1016/j.ejphar.2004.09.006.
489 -Carotene Induces Apoptosis in Human Esophageal Squamous Cell Carcinoma Cell Lines via the Cav-1/AKT/NF-B Signaling Pathway. J Biochem Mol Toxicol. 2016 Mar;30(3):148-57. doi: 10.1002/jbt.21773. Epub 2016 Jan 6.
490 Secretory defect and cytotoxicity: the potential disease mechanisms for the retinitis pigmentosa (RP)-associated interphotoreceptor retinoid-binding protein (IRBP). J Biol Chem. 2013 Apr 19;288(16):11395-406. doi: 10.1074/jbc.M112.418251. Epub 2013 Mar 13.
491 Identification of genes linked to gefitinib treatment in prostate cancer cell lines with or without resistance to androgen: a clue to application of gefitinib to hormone-resistant prostate cancer. Oncol Rep. 2006 Jun;15(6):1453-60.
492 Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling. Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21737-42. doi: 10.1073/pnas.1007863107. Epub 2010 Nov 22.
493 Induction of fibroblast growth factor-9 and interleukin-1alpha gene expression by motorcycle exhaust particulate extracts and benzo(a)pyrene in human lung adenocarcinoma cells. Toxicol Sci. 2005 Oct;87(2):483-96. doi: 10.1093/toxsci/kfi251. Epub 2005 Jul 7.
494 Effects of chlorpromazine with and without UV irradiation on gene expression of HepG2 cells. Mutat Res. 2005 Aug 4;575(1-2):47-60. doi: 10.1016/j.mrfmmm.2005.03.002. Epub 2005 Apr 26.
495 Thalidomide and Its Analogs Differentially Target Fibroblast Growth Factor Receptors: Thalidomide Suppresses FGFR Gene Expression while Pomalidomide Dampens FGFR2 Activity. Chem Res Toxicol. 2019 Apr 15;32(4):589-602. doi: 10.1021/acs.chemrestox.8b00286. Epub 2019 Mar 15.
496 Low-expressional IGF1 mediated methimazole-induced liver developmental toxicity in fetal mice. Toxicology. 2018 Sep 1;408:70-79. doi: 10.1016/j.tox.2018.07.004. Epub 2018 Jul 7.
497 Epinephrine facilitates the growth of T cell lymphoma by altering cell proliferation, apoptosis, and glucose metabolism. Chem Biol Interact. 2023 Jan 5;369:110278. doi: 10.1016/j.cbi.2022.110278. Epub 2022 Nov 22.
498 Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. Toxicol Appl Pharmacol. 2022 Aug 15;449:116110. doi: 10.1016/j.taap.2022.116110. Epub 2022 Jun 7.
499 Delta9-tetrahydrocannabinol inhibits cytotrophoblast cell proliferation and modulates gene transcription. Mol Hum Reprod. 2006 May;12(5):321-33. doi: 10.1093/molehr/gal036. Epub 2006 Apr 5.
500 Inhibition of interleukin-1-induced endothelial tissue factor expression by the synthetic cannabinoid WIN 55,212-2. Oncotarget. 2016 Sep 20;7(38):61438-61457. doi: 10.18632/oncotarget.11367.
501 Elucidating mechanisms of toxicity using phenotypic data from primary human cell systems--a chemical biology approach for thrombosis-related side effects. Int J Mol Sci. 2015 Jan 5;16(1):1008-29. doi: 10.3390/ijms16011008.
502 The effects of chemotherapeutic agents on the regulation of thrombin on cell surfaces. Br J Haematol. 2003 Jan;120(2):315-24. doi: 10.1046/j.1365-2141.2003.03971.x.
503 Mechanisms of tissue factor induction by the uremic toxin indole-3 acetic acid through aryl hydrocarbon receptor/nuclear factor-kappa B signaling pathway in human endothelial cells. Arch Toxicol. 2019 Jan;93(1):121-136.
504 Simvastatin attenuates vascular hypercoagulability in cardiac transplant recipients. Transplantation. 2000 May 15;69(9):1830-6. doi: 10.1097/00007890-200005150-00017.
505 Resveratrol and quercetin down-regulate tissue factor expression by human stimulated vascular cells. J Thromb Haemost. 2003 May;1(5):1089-95. doi: 10.1046/j.1538-7836.2003.00217.x.
506 Tissue factors on acute promyelocytic leukemia and endothelial cells are differently regulated by retinoic acid, arsenic trioxide and chemotherapeutic agents. Leukemia. 1999 Jul;13(7):1062-70. doi: 10.1038/sj.leu.2401448.
507 The effect of DNA methylation inhibitor 5-Aza-2'-deoxycytidine on human endometrial stromal cells. Hum Reprod. 2010 Nov;25(11):2859-69.
508 Gene expression levels in normal human lymphoblasts with variable sensitivities to arsenite: identification of GGT1 and NFKBIE expression levels as possible biomarkers of susceptibility. Toxicol Appl Pharmacol. 2008 Jan 15;226(2):199-205. doi: 10.1016/j.taap.2007.09.004. Epub 2007 Sep 15.
509 Tryptophan and kynurenine stimulate human decidualization via activating Aryl hydrocarbon receptor: Short title: Kynurenine action on human decidualization. Reprod Toxicol. 2020 Sep;96:282-292. doi: 10.1016/j.reprotox.2020.07.011. Epub 2020 Aug 8.
510 Oxidative stress modulates expression of immune checkpoint genes via activation of AhR signaling. Toxicol Appl Pharmacol. 2022 Dec 15;457:116314. doi: 10.1016/j.taap.2022.116314. Epub 2022 Nov 9.
511 Immune regulatory effects of simvastatin on regulatory T cell-mediated tumour immune tolerance. Clin Exp Immunol. 2010 Aug;161(2):298-305. doi: 10.1111/j.1365-2249.2010.04170.x. Epub 2010 May 18.
512 Protein expression profiling identifies molecular targets of quercetin as a major dietary flavonoid in human colon cancer cells. Proteomics. 2004 Jul;4(7):2160-74.
513 Arsenic trioxide induces differentiation of cancer stem cells in hepatocellular carcinoma through inhibition of LIF/JAK1/STAT3 and NF-kB signaling pathways synergistically. Clin Transl Med. 2021 Feb;11(2):e335. doi: 10.1002/ctm2.335.
514 Identification of estrogen-responsive genes by complementary deoxyribonucleic acid microarray and characterization of a novel early estrogen-induced gene: EEIG1. Mol Endocrinol. 2004 Feb;18(2):402-11. doi: 10.1210/me.2003-0202. Epub 2003 Nov 6.
515 Cytosolic proteomic alterations in the nucleus accumbens of cocaine overdose victims. Mol Psychiatry. 2007 Jan;12(1):55-73. doi: 10.1038/sj.mp.4001914. Epub 2006 Oct 31.
516 Cell death mechanisms of the anti-cancer drug etoposide on human cardiomyocytes isolated from pluripotent stem cells. Arch Toxicol. 2018 Apr;92(4):1507-1524.
517 Functional cardiotoxicity assessment of cosmetic compounds using human-induced pluripotent stem cell-derived cardiomyocytes. Arch Toxicol. 2018 Jan;92(1):371-381.
518 Peroxisome proliferator activated receptor gamma (PPAR-gama) ligand pioglitazone regulated gene networks in term human primary trophoblast cells. Reprod Toxicol. 2018 Oct;81:99-107.
519 Gene expression profiles in peripheral lymphocytes by arsenic exposure and skin lesion status in a Bangladeshi population. Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1367-75. doi: 10.1158/1055-9965.EPI-06-0106.
520 RNA sequence analysis of inducible pluripotent stem cell-derived cardiomyocytes reveals altered expression of DNA damage and cell cycle genes in response to doxorubicin. Toxicol Appl Pharmacol. 2018 Oct 1;356:44-53.
521 Genome-wide transcriptional and functional analysis of human T lymphocytes treated with benzo[alpha]pyrene. Int J Mol Sci. 2018 Nov 17;19(11).
522 Prediction of the contact sensitizing potential of chemicals using analysis of gene expression changes in human THP-1 monocytes. Toxicol Lett. 2010 Nov 10;199(1):51-9.
523 Drug-induced hepatic steatosis in absence of severe mitochondrial dysfunction in HepaRG cells: proof of multiple mechanism-based toxicity. Cell Biol Toxicol. 2021 Apr;37(2):151-175. doi: 10.1007/s10565-020-09537-1. Epub 2020 Jun 14.
524 Editor's Highlight: Mechanistic Toxicity Tests Based on an Adverse Outcome Pathway Network for Hepatic Steatosis. Toxicol Sci. 2017 Sep 1;159(1):159-169. doi: 10.1093/toxsci/kfx121.
525 Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy. Thromb Res. 2004;113(3-4):197-204. doi: 10.1016/j.thromres.2004.03.002.
526 Effect of the Catechol-O-Methyltransferase Inhibitors Tolcapone and Entacapone on Fatty Acid Metabolism in HepaRG Cells. Toxicol Sci. 2018 Aug 1;164(2):477-488.
527 Regulation of CD36 expression in human melanoma cells. Adv Exp Med Biol. 2002;507:337-42. doi: 10.1007/978-1-4615-0193-0_52.
528 Comparative study of the effects of ziram and disulfiram on human monocyte-derived macrophage functions and polarization: involvement of zinc. Cell Biol Toxicol. 2021 Jun;37(3):379-400. doi: 10.1007/s10565-020-09540-6. Epub 2020 Jul 25.
529 Magnitude and time course of platelet inhibition with Aggrenox and Aspirin in patients after ischemic stroke: the AGgrenox versus Aspirin Therapy Evaluation (AGATE) trial. Eur J Pharmacol. 2004 Sep 24;499(3):315-24. doi: 10.1016/j.ejphar.2004.07.114.
530 Oxidative stress modulates theophylline effects on steroid responsiveness. Biochem Biophys Res Commun. 2008 Dec 19;377(3):797-802.
531 In vitro stimulation of polymorphonuclear cell adhesion by ribomunyl and antibiotic + ribomunyl combinations: effects on CD18, CD35 and CD16 expression. Int J Immunopharmacol. 1993 Feb;15(2):163-73. doi: 10.1016/0192-0561(93)90092-d.
532 Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass. Ann Thorac Surg. 1997 Jan;63(1):105-11. doi: 10.1016/s0003-4975(96)00743-6.
533 Profiling transcriptomes of human SH-SY5Y neuroblastoma cells exposed to maleic acid. PeerJ. 2017 Apr 5;5:e3175.
534 Inhibitory effect of quercetin on tryptase and MCP-1 chemokine release, and histidine decarboxylase mRNA transcription by human mast cell-1 cell line. Neuroimmunomodulation. 2006;13(3):179-86. doi: 10.1159/000098131. Epub 2006 Dec 21.
535 Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemia. Proc Natl Acad Sci U S A. 2005 May 24;102(21):7653-8.
536 The CML-related oncoprotein BCR/ABL induces expression of histidine decarboxylase (HDC) and the synthesis of histamine in leukemic cells. Blood. 2006 Nov 15;108(10):3538-47. doi: 10.1182/blood-2005-12-028456. Epub 2006 Jul 18.
537 Decarboxylases as hypothetical targets for actions of organophosphates: Molecular modeling for prediction of hidden and unexpected health threats. Food Chem Toxicol. 2022 Mar;161:112856. doi: 10.1016/j.fct.2022.112856. Epub 2022 Feb 11.
538 Modulation of histidine decarboxylase activity and cytokine synthesis in human leukemic cell lines: relationship with basophilic and/or megakaryocytic differentiation. Exp Hematol. 1999 Aug;27(8):1295-305. doi: 10.1016/s0301-472x(99)00070-3.
539 Chemicals with weak skin sensitizing properties can be identified using low-density microarrays on immature dendritic cells. Toxicol Lett. 2007 Nov 1;174(1-3):98-109. doi: 10.1016/j.toxlet.2007.08.015. Epub 2007 Sep 5.
540 Focal striatal dopamine may potentiate dyskinesias in parkinsonian monkeys. Exp Neurol. 2006 Feb;197(2):363-72. doi: 10.1016/j.expneurol.2005.10.022. Epub 2005 Dec 9.
541 Nephrotoxicity induced by cisplatin is primarily due to the activation of the 5-hydroxytryptamine degradation system in proximal renal tubules. Chem Biol Interact. 2021 Nov 1;349:109662. doi: 10.1016/j.cbi.2021.109662. Epub 2021 Sep 21.
542 Darinaparsin: solid tumor hypoxic cytotoxin and radiosensitizer. Clin Cancer Res. 2012 Jun 15;18(12):3366-76.
543 Heme oxygenase-1 and interleukin-11 are overexpressed in stress-induced premature senescence of human WI-38 fibroblasts induced by tert-butylhydroperoxide and ethanol. Biogerontology. 2007 Aug;8(4):409-22. doi: 10.1007/s10522-007-9084-8. Epub 2007 Feb 13.
544 Contribution of CYP3A5 to hepatic and renal ifosfamide N-dechloroethylation. Drug Metab Dispos. 2005 Jul;33(7):1074-81. doi: 10.1124/dmd.104.002279. Epub 2005 Apr 8.
545 Use of mRNA expression to detect the induction of drug metabolising enzymes in rat and human hepatocytes. Toxicol Appl Pharmacol. 2009 Feb 15;235(1):86-96.
546 Induction of human cytochrome P450 3A enzymes in cultured placental cells by thalidomide and relevance to bioactivation and toxicity. J Toxicol Sci. 2017;42(3):343-348.
547 Induction of hepatic CYP3A enzymes by pregnancy-related hormones: studies in human hepatocytes and hepatic cell lines. Drug Metab Dispos. 2013 Feb;41(2):281-90.
548 Chemokine induction by all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia: triggering the differentiation syndrome. Blood. 2009 Dec 24;114(27):5512-21. doi: 10.1182/blood-2009-02-204834. Epub 2009 Oct 14.
549 Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation. Blood. 2008 Feb 1;111(3):1366-77. doi: 10.1182/blood-2007-04-084814. Epub 2007 Oct 25.
550 Pattern of expression of apoptosis and inflammatory genes in humans exposed to arsenic and/or fluoride. Sci Total Environ. 2010 Jan 15;408(4):760-7. doi: 10.1016/j.scitotenv.2009.11.016. Epub 2009 Dec 4.
551 Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer. Cancer Res. 2007 May 15;67(10):5033-41.
552 Human Mincle Binds to Cholesterol Crystals and Triggers Innate Immune Responses. J Biol Chem. 2015 Oct 16;290(42):25322-32. doi: 10.1074/jbc.M115.645234. Epub 2015 Aug 20.
553 Inhibition of Super-Enhancer Activity in Autoinflammatory Site-Derived T Cells Reduces Disease-Associated Gene Expression. Cell Rep. 2015 Sep 29;12(12):1986-96. doi: 10.1016/j.celrep.2015.08.046. Epub 2015 Sep 17.
554 Aryl hydrocarbon receptor- and calcium-dependent induction of the chemokine CCL1 by the environmental contaminant benzo[a]pyrene. J Biol Chem. 2006 Jul 21;281(29):19906-15. doi: 10.1074/jbc.M601192200. Epub 2006 May 5.
555 Ni(II) ions dysregulate cytokine secretion from human monocytes. J Biomed Mater Res B Appl Biomater. 2009 Feb;88(2):358-65. doi: 10.1002/jbm.b.31063.
556 Comparative gene expression profiling reveals partially overlapping but distinct genomic actions of different antiestrogens in human breast cancer cells. J Cell Biochem. 2006 Aug 1;98(5):1163-84.
557 Polyunsaturated fatty acids synergize with lipid droplet binding thalidomide analogs to induce oxidative stress in cancer cells. Lipids Health Dis. 2010 Jun 2;9:56. doi: 10.1186/1476-511X-9-56.
558 Febuxostat Increases Ventricular Arrhythmogenesis Through Calcium Handling Dysregulation in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Toxicol Sci. 2022 Sep 24;189(2):216-224. doi: 10.1093/toxsci/kfac073.
559 Identification of a transcriptomic signature of food-relevant genotoxins in human HepaRG hepatocarcinoma cells. Food Chem Toxicol. 2020 Jun;140:111297. doi: 10.1016/j.fct.2020.111297. Epub 2020 Mar 28.
560 Retinoic acid and hydroquinone induce inverse expression patterns on cornified envelope-associated proteins: implication in skin irritation. J Dermatol Sci. 2014 Nov;76(2):112-9. doi: 10.1016/j.jdermsci.2014.08.003. Epub 2014 Aug 26.
561 Integrated assessment by multiple gene expression analysis of quercetin bioactivity on anticancer-related mechanisms in colon cancer cells in vitro. Eur J Nutr. 2005 Mar;44(3):143-56. doi: 10.1007/s00394-004-0503-1. Epub 2004 Apr 30.
562 Comparison of the gene expression profiles of monocytic versus granulocytic lineages of HL-60 leukemia cell differentiation by DNA microarray analysis. Life Sci. 2003 Aug 15;73(13):1705-19. doi: 10.1016/s0024-3205(03)00515-0.
563 Bisphenol A and bisphenol S induce distinct transcriptional profiles in differentiating human primary preadipocytes. PLoS One. 2016 Sep 29;11(9):e0163318.
564 The differential effects of neuroleptic drugs and PACAP on the expression of BDNF mRNA and protein in a human glioblastoma cell line. Acta Neurobiol Exp (Wars). 2017;77(3):205-213.
565 Tea polyphenols ameliorates neural redox imbalance and mitochondrial dysfunction via mechanisms linking the key circadian regular Bmal1. Food Chem Toxicol. 2017 Dec;110:189-199. doi: 10.1016/j.fct.2017.10.031. Epub 2017 Oct 20.
566 LncRNA SNHG12 ameliorates bupivacaine-induced neurotoxicity by sponging miR-497-5p to upregulate NLRX1. Hum Exp Toxicol. 2022 Jan-Dec;41:9603271221089001. doi: 10.1177/09603271221089001.
567 Mechanism of arsenic trioxide inhibiting angiogenesis in multiple myeloma. J Huazhong Univ Sci Technolog Med Sci. 2006;26(1):43-6. doi: 10.1007/BF02828035.
568 Treatment with anticancer agents induces dysregulation of specific Wnt signaling pathways in human ovarian luteinized granulosa cells in vitro. Toxicol Sci. 2013 Nov;136(1):183-92. doi: 10.1093/toxsci/kft175. Epub 2013 Aug 16.
569 Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan. Cancer Sci. 2013 Aug;104(8):1074-82. doi: 10.1111/cas.12186. Epub 2013 Jun 10.
570 Cellular reactions to long-term volatile organic compound (VOC) exposures. Sci Rep. 2016 Dec 1;6:37842. doi: 10.1038/srep37842.
571 Effects of Cyanobacterial Harmful Algal Bloom Toxin Microcystin-LR on Gonadotropin-Dependent Ovarian Follicle Maturation and Ovulation in Mice. Environ Health Perspect. 2023 Jun;131(6):67010. doi: 10.1289/EHP12034. Epub 2023 Jun 21.
572 Chymase mediates paraquat-induced collagen production in human lung fibroblasts. Toxicol Lett. 2010 Mar 1;193(1):19-25. doi: 10.1016/j.toxlet.2009.12.001. Epub 2009 Dec 5.
573 Induction of CYP3As in HepG2 cells by several drugs. Association between induction of CYP3A4 and expression of glucocorticoid receptor. Biol Pharm Bull. 2003 Apr;26(4):510-7.
574 Human drug metabolism genes in parathion-and estrogen-treated breast cells. Int J Mol Med. 2007 Dec;20(6):875-81.
575 Dose- and time-dependent effects of phenobarbital on gene expression profiling in human hepatoma HepaRG cells. Toxicol Appl Pharmacol. 2009 Feb 1;234(3):345-60.
576 Variability of CYP3A7 expression in human fetal liver. J Pharmacol Exp Ther. 2005 Aug;314(2):626-35. doi: 10.1124/jpet.105.086504. Epub 2005 Apr 21.
577 Participation of CYP2C8 and CYP3A4 in the N-demethylation of imatinib in human hepatic microsomes. Br J Pharmacol. 2010 Nov;161(5):1059-69. doi: 10.1111/j.1476-5381.2010.00946.x.
578 Effect of nephrotoxicants and hepatotoxicants on gene expression profile in human peripheral blood mononuclear cells. Biochem Biophys Res Commun. 2010 Oct 15;401(2):245-50. doi: 10.1016/j.bbrc.2010.09.039. Epub 2010 Sep 16.
579 Cardiac toxicity from ethanol exposure in human-induced pluripotent stem cell-derived cardiomyocytes. Toxicol Sci. 2019 May 1;169(1):280-292.
580 Rosiglitazone attenuates endothelin-1-induced vasoconstriction by upregulating endothelial expression of endothelin B receptor. Hypertension. 2010 Jul;56(1):129-35. doi: 10.1161/HYPERTENSIONAHA.110.150375. Epub 2010 Jun 1.
581 Down-regulation and decreased activity of cyclin-dependent kinase 2 in H2O2-induced premature senescence. Int J Biochem Cell Biol. 2003 Feb;35(2):246-54. doi: 10.1016/s1357-2725(02)00129-2.
582 Nonsteroidal anti-inflammatory drugs inhibit growth of human neuroendocrine tumor cells via G1 cell-cycle arrest. Int J Cancer. 2003 Dec 10;107(5):844-53. doi: 10.1002/ijc.11446.
583 Peripheral blood expression of nuclear factor-kappab-regulated genes is associated with rheumatoid arthritis disease activity and responds differentially to anti-tumor necrosis factor-alpha versus methotrexate. J Rheumatol. 2007 Sep;34(9):1817-22. Epub 2007 Aug 1.
584 Simvastatin inhibits cell growth and induces apoptosis and G0/G1 cell cycle arrest in hepatic cancer cells. Int J Mol Med. 2010 Nov;26(5):735-41. doi: 10.3892/ijmm_00000520.
585 Inhibition of prostate cancer cell colony formation by the flavonoid quercetin correlates with modulation of specific regulatory genes. Clin Diagn Lab Immunol. 2004 Jan;11(1):63-9. doi: 10.1128/cdli.11.1.63-69.2004.
586 Perfluorooctanoic acid alters progesterone activity in human endometrial cells and induces reproductive alterations in young women. Chemosphere. 2020 Mar;242:125208. doi: 10.1016/j.chemosphere.2019.125208. Epub 2019 Oct 24.
587 Neuroprotective effects of glucomoringin-isothiocyanate against H(2)O(2)-Induced cytotoxicity in neuroblastoma (SH-SY5Y) cells. Neurotoxicology. 2019 Dec;75:89-104. doi: 10.1016/j.neuro.2019.09.008. Epub 2019 Sep 12.
588 Complex genetic response of human cells to sublethal levels of pure nitric oxide. Cancer Res. 1998 Aug 1;58(15):3435-40.
589 Inflammation in methotrexate-induced pulmonary toxicity occurs via the p38 MAPK pathway. Toxicology. 2009 Feb 27;256(3):183-90. doi: 10.1016/j.tox.2008.11.016. Epub 2008 Nov 28.
590 Chromium III histidinate exposure modulates gene expression in HaCaT human keratinocytes exposed to oxidative stress. Biol Trace Elem Res. 2010 Oct;137(1):23-39.
591 Antiepileptic drugs are endocrine disruptors for the human fetal testis ex vivo. Toxicol Sci. 2023 Sep 28;195(2):169-183. doi: 10.1093/toxsci/kfad076.
592 Synergistic antiproliferative effect of arsenic trioxide combined with bortezomib in HL60 cell line and primary blasts from patients affected by myeloproliferative disorders. Cancer Genet Cytogenet. 2010 Jun;199(2):110-20. doi: 10.1016/j.cancergencyto.2010.02.010.
593 The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet. 2009 Feb;41(2):178-186.
594 Differential gene expression of sulindac-treated human breast epithelial cells. Int J Oncol. 2005 Dec;27(6):1727-36.
595 Evidence for direct involvement of epirubicin in the formation of chromosomal translocations in t(15;17) therapy-related acute promyelocytic leukemia. Blood. 2010 Jan 14;115(2):326-30. doi: 10.1182/blood-2009-07-235051. Epub 2009 Nov 2.
596 Differential protein expression of peroxiredoxin I and II by benzo(a)pyrene and quercetin treatment in 22Rv1 and PrEC prostate cell lines. Toxicol Appl Pharmacol. 2007 Apr 15;220(2):197-210. doi: 10.1016/j.taap.2006.12.030. Epub 2007 Jan 9.
597 Morphological and molecular course of mitochondrial pathology in cultured human cells exposed long-term to Zidovudine. Environ Mol Mutagen. 2007 Apr-May;48(3-4):179-89. doi: 10.1002/em.20245.
598 Proteomic analysis of the nucleus accumbens of rats with different vulnerability to cocaine addiction. Neuropharmacology. 2009 Jul;57(1):41-8. doi: 10.1016/j.neuropharm.2009.04.005. Epub 2009 Apr 22.
599 Medicinal chemistry of somatostatin analogs leading to the DTPA and DOTA conjugates of the multi-receptor-ligand SOM230. J Endocrinol Invest. 2005;28(11 Suppl International):15-20.
600 Locoregional regulatory peptide receptor targeting with the diffusible somatostatin analogue 90Y-labeled DOTA0-D-Phe1-Tyr3-octreotide (DOTATOC): a pilot study in human gliomas. Clin Cancer Res. 1999 May;5(5):1025-33.
601 Preoperative growth inhibition of human gastric adenocarcinoma treated with a combination of celecoxib and octreotide. Acta Pharmacol Sin. 2007 Nov;28(11):1842-50. doi: 10.1111/j.1745-7254.2007.00652.x.
602 Benzyl isothiocyanate attenuates the hydrogen peroxide-induced interleukin-13 expression through glutathione S-transferase P induction in T lymphocytic leukemia cells. J Biochem Mol Toxicol. 2018 Jun;32(6):e22054.
603 Alterations in eotaxin, monocyte chemoattractant protein-4, interleukin-5, and interleukin-13 after systemic steroid treatment for nasal polyps. Otolaryngol Head Neck Surg. 2004 Nov;131(5):585-9. doi: 10.1016/j.otohns.2004.05.028.
604 Editor's Highlight: Modeling Compound-Induced Fibrogenesis In Vitro Using Three-Dimensional Bioprinted Human Liver Tissues. Toxicol Sci. 2016 Dec;154(2):354-367. doi: 10.1093/toxsci/kfw169. Epub 2016 Sep 7.
605 Detection of Drug-Responsive T-Lymphocytes in a Case of Fatal Antituberculosis Drug-Related Liver Injury. Chem Res Toxicol. 2016 Nov 21;29(11):1793-1795. doi: 10.1021/acs.chemrestox.6b00393. Epub 2016 Nov 9.
606 Inhibition of interleukin-13 gene expression in T cells through GATA-3 pathway by arsenic trioxide. Chin Med J (Engl). 2008 Nov 20;121(22):2346-9.
607 [Effects of beclomethasone dipropionate and budesonide on interleukin-13 induced cytokine release, proliferation and differentiation of the human lung fibroblasts]. Zhonghua Jie He He Hu Xi Za Zhi. 2007 Aug;30(8):599-604.
608 Synergistic activity of BET protein antagonist-based combinations in mantle cell lymphoma cells sensitive or resistant to ibrutinib. Blood. 2015 Sep 24;126(13):1565-74.
609 Rosiglitazone impairs proliferation of human adrenocortical cancer: preclinical study in a xenograft mouse model. Endocr Relat Cancer. 2010 Feb 18;17(1):169-77. doi: 10.1677/ERC-09-0170. Print 2010 Mar.
610 Neuronal Bmi-1 is critical for melatonin induced ubiquitination and proteasomal degradation of -synuclein in experimental Parkinson's disease models. Neuropharmacology. 2021 Aug 15;194:108372. doi: 10.1016/j.neuropharm.2020.108372. Epub 2020 Nov 4.
611 Bisphenol A promotes human prostate stem-progenitor cell self-renewal and increases in vivo carcinogenesis in human prostate epithelium. Endocrinology. 2014 Mar;155(3):805-17. doi: 10.1210/en.2013-1955. Epub 2014 Jan 1.
612 DNA array analysis of the effects of aspirin on colon cancer cells: involvement of Rac1. Carcinogenesis. 2004 Jul;25(7):1293-8.
613 Genomic and proteomic analysis of the effects of cannabinoids on normal human astrocytes. Brain Res. 2008 Jan 29;1191:1-11.
614 Effects of acute ethanol treatment on NCCIT cells and NCCIT cell-derived embryoid bodies (EBs). Toxicol In Vitro. 2010 Sep;24(6):1696-704. doi: 10.1016/j.tiv.2010.05.017. Epub 2010 May 26.
615 Cannabidiol Activates Neuronal Precursor Genes in Human Gingival Mesenchymal Stromal Cells. J Cell Biochem. 2017 Jun;118(6):1531-1546. doi: 10.1002/jcb.25815. Epub 2016 Dec 29.
616 Novel functional view of the crocidolite asbestos-treated A549 human lung epithelial transcriptome reveals an intricate network of pathways with opposing functions. BMC Genomics. 2008 Aug 7;9:376.
617 Dexamethasone and the inflammatory response in explants of human omental adipose tissue. Mol Cell Endocrinol. 2010 Feb 5;315(1-2):292-8.
618 Docosahexaenoic acid regulates gene expression in HUVEC cells treated with polycyclic aromatic hydrocarbons. Toxicol Lett. 2015 Jul 16;236(2):75-81.
619 Etoposide induces necrosis through p53-mediated antiapoptosis in human kidney proximal tubule cells. Toxicol Sci. 2015 Nov;148(1):204-19.
620 Conjugated linoleic acid, unlike other unsaturated fatty acids, strongly induces glutathione synthesis without any lipoperoxidation. Br J Nutr. 2006 Nov;96(5):811-9.
621 COX-2 and PPAR-gama confer cannabidiol-induced apoptosis of human lung cancer cells. Mol Cancer Ther. 2013 Jan;12(1):69-82.
622 Mitochondrial involvement in schizophrenia and other functional psychoses. Neurochem Res. 1996 Sep;21(9):995-1004.
623 Immunomodulatory effect of selective serotonin reuptake inhibitors (SSRIs) on human T lymphocyte function and gene expression. Eur Neuropsychopharmacol. 2007 Dec;17(12):774-80.
624 Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer. Cancer Res. 2006 Feb 15;66(4):2067-73.
625 A2E selectively induces cox-2 in ARPE-19 and human neural cells. Curr Eye Res. 2006 Mar;31(3):259-63.
626 Multifaceted preventive effects of single agent quercetin on a human prostate adenocarcinoma cell line (PC-3): implications for nutritional transcriptomics and multi-target therapy. Med Oncol. 2011 Dec;28(4):1395-404. doi: 10.1007/s12032-010-9603-3. Epub 2010 Jul 2.
627 [Effect of arsenic trioxide on vascular endothelial growth factor-C and its receptor (VEGFR-3) in nude mice with gastric cancer]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Dec;16(6):1303-7.
628 Antitumor activity and biomarker analysis of sunitinib in patients with bevacizumab-refractory metastatic renal cell carcinoma. J Clin Oncol. 2008 Aug 1;26(22):3743-8. doi: 10.1200/JCO.2007.15.5416.
629 Discovery of 5-(arenethynyl) hetero-monocyclic derivatives as potent inhibitors of BCR-ABL including the T315I gatekeeper mutant. Bioorg Med Chem Lett. 2011 Jun 15;21(12):3743-8.
630 Histone deacetylase inhibitor scriptaid induces cell cycle arrest and epigenetic change in colon cancer cells. Int J Oncol. 2008 Oct;33(4):767-76.
631 Isobaric tags for relative and absolute quantitation-based proteomics analysis of the effect of ginger oil on bisphenol A-induced breast cancer cell proliferation. Oncol Lett. 2021 Feb;21(2):101. doi: 10.3892/ol.2020.12362. Epub 2020 Dec 8.
632 3-Nitrobenzanthrone promotes malignant transformation in human lung epithelial cells through the epiregulin-signaling pathway. Cell Biol Toxicol. 2022 Oct;38(5):865-887. doi: 10.1007/s10565-021-09612-1. Epub 2021 May 25.
633 Transcriptomic alterations induced by Ochratoxin A in rat and human renal proximal tubular in vitro models and comparison to a rat in vivo model. Arch Toxicol. 2012 Apr;86(4):571-89.
634 "Exposure to the insecticides permethrin and malathion induces leukemia and lymphoma-associated gene aberrations in vitro". Toxicol In Vitro. 2017 Oct;44:17-26. doi: 10.1016/j.tiv.2017.06.013. Epub 2017 Jun 15.
635 In vitro and in vivo irinotecan-induced changes in expression profiles of cell cycle and apoptosis-associated genes in acute myeloid leukemia cells. Mol Cancer Ther. 2005 Jun;4(6):885-900.
636 Translocation t(12;21) is related to in vitro cellular drug sensitivity to doxorubicin and etoposide in childhood acute lymphoblastic leukemia. Blood. 2004 Oct 15;104(8):2452-7. doi: 10.1182/blood-2003-12-4426. Epub 2004 Jun 24.
637 Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma. Oncotarget. 2014 May 15;5(9):2355-71.
638 Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosis. Oncogene. 2010 Sep 16;29(37):5159-70. doi: 10.1038/onc.2010.255. Epub 2010 Jun 21.
639 Inhibition of cardiomyocyte differentiation of human induced pluripotent stem cells by Ribavirin: Implication for its cardiac developmental toxicity. Toxicology. 2020 Apr 15;435:152422. doi: 10.1016/j.tox.2020.152422. Epub 2020 Feb 26.
640 Molecular characterization of a toxicological tipping point during human stem cell differentiation. Reprod Toxicol. 2020 Jan;91:1-13. doi: 10.1016/j.reprotox.2019.10.001. Epub 2019 Oct 7.
641 Arsenic induces human chondrocyte senescence and accelerates rat articular cartilage aging. Arch Toxicol. 2020 Jan;94(1):89-101. doi: 10.1007/s00204-019-02607-2. Epub 2019 Nov 16.
642 Nuclear and Mitochondrial DNA Methylation Patterns Induced by Valproic Acid in Human Hepatocytes. Chem Res Toxicol. 2017 Oct 16;30(10):1847-1854. doi: 10.1021/acs.chemrestox.7b00171. Epub 2017 Sep 13.
643 Neuronal and cardiac toxicity of pharmacological compounds identified through transcriptomic analysis of human pluripotent stem cell-derived embryoid bodies. Toxicol Appl Pharmacol. 2021 Dec 15;433:115792. doi: 10.1016/j.taap.2021.115792. Epub 2021 Nov 3.
644 Drug-induced endoplasmic reticulum and oxidative stress responses independently sensitize toward TNF-mediated hepatotoxicity. Toxicol Sci. 2014 Jul;140(1):144-59. doi: 10.1093/toxsci/kfu072. Epub 2014 Apr 20.
645 Sevoflurane-mediated activation of p38-mitogen-activated stresskinase is independent of apoptosis in Jurkat T-cells. Anesth Analg. 2008 Apr;106(4):1150-60, table of contents. doi: 10.1213/ane.0b013e3181683d37.
646 Quercetin induced cell apoptosis and altered gene expression in AGS human gastric cancer cells. Environ Toxicol. 2018 Nov;33(11):1168-1181. doi: 10.1002/tox.22623. Epub 2018 Aug 27.
647 Arsenic trioxide (As(2)O(3)) induced apoptosis and its mechanisms in a human esophageal squamous carcinoma cell line. Chin Med J (Engl). 2002 Feb;115(2):280-5.
648 Role of unfolded protein response dysregulation in oxidative injury of retinal pigment epithelial cells. Antioxid Redox Signal. 2014 May 10;20(14):2091-106. doi: 10.1089/ars.2013.5240. Epub 2013 Dec 17.
649 Ouabain induces apoptotic cell death in human prostate DU 145 cancer cells through DNA damage and TRAIL pathways. Environ Toxicol. 2019 Dec;34(12):1329-1339. doi: 10.1002/tox.22834. Epub 2019 Aug 21.
650 Thyroid organotypic rat and human cultures used to investigate drug effects on thyroid function, hormone synthesis and release pathways. Toxicol Appl Pharmacol. 2012 Apr 1;260(1):81-8. doi: 10.1016/j.taap.2012.01.029. Epub 2012 Feb 8.
651 Screening the ToxCast Phase 1, Phase 2, and e1k Chemical Libraries for Inhibitors of Iodothyronine Deiodinases. Toxicol Sci. 2019 Apr 1;168(2):430-442. doi: 10.1093/toxsci/kfy302.
652 Effects of all-trans and 9-cis retinoic acid on differentiating human neural stem cells in vitro. Toxicology. 2023 Mar 15;487:153461. doi: 10.1016/j.tox.2023.153461. Epub 2023 Feb 16.
653 Regulation of type 1 iodothyronine deiodinase in health and disease. Thyroid. 2005 Aug;15(8):835-40. doi: 10.1089/thy.2005.15.835.
654 Structure and function of human histamine N-methyltransferase: critical enzyme in histamine metabolism in airway. Am J Physiol. 1994 Sep;267(3 Pt 1):L342-9.
655 Genome-wide association for methamphetamine dependence: convergent results from 2 samples. Arch Gen Psychiatry. 2008 Mar;65(3):345-55. doi: 10.1001/archpsyc.65.3.345.
656 Characterization of arsenic trioxide resistant clones derived from Jurkat leukemia T cell line: focus on PI3K/Akt signaling pathway. Chem Biol Interact. 2013 Oct 5;205(3):198-211. doi: 10.1016/j.cbi.2013.07.011. Epub 2013 Aug 2.
657 MiR-146a affects the alteration in myeloid differentiation induced by hydroquinone in human CD34(+) hematopoietic progenitor cells and HL-60 cells. Toxicol Res (Camb). 2016 Feb 16;5(3):848-858. doi: 10.1039/c5tx00419e. eCollection 2016 May 1.
658 Folic acid modulates cancer-associated micro RNAs and inflammatory mediators in neoplastic and non-neoplastic colonic cells in a different way. Mol Nutr Food Res. 2017 Dec;61(12). doi: 10.1002/mnfr.201700260. Epub 2017 Nov 9.
659 Inorganic arsenic as an endocrine disruptor: modulation of the glucocorticoid receptor pathway in placental cells via CpG methylation. Chem Res Toxicol. 2019 Mar 18;32(3):493-499.
660 Epigallocatechin-3-gallate (EGCG) protects against chromate-induced toxicity in vitro. Toxicol Appl Pharmacol. 2012 Jan 15;258(2):166-75.
661 Identification of biomarkers modulated by the rexinoid LGD1069 (bexarotene) in human breast cells using oligonucleotide arrays. Cancer Res. 2006 Dec 15;66(24):12009-18.
662 Apoptosis induced by piroxicam plus cisplatin combined treatment is triggered by p21 in mesothelioma. PLoS One. 2011;6(8):e23569.
663 Long-term estrogen exposure promotes carcinogen bioactivation, induces persistent changes in gene expression, and enhances the tumorigenicity of MCF-7 human breast cancer cells. Toxicol Appl Pharmacol. 2009 Nov 1;240(3):355-66.
664 Moving toward integrating gene expression profiling into high-throughput testing: a gene expression biomarker accurately predicts estrogen receptor alpha modulation in a microarray compendium. Toxicol Sci. 2016 May;151(1):88-103.
665 The platelet P2Y12 receptor contributes to granule secretion through Ephrin A4 receptor. Platelets. 2012;23(8):617-25. doi: 10.3109/09537104.2011.645924. Epub 2012 Jan 24.
666 The use of genomics technology to investigate gene expression changes in cultured human liver cells. Toxicol In Vitro. 2001 Aug-Oct;15(4-5):399-405. doi: 10.1016/s0887-2333(01)00043-1.
667 10mM glucosamine prevents activation of proADAMTS5 (aggrecanase-2) in transfected cells by interference with post-translational modification of furin. Osteoarthritis Cartilage. 2010 Mar;18(3):455-63. doi: 10.1016/j.joca.2009.10.014. Epub 2009 Nov 4.
668 Coordinate up-regulation of TMEM97 and cholesterol biosynthesis genes in normal ovarian surface epithelial cells treated with progesterone: implications for pathogenesis of ovarian cancer. BMC Cancer. 2007 Dec 11;7:223.
669 Genome-wide mapping for clinically relevant predictors of lamotrigine- and phenytoin-induced hypersensitivity reactions. Pharmacogenomics. 2012 Mar;13(4):399-405. doi: 10.2217/pgs.11.165.
670 Transcriptional profiling in the human prefrontal cortex: evidence for two activational states associated with cocaine abuse. Pharmacogenomics J. 2003;3(1):27-40.
671 Characterization of the functional and growth properties of long-term cell cultures established from a human somatostatinoma. Endocr Relat Cancer. 2006 Mar;13(1):79-93. doi: 10.1677/erc.1.00988.
672 Hypermethylation of the somatostatin promoter is a common, early event in human esophageal carcinogenesis. Cancer. 2008 Jan 1;112(1):43-9. doi: 10.1002/cncr.23135.
673 Utilization of CDKN1A/p21 gene for class discrimination of DNA damage-induced clastogenicity. Toxicology. 2014 Jan 6;315:8-16. doi: 10.1016/j.tox.2013.10.009. Epub 2013 Nov 6.
674 Gene expression profile of multiple myeloma cell line treated by arsenic trioxide. J Huazhong Univ Sci Technolog Med Sci. 2007 Dec;27(6):646-9. doi: 10.1007/s11596-007-0606-z.
675 Gamma-irradiation and doxorubicin treatment of normal human cells cause cell cycle arrest via different pathways. Mol Cells. 2005 Dec 31;20(3):331-8.
676 DNA methyltransferase inhibitors coordinately induce expression of the human reelin and glutamic acid decarboxylase 67 genes. Mol Pharmacol. 2007 Mar;71(3):644-53. doi: 10.1124/mol.106.030635. Epub 2006 Oct 25.
677 Gene expression profiling in Ishikawa cells: a fingerprint for estrogen active compounds. Toxicol Appl Pharmacol. 2009 Apr 1;236(1):85-96.
678 Mechanical stress-activated immune response genes via Sirtuin 1 expression in human periodontal ligament cells. Clin Exp Immunol. 2012 Apr;168(1):113-24. doi: 10.1111/j.1365-2249.2011.04549.x.
679 Isoproterenol effects evaluated in heart slices of human and rat in comparison to rat heart in vivo. Toxicol Appl Pharmacol. 2014 Jan 15;274(2):302-12.
680 PCI-24781 induces caspase and reactive oxygen species-dependent apoptosis through NF-kappaB mechanisms and is synergistic with bortezomib in lymphoma cells. Clin Cancer Res. 2009 May 15;15(10):3354-65. doi: 10.1158/1078-0432.CCR-08-2365. Epub 2009 May 5.
681 Bisphenol A induces DSB-ATM-p53 signaling leading to cell cycle arrest, senescence, autophagy, stress response, and estrogen release in human fetal lung fibroblasts. Arch Toxicol. 2018 Apr;92(4):1453-1469.
682 Environmental pollutant induced cellular injury is reflected in exosomes from placental explants. Placenta. 2020 Jan 1;89:42-49. doi: 10.1016/j.placenta.2019.10.008. Epub 2019 Oct 17.
683 Mechanisms of L-Serine Neuroprotection in vitro Include ER Proteostasis Regulation. Neurotox Res. 2018 Jan;33(1):123-132. doi: 10.1007/s12640-017-9829-3. Epub 2017 Nov 2.
684 Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma. Cancer Res. 2023 Jan 18;83(2):181-194. doi: 10.1158/0008-5472.CAN-22-1029.
685 CXCL14 downregulation in human keratinocytes is a potential biomarker for a novel in vitro skin sensitization test. Toxicol Appl Pharmacol. 2020 Jan 1;386:114828. doi: 10.1016/j.taap.2019.114828. Epub 2019 Nov 14.
686 Modulation of FoxO signaling in human hepatoma cells by exposure to copper or zinc ions. Arch Biochem Biophys. 2006 Oct 15;454(2):107-13. doi: 10.1016/j.abb.2006.08.016. Epub 2006 Aug 30.
687 450K epigenome-wide scan identifies differential DNA methylation in newborns related to maternal smoking during pregnancy. Environ Health Perspect. 2012 Oct;120(10):1425-31. doi: 10.1289/ehp.1205412. Epub 2012 Jul 31.
688 Circulating endothelial progenitor cells in multiple myeloma: implications and significance. Blood. 2005 Apr 15;105(8):3286-94. doi: 10.1182/blood-2004-06-2101. Epub 2004 Dec 23.
689 Propranolol inhibits proliferation and induces apoptosis of hemangioma-derived endothelial cells via Akt pathway by down-regulating Ang-2 expression. Chem Biol Interact. 2020 Jan 25;316:108925. doi: 10.1016/j.cbi.2019.108925. Epub 2019 Dec 12.
690 Capsaicin promotes a more aggressive gene expression phenotype and invasiveness in null-TRPV1 urothelial cancer cells. Carcinogenesis. 2011 May;32(5):686-94. doi: 10.1093/carcin/bgr025. Epub 2011 Feb 10.
691 Rigosertib as a selective anti-tumor agent can ameliorate multiple dysregulated signaling transduction pathways in high-grade myelodysplastic syndrome. Sci Rep. 2014 Dec 4;4:7310. doi: 10.1038/srep07310.
692 Dietary flavonoids induce MLL translocations in primary human CD34+ cells. Carcinogenesis. 2007 Aug;28(8):1703-9. doi: 10.1093/carcin/bgm102. Epub 2007 Apr 29.
693 Differential responses to retinoic acid and endocrine disruptor compounds of subpopulations within human embryonic stem cell lines. Differentiation. 2012 Nov;84(4):330-43. doi: 10.1016/j.diff.2012.07.006. Epub 2012 Aug 18.
694 Alcohol triggered bile acid disequilibrium by suppressing BSEP to sustain hepatocellular carcinoma progression. Chem Biol Interact. 2022 Apr 1;356:109847. doi: 10.1016/j.cbi.2022.109847. Epub 2022 Feb 9.
695 Prefrontal dysfunction in schizophrenia involves mixed-lineage leukemia 1-regulated histone methylation at GABAergic gene promoters. J Neurosci. 2007 Oct 17;27(42):11254-62. doi: 10.1523/JNEUROSCI.3272-07.2007.
696 The broken MLL gene is frequently located outside the inherent chromosome territory in human lymphoid cells treated with DNA topoisomerase II poison etoposide. PLoS One. 2013 Sep 25;8(9):e75871. doi: 10.1371/journal.pone.0075871. eCollection 2013.
697 Nicotine stimulates urokinase-type plasminogen activator receptor expression and cell invasiveness through mitogen-activated protein kinase and reactive oxygen species signaling in ECV304 endothelial cells. Toxicol Appl Pharmacol. 2012 Mar 1;259(2):248-56. doi: 10.1016/j.taap.2012.01.002. Epub 2012 Jan 9.
698 [Clinical study on the fibrinolytic activity in patients with acute promyelocytic leukemia]. Zhonghua Xue Ye Xue Za Zhi. 2009 Mar;30(3):145-9.
699 Aspirin upregulates expression of urokinase type plasminogen activator receptor (uPAR) gene in human colon cancer cells through AP1. Biochem Biophys Res Commun. 2006 Sep 22;348(2):618-27. doi: 10.1016/j.bbrc.2006.07.098. Epub 2006 Jul 28.
700 Ouabain impairs cell migration, and invasion and alters gene expression of human osteosarcoma U-2 OS cells. Environ Toxicol. 2017 Nov;32(11):2400-2413. doi: 10.1002/tox.22453. Epub 2017 Aug 10.
701 Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes. Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2716-23.
702 Prevention of deoxycholate-induced gastric apoptosis by aspirin: roles of NF-kappaB and PKC signaling. J Surg Res. 2008 Mar;145(1):66-73. doi: 10.1016/j.jss.2007.04.039. Epub 2007 Jul 20.
703 Peroxisome proliferator-activated receptor-gamma agonists inhibit respiratory syncytial virus-induced expression of intercellular adhesion molecule-1 in human lung epithelial cells. Immunology. 2007 May;121(1):71-81. doi: 10.1111/j.1365-2567.2006.02539.x.
704 Glucosamine regulation of LPS-mediated inflammation in human bronchial epithelial cells. Eur J Pharmacol. 2010 Jun 10;635(1-3):219-26. doi: 10.1016/j.ejphar.2010.02.044. Epub 2010 Mar 20.
705 Effects of 1 alpha,25-dihydroxy-vitamin D3 and calcipotriol on organotypic cultures of outer root sheath cells: a potential model to evaluate antipsoriatic drugs. Arch Dermatol Res. 1993;285(7):402-9. doi: 10.1007/BF00372133.
706 Direct effect of 2-palmitoyl glycerol on promotion of gamma aminobutyric acid synthesis in normal human fetal-derived astrocytes. FEBS Open Bio. 2023 Jul;13(7):1320-1332. doi: 10.1002/2211-5463.13649. Epub 2023 May 24.
707 Differential regulation of proliferation, cell cycle control and gene expression in cultured human aortic and pulmonary artery endothelial cells by resveratrol. Int J Mol Med. 2010 Nov;26(5):743-9.
708 Transcriptome-based functional classifiers for direct immunotoxicity. Arch Toxicol. 2014 Mar;88(3):673-89.
709 Cannabis-induced cytotoxicity in leukemic cell lines: the role of the cannabinoid receptors and the MAPK pathway. Blood. 2005 Feb 1;105(3):1214-21. doi: 10.1182/blood-2004-03-1182. Epub 2004 Sep 28.
710 Analysis of gene expression induced by diethylstilbestrol (DES) in human primitive Mullerian duct cells using microarray. Cancer Lett. 2005 Apr 8;220(2):197-210.
711 Differential effects of estrogen and progesterone on potassium channels expressed in Xenopus oocytes. Steroids. 2008 Mar;73(3):272-9. doi: 10.1016/j.steroids.2007.10.010. Epub 2007 Nov 4.
712 Sulindac enhances adenoviral vector expressing mda-7/IL-24-mediated apoptosis in human lung cancer. Mol Cancer Ther. 2005 Feb;4(2):291-304.
713 Inorganic arsenic exposure promotes malignant progression by HDAC6-mediated down-regulation of HTRA1. J Appl Toxicol. 2023 Aug;43(8):1214-1224. doi: 10.1002/jat.4457. Epub 2023 Mar 11.
714 Antiproliferative effect of ascorbic acid is associated with the inhibition of genes necessary to cell cycle progression. PLoS One. 2009;4(2):e4409.
715 Comprehensive transcriptome profiling of BET inhibitor-treated HepG2 cells. PLoS One. 2022 Apr 29;17(4):e0266966. doi: 10.1371/journal.pone.0266966. eCollection 2022.
716 Endoplasmic reticulum stress impairs insulin signaling through mitochondrial damage in SH-SY5Y cells. Neurosignals. 2012;20(4):265-80.
717 Prolyl endopeptidase is involved in cellular signalling in human neuroblastoma SH-SY5Y cells. Neurosignals. 2011;19(2):97-109. doi: 10.1159/000326342. Epub 2011 Apr 10.
718 Transcriptional profiling of lactic acid treated reconstructed human epidermis reveals pathways underlying stinging and itch. Toxicol In Vitro. 2019 Jun;57:164-173.
719 A trichostatin A expression signature identified by TempO-Seq targeted whole transcriptome profiling. PLoS One. 2017 May 25;12(5):e0178302. doi: 10.1371/journal.pone.0178302. eCollection 2017.
720 Transcellular movement of hydroxyurea is mediated by specific solute carrier transporters. Exp Hematol. 2011 Apr;39(4):446-56.
721 Tumor necrosis factor-alpha-induced protein 3 as a putative regulator of nuclear factor-kappaB-mediated resistance to O6-alkylating agents in human glioblastomas. J Clin Oncol. 2006 Jan 10;24(2):274-87. doi: 10.1200/JCO.2005.02.9405. Epub 2005 Dec 19.
722 CRISPR-based DNA methylation editing of NNT rescues the cisplatin resistance of lung cancer cells by reducing autophagy. Arch Toxicol. 2023 Feb;97(2):441-456. doi: 10.1007/s00204-022-03404-0. Epub 2022 Nov 6.
723 Multi-parameter in vitro toxicity testing of crizotinib, sunitinib, erlotinib, and nilotinib in human cardiomyocytes. Toxicol Appl Pharmacol. 2013 Oct 1;272(1):245-55.
724 Evaluation of nefazodone-induced cardiotoxicity in human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2016 Apr 1;296:42-53. doi: 10.1016/j.taap.2016.01.015. Epub 2016 Jan 25.
725 Modulation of the heart's electrical properties by the anticonvulsant drug retigabine. Toxicol Appl Pharmacol. 2017 Aug 15;329:309-317. doi: 10.1016/j.taap.2017.06.018. Epub 2017 Jun 20.
726 CACNA1C gene polymorphisms, cardiovascular disease outcomes, and treatment response. Circ Cardiovasc Genet. 2009 Aug;2(4):362-70. doi: 10.1161/CIRCGENETICS.109.857839. Epub 2009 Jun 3.
727 Differential effects of omega-3 and omega-6 Fatty acids on gene expression in breast cancer cells. Breast Cancer Res Treat. 2007 Jan;101(1):7-16. doi: 10.1007/s10549-006-9269-x. Epub 2006 Jul 6.
728 Chemical genomic screening for methylation-silenced genes in gastric cancer cell lines using 5-aza-2'-deoxycytidine treatment and oligonucleotide microarray. Cancer Sci. 2006 Jan;97(1):64-71.
729 Progesterone promotes differentiation of human cord blood fetal T cells into T regulatory cells but suppresses their differentiation into Th17 cells. J Immunol. 2011 Aug 15;187(4):1778-87. doi: 10.4049/jimmunol.1003919. Epub 2011 Jul 18.
730 Integrated transcriptomic and metabolomic analyses to characterize the anti-cancer effects of (-)-epigallocatechin-3-gallate in human colon cancer cells. Toxicol Appl Pharmacol. 2020 Aug 15;401:115100. doi: 10.1016/j.taap.2020.115100. Epub 2020 Jun 6.
731 Expression profiling in squamous carcinoma cells reveals pleiotropic effects of vitamin D3 analog EB1089 signaling on cell proliferation, differentiation, and immune system regulation. Mol Endocrinol. 2002 Jun;16(6):1243-56.
732 Bisphenol A effects on gene expression in adipocytes from children: association with metabolic disorders. J Mol Endocrinol. 2015 Jun;54(3):289-303.
733 A natural piper-amide-like compound NED-135 exhibits a potent inhibitory effect on the invasive breast cancer cells. Chem Biol Interact. 2015 Jul 25;237:58-65. doi: 10.1016/j.cbi.2015.05.006. Epub 2015 May 14.
734 Arsenic trioxide and cisplatin synergism increase cytotoxicity in human ovarian cancer cells: therapeutic potential for ovarian cancer. Cancer Sci. 2009 Dec;100(12):2459-64.
735 Abeta42-lowering nonsteroidal anti-inflammatory drugs preserve intramembrane cleavage of the amyloid precursor protein (APP) and ErbB-4 receptor and signaling through the APP intracellular domain. J Biol Chem. 2003 Aug 15;278(33):30748-54. doi: 10.1074/jbc.M304824200. Epub 2003 May 31.
736 The DNA damaging agent VP16 induces the expression of a subset of ligands from the EGF system in bladder cancer cells, whereas none of the four EGF receptors are induced. Mol Cell Biochem. 2004 May;260(1-2):129-35. doi: 10.1023/b:mcbi.0000026063.96267.98.
737 Exome-wide mutation profile in benzo[a]pyrene-derived post-stasis and immortal human mammary epithelial cells. Mutat Res Genet Toxicol Environ Mutagen. 2014 Dec;775-776:48-54. doi: 10.1016/j.mrgentox.2014.10.011. Epub 2014 Nov 4.
738 Inhibitory effects of cannabidiol on voltage-dependent sodium currents. J Biol Chem. 2018 Oct 26;293(43):16546-16558. doi: 10.1074/jbc.RA118.004929. Epub 2018 Sep 14.
739 The TTX metabolite 4,9-anhydro-TTX is a highly specific blocker of the Na(v1.6) voltage-dependent sodium channel. Am J Physiol Cell Physiol. 2007 Aug;293(2):C783-9.
740 Selenium is critical for cancer-signaling gene expression but not cell proliferation in human colon Caco-2 cells. Biofactors. 2007;31(3-4):155-64. doi: 10.1002/biof.5520310302.
741 Molecular basis for the induction of an angiogenesis inhibitor, thrombospondin-1, by 5-fluorouracil. Cancer Res. 2008 Sep 1;68(17):7035-41. doi: 10.1158/0008-5472.CAN-07-6496.
742 Nuclear proteomics with XRCC3 knockdown to reveal the development of doxorubicin-resistant uterine cancer. Toxicol Sci. 2014 Jun;139(2):396-406. doi: 10.1093/toxsci/kfu051. Epub 2014 Mar 27.
743 Low-dose Bisphenol A exposure alters the functionality and cellular environment in a human cardiomyocyte model. Environ Pollut. 2023 Oct 15;335:122359. doi: 10.1016/j.envpol.2023.122359. Epub 2023 Aug 9.
744 Linalool preferentially induces robust apoptosis of a variety of leukemia cells via upregulating p53 and cyclin-dependent kinase inhibitors. Toxicology. 2010 Jan 31;268(1-2):19-24. doi: 10.1016/j.tox.2009.11.013. Epub 2009 Nov 14.
745 Gene expression profile of the nucleus accumbens of human cocaine abusers: evidence for dysregulation of myelin. J Neurochem. 2004 Mar;88(5):1211-9. doi: 10.1046/j.1471-4159.2003.02247.x.
746 Effects of tobacco compounds on gene expression in fetal lung fibroblasts. Environ Toxicol. 2008 Aug;23(4):423-34.
747 The neurotrophin receptor TrkB cooperates with c-Met in enhancing neuroblastoma invasiveness. Carcinogenesis. 2005 Dec;26(12):2105-15. doi: 10.1093/carcin/bgi192. Epub 2005 Jul 28.
748 Distinctive profiles of gene expression in the human nucleus accumbens associated with cocaine and heroin abuse. Neuropsychopharmacology. 2006 Oct;31(10):2304-12. doi: 10.1038/sj.npp.1301089. Epub 2006 May 3.
749 Different pathways are involved in arsenic-trioxide-induced cell proliferation and growth inhibition in human keratinocytes. Skin Pharmacol Physiol. 2010;23(2):68-78. doi: 10.1159/000265677. Epub 2009 Dec 14.
750 Transcriptome and DNA methylation changes modulated by sulforaphane induce cell cycle arrest, apoptosis, DNA damage, and suppression of proliferation in human liver cancer cells. Food Chem Toxicol. 2020 Feb;136:111047. doi: 10.1016/j.fct.2019.111047. Epub 2019 Dec 12.
751 Susceptibility to natural killer cell-mediated lysis of colon cancer cells is enhanced by treatment with epidermal growth factor receptor inhibitors through UL16-binding protein-1 induction. Cancer Sci. 2012 Jan;103(1):7-16. doi: 10.1111/j.1349-7006.2011.02109.x. Epub 2011 Nov 15.
752 Induction of NKG2D ligands and subsequent enhancement of NK cell-mediated lysis of cancer cells by arsenic trioxide. J Immunother. 2008 Jun;31(5):475-86. doi: 10.1097/CJI.0b013e3181755deb.
753 Effects of folate deficiency on gene expression in the apoptosis and cancer pathways in colon cancer cells. Carcinogenesis. 2006 May;27(5):916-24. doi: 10.1093/carcin/bgi312. Epub 2005 Dec 16.
754 NF-kappa B regulates expression of the MHC class I-related chain A gene in activated T lymphocytes. J Immunol. 2004 Nov 1;173(9):5583-90. doi: 10.4049/jimmunol.173.9.5583.
755 Epidermal growth factor receptor signalling in human breast cancer cells operates parallel to estrogen receptor alpha signalling and results in tamoxifen insensitive proliferation. BMC Cancer. 2014 Apr 23;14:283.
756 Farnesol induces fatty acid oxidation and decreases triglyceride accumulation in steatotic HepaRG cells. Toxicol Appl Pharmacol. 2019 Feb 15;365:61-70.
757 Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine 2 phosphorylation in human CD4+ T cells. J Biol Chem. 2012 Dec 14;287(51):43137-55.
758 A genome-wide association study for irinotecan-related severe toxicities in patients with advanced non-small-cell lung cancer. Pharmacogenomics J. 2013 Oct;13(5):417-22. doi: 10.1038/tpj.2012.24. Epub 2012 Jun 5.
759 Identification of troglitazone responsive genes: induction of RTP801 during troglitazone-induced apoptosis in Hep 3B cells. BMB Rep. 2010 Sep;43(9):599-603. doi: 10.5483/BMBRep.2010.43.9.599.
760 Flavones and flavonols exert cytotoxic effects on a human oesophageal adenocarcinoma cell line (OE33) by causing G2/M arrest and inducing apoptosis. Food Chem Toxicol. 2008 Jun;46(6):2042-53. doi: 10.1016/j.fct.2008.01.049. Epub 2008 Feb 7.
761 The retinoid anticancer signal: mechanisms of target gene regulation. Br J Cancer. 2005 Aug 8;93(3):310-8. doi: 10.1038/sj.bjc.6602700.
762 Amifostine impairs p53-mediated apoptosis of human myeloid leukemia cells. Mol Cancer Ther. 2003 Sep;2(9):893-900.
763 Inhibition of fatty acid synthase expression by 1alpha,25-dihydroxyvitamin D3 in prostate cancer cells. J Steroid Biochem Mol Biol. 2003 May;85(1):1-8. doi: 10.1016/s0960-0760(03)00142-0.
764 Early Transcriptomic Changes upon Thalidomide Exposure Influence the Later Neuronal Development in Human Embryonic Stem Cell-Derived Spheres. Int J Mol Sci. 2020 Aug 3;21(15):5564. doi: 10.3390/ijms21155564.
765 PPARgamma controls CD1d expression by turning on retinoic acid synthesis in developing human dendritic cells. J Exp Med. 2006 Oct 2;203(10):2351-62.
766 Changes in gene expressions elicited by physiological concentrations of genistein on human endometrial cancer cells. Mol Carcinog. 2006 Oct;45(10):752-63.
767 GRAMD4 mimics p53 and mediates the apoptotic function of p73 at mitochondria. Cell Death Differ. 2011 May;18(5):874-86. doi: 10.1038/cdd.2010.153. Epub 2010 Dec 3.
768 Expression Profiling of Human Pluripotent Stem Cell-Derived Cardiomyocytes Exposed to Doxorubicin-Integration and Visualization of Multi-Omics Data. Toxicol Sci. 2018 May 1;163(1):182-195. doi: 10.1093/toxsci/kfy012.
769 Neurotoxicity and underlying cellular changes of 21 mitochondrial respiratory chain inhibitors. Arch Toxicol. 2021 Feb;95(2):591-615. doi: 10.1007/s00204-020-02970-5. Epub 2021 Jan 29.
770 [Association of a polymorphic marker Trp719Arg of KIF6 gene with effects of atorvastatin and simvastatin in patients with early ischemic heart disease]. Kardiologiia. 2011;51(9):4-12.
771 Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trials. J Am Coll Cardiol. 2008 Jan 29;51(4):435-43. doi: 10.1016/j.jacc.2007.05.057.
772 The Bromodomain Inhibitor JQ1 and the Histone Deacetylase Inhibitor Panobinostat Synergistically Reduce N-Myc Expression and Induce Anticancer Effects. Clin Cancer Res. 2016 May 15;22(10):2534-44. doi: 10.1158/1078-0432.CCR-15-1666. Epub 2016 Jan 5.
773 Effect of prenatal arsenic exposure on DNA methylation and leukocyte subpopulations in cord blood. Epigenetics. 2014 May;9(5):774-82. doi: 10.4161/epi.28153. Epub 2014 Feb 13.
774 Gene expression profile analysis of gallic acid-induced cell death process. Sci Rep. 2021 Aug 18;11(1):16743. doi: 10.1038/s41598-021-96174-1.
775 Fenfluramine-induced gene dysregulation in human pulmonary artery smooth muscle and endothelial cells. Pulm Circ. 2011 Jul-Sep;1(3):405-18. doi: 10.4103/2045-8932.87310.
776 Gene profiles of THP-1 macrophages after in vitro exposure to respiratory (non-)sensitizing chemicals: identification of discriminating genetic markers and pathway analysis. Toxicol In Vitro. 2009 Sep;23(6):1151-62. doi: 10.1016/j.tiv.2009.06.007. Epub 2009 Jun 13.
777 Monitoring of deiodinase deficiency based on transcriptomic responses in SH-SY5Y cells. Arch Toxicol. 2013 Jun;87(6):1103-13. doi: 10.1007/s00204-013-1018-4. Epub 2013 Feb 10.
778 Inhibition of CXCL12-mediated chemotaxis of Jurkat cells by direct immunotoxicants. Arch Toxicol. 2016 Jul;90(7):1685-94. doi: 10.1007/s00204-015-1585-7. Epub 2015 Aug 28.
779 Anti-oncogenic and pro-differentiation effects of clorgyline, a monoamine oxidase A inhibitor, on high grade prostate cancer cells. BMC Med Genomics. 2009 Aug 20;2:55. doi: 10.1186/1755-8794-2-55.
780 The genomic response of Ishikawa cells to bisphenol A exposure is dose- and time-dependent. Toxicology. 2010 Apr 11;270(2-3):137-49. doi: 10.1016/j.tox.2010.02.008. Epub 2010 Feb 17.
781 New insights into BaP-induced toxicity: role of major metabolites in transcriptomics and contribution to hepatocarcinogenesis. Arch Toxicol. 2016 Jun;90(6):1449-58.
782 In vitro assessment of drug-induced liver steatosis based on human dermal stem cell-derived hepatic cells. Arch Toxicol. 2016 Mar;90(3):677-89. doi: 10.1007/s00204-015-1483-z. Epub 2015 Feb 26.
783 Novel ATP-competitive Akt inhibitor afuresertib suppresses the proliferation of malignant pleural mesothelioma cells. Cancer Med. 2017 Nov;6(11):2646-2659. doi: 10.1002/cam4.1179. Epub 2017 Sep 27.
784 Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancer. Mol Oncol. 2011 Oct;5(5):438-53. doi: 10.1016/j.molonc.2011.07.003. Epub 2011 Jul 26.
785 Three epigenetic drugs up-regulate homeobox gene Rhox5 in cancer cells through overlapping and distinct molecular mechanisms. Mol Pharmacol. 2009 Nov;76(5):1072-81. doi: 10.1124/mol.109.056291. Epub 2009 Aug 13.
786 The genomic response of a human uterine endometrial adenocarcinoma cell line to 17alpha-ethynyl estradiol. Toxicol Sci. 2009 Jan;107(1):40-55.
787 Hypoxia-inducible factor-1 (HIF-1) pathway activation by quercetin in human lens epithelial cells. Exp Eye Res. 2009 Dec;89(6):995-1002. doi: 10.1016/j.exer.2009.08.011. Epub 2009 Sep 1.
788 White-to-brown metabolic conversion of human adipocytes by JAK inhibition. Nat Cell Biol. 2015 Jan;17(1):57-67. doi: 10.1038/ncb3075. Epub 2014 Dec 8.
789 Regulation of chromatin assembly and cell transformation by formaldehyde exposure in human cells. Environ Health Perspect. 2017 Sep 21;125(9):097019.
790 ST1926, a novel and orally active retinoid-related molecule inducing apoptosis in myeloid leukemia cells: modulation of intracellular calcium homeostasis. Blood. 2004 Jan 1;103(1):194-207.
791 Proteomic analysis of anti-cancer effects by paclitaxel treatment in cervical cancer cells. Gynecol Oncol. 2005 Jul;98(1):45-53. doi: 10.1016/j.ygyno.2005.04.010.
792 Examining the genomic influence of skin antioxidants in vitro. Mediators Inflamm. 2010;2010.
793 Contact allergen (PPD and DNCB)-induced keratinocyte sensitization is partly mediated through a low molecular weight hyaluronan (LMWHA)/TLR4/NF-B signaling axis. Toxicol Appl Pharmacol. 2019 Aug 15;377:114632. doi: 10.1016/j.taap.2019.114632. Epub 2019 Jun 19.
794 Effects of methyl paraben on skin keratinocytes. J Appl Toxicol. 2007 Jan-Feb;27(1):1-9. doi: 10.1002/jat.1176.
795 Differential gene expression in human hepatocyte cell lines exposed to the antiretroviral agent zidovudine. Arch Toxicol. 2014 Mar;88(3):609-23. doi: 10.1007/s00204-013-1169-3. Epub 2013 Nov 30.
796 Comparative Analysis of Transcriptomic Changes including mRNA and microRNA Expression Induced by the Xenoestrogens Zearalenone and Bisphenol A in Human Ovarian Cells. Toxins (Basel). 2023 Feb 9;15(2):140. doi: 10.3390/toxins15020140.
797 Inter- and intra-laboratory study to determine the reproducibility of toxicogenomics datasets. Toxicology. 2011 Nov 28;290(1):50-8.
798 Targeting MYCN in neuroblastoma by BET bromodomain inhibition. Cancer Discov. 2013 Mar;3(3):308-23.
799 Inhibiting ubiquitination causes an accumulation of SUMOylated newly synthesized nuclear proteins at PML bodies. J Biol Chem. 2019 Oct 18;294(42):15218-15234. doi: 10.1074/jbc.RA119.009147. Epub 2019 Jul 8.
800 Levonorgestrel enhances spermatogenesis suppression by testosterone with greater alteration in testicular gene expression in men. Biol Reprod. 2009 Mar;80(3):484-92.
801 Drinking-water arsenic exposure modulates gene expression in human lymphocytes from a U.S. population. Environ Health Perspect. 2008 Apr;116(4):524-31. doi: 10.1289/ehp.10861.
802 Clinical response to Nabiximols correlates with the downregulation of immune pathways in multiple sclerosis. Eur J Neurol. 2018 Jul;25(7):934-e70. doi: 10.1111/ene.13623. Epub 2018 Apr 16.
803 Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans. Pharmacogenomics J. 2014 Feb;14(1):35-40. doi: 10.1038/tpj.2013.3. Epub 2013 Feb 12.
804 Genetic and epigenetic changes in the common 1p36 deletion in neuroblastoma tumours. Br J Cancer. 2007 Nov 19;97(10):1416-24. doi: 10.1038/sj.bjc.6604032. Epub 2007 Oct 16.
805 Vanadium-induced HB-EGF expression in human lung fibroblasts is oxidant dependent and requires MAP kinases. Am J Physiol Lung Cell Mol Physiol. 2003 May;284(5):L774-82. doi: 10.1152/ajplung.00189.2002. Epub 2003 Jan 10.
806 Osmotic Induction of Angiogenic Growth Factor Expression in Human Retinal Pigment Epithelial Cells. PLoS One. 2016 Jan 22;11(1):e0147312. doi: 10.1371/journal.pone.0147312. eCollection 2016.
807 Endoplasmic reticulum stress contributes to arsenic trioxide-induced intrinsic apoptosis in human umbilical and bone marrow mesenchymal stem cells. Environ Toxicol. 2016 Mar;31(3):314-28.
808 Gene expression profiling of rheumatoid arthritis synovial cells treated with antirheumatic drugs. J Biomol Screen. 2007 Apr;12(3):328-40. doi: 10.1177/1087057107299261. Epub 2007 Mar 22.
809 Detection of the mechanism of immunotoxicity of cyclosporine A in murine in vitro and in vivo models. Arch Toxicol. 2015 Dec;89(12):2325-37. doi: 10.1007/s00204-014-1365-9. Epub 2014 Sep 17.
810 Gene expression responses reflecting 5-FU-induced toxicity: Comparison between patient colon tissue and 3D human colon organoids. Toxicol Lett. 2022 Dec 1;371:17-24. doi: 10.1016/j.toxlet.2022.09.013. Epub 2022 Sep 29.
811 Differential response of Mono Mac 6, BEAS-2B, and Jurkat cells to indoor dust. Environ Health Perspect. 2007 Sep;115(9):1325-32.
812 RBP4 disrupts vitamin A uptake homeostasis in a STRA6-deficient animal model for Matthew-Wood syndrome. Cell Metab. 2008 Mar;7(3):258-68. doi: 10.1016/j.cmet.2008.01.009.
813 Transcriptional responses to estrogen and progesterone in mammary gland identify networks regulating p53 activity. Endocrinology. 2008 Oct;149(10):4809-20. doi: 10.1210/en.2008-0035. Epub 2008 Jun 12.
814 Omics-based responses induced by bosentan in human hepatoma HepaRG cell cultures. Arch Toxicol. 2018 Jun;92(6):1939-1952.
815 Resveratrol inhibits pancreatic cancer cell proliferation through transcriptional induction of macrophage inhibitory cytokine-1. J Surg Res. 2007 Apr;138(2):163-9. doi: 10.1016/j.jss.2006.05.037. Epub 2007 Jan 25.
816 Substance dependence low-density whole genome association study in two distinct American populations. Hum Genet. 2008 Jun;123(5):495-506. doi: 10.1007/s00439-008-0501-0. Epub 2008 Apr 26.
817 Clomiphene citrate versus letrozole: molecular analysis of the endometrium in women with polycystic ovary syndrome. Fertil Steril. 2011 Oct;96(4):1051-6. doi: 10.1016/j.fertnstert.2011.07.1092.
818 Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling. J Exp Med. 2009 Mar 16;206(3):535-48. doi: 10.1084/jem.20082293. Epub 2009 Mar 9.
819 Induction of heme oxygenase-1 by cobalt protoporphyrin enhances the antitumour effect of bortezomib in adult T-cell leukaemia cells. Br J Cancer. 2007 Oct 22;97(8):1099-105. doi: 10.1038/sj.bjc.6604003. Epub 2007 Sep 25.
820 HCV RNA Activates APCs via TLR7/TLR8 While Virus Selectively Stimulates Macrophages Without Inducing Antiviral Responses. Sci Rep. 2016 Jul 7;6:29447. doi: 10.1038/srep29447.
821 Transcriptomics and methylomics of CD4-positive T cells in arsenic-exposed women. Arch Toxicol. 2017 May;91(5):2067-2078. doi: 10.1007/s00204-016-1879-4. Epub 2016 Nov 12.
822 Chloroquine modulates HIV-1-induced plasmacytoid dendritic cell alpha interferon: implication for T-cell activation. Antimicrob Agents Chemother. 2010 Feb;54(2):871-81. doi: 10.1128/AAC.01246-09. Epub 2009 Nov 30.
823 Association of Disrupted in Schizophrenia 1 (DISC1) missense variants with ultra-resistant schizophrenia. Pharmacogenomics J. 2011 Aug;11(4):267-73. doi: 10.1038/tpj.2010.40. Epub 2010 Jun 8.
824 Misassembly of full-length Disrupted-in-Schizophrenia 1 protein is linked to altered dopamine homeostasis and behavioral deficits. Mol Psychiatry. 2016 Nov;21(11):1561-1572. doi: 10.1038/mp.2015.194. Epub 2016 Jan 12.
825 Effect of benzo[a]pyrene on proliferation and metastasis of oral squamous cell carcinoma cells: A transcriptome analysis based on RNA-seq. Environ Toxicol. 2022 Nov;37(11):2589-2604. doi: 10.1002/tox.23621. Epub 2022 Jul 23.
826 Essential role of HDAC6 in the regulation of PD-L1 in?melanoma. Mol Oncol. 2016 May;10(5):735-750. doi: 10.1016/j.molonc.2015.12.012. Epub 2016 Jan 6.
827 Thalidomide suppresses angiogenesis and immune evasion via lncRNA FGD5-AS1/miR-454-3p/ZEB1 axis-mediated VEGFA expression and PD-1/PD-L1 checkpoint in NSCLC. Chem Biol Interact. 2021 Nov 1;349:109652. doi: 10.1016/j.cbi.2021.109652. Epub 2021 Sep 11.
828 CircRNA VIM silence synergizes with sevoflurane to inhibit immune escape and multiple oncogenic activities of esophageal cancer by simultaneously regulating miR-124/PD-L1 axis. Cell Biol Toxicol. 2022 Oct;38(5):825-845. doi: 10.1007/s10565-021-09613-0. Epub 2021 May 20.
829 Investigation of in vitro odonto/osteogenic capacity of cannabidiol on human dental pulp cell. J Dent. 2021 Jun;109:103673. doi: 10.1016/j.jdent.2021.103673. Epub 2021 Apr 16.
830 Simvastatin induces the odontogenic differentiation of human dental pulp stem cells in vitro and in vivo. J Endod. 2009 Mar;35(3):367-72. doi: 10.1016/j.joen.2008.11.024.
831 Stimulating effects of quercetin and phenamil on differentiation of human dental pulp cells. Eur J Oral Sci. 2013 Dec;121(6):559-65. doi: 10.1111/eos.12086. Epub 2013 Sep 17.
832 Glucosamine promotes osteogenic differentiation of dental pulp stem cells through modulating the level of the transforming growth factor-beta type I receptor. J Cell Physiol. 2010 Oct;225(1):140-51.
833 Dentin sialophosphoprotein (DSPP) gene-silencing inhibits key tumorigenic activities in human oral cancer cell line, OSC2. PLoS One. 2010 Nov 12;5(11):e13974. doi: 10.1371/journal.pone.0013974.
834 Activation of TRPV3 by Wood Smoke Particles and Roles in Pneumotoxicity. Chem Res Toxicol. 2018 May 21;31(5):291-301. doi: 10.1021/acs.chemrestox.7b00336. Epub 2018 Apr 30.
835 Clarifying off-target effects for torcetrapib using network pharmacology and reverse docking approach. BMC Syst Biol. 2012 Dec 10;6:152.
836 The potential effects of HECTD4 variants on fasting glucose and triglyceride levels in relation to prevalence of type 2 diabetes based on alcohol intake. Arch Toxicol. 2022 Sep;96(9):2487-2499. doi: 10.1007/s00204-022-03325-y. Epub 2022 Jun 17.
837 Pleiotropic combinatorial transcriptomes of human breast cancer cells exposed to mixtures of dietary phytoestrogens. Food Chem Toxicol. 2009 Apr;47(4):787-95.
838 Changes in gene expression profiles of multiple myeloma cells induced by arsenic trioxide (ATO): possible mechanisms to explain ATO resistance in vivo. Br J Haematol. 2005 Mar;128(5):636-44.